cid,chemical,atc_codes,disease,is_infectious,is_noncommunicable
PA166178312,(R)-methadone,,,0,1
PA166178312,(R)-methadone,,Opioid-Related Disorders,0,1
PA166178554,(S)-methadone,,,0,1
PA166247601,2-hydroxyatorvastatin,,,0,1
PA166131262,3-hydroxycotinine,,,0,1
PA166131242,3-hydroxycotinine glucuronide,,,0,1
PA131887008,"3,4-methylenedioxymethamphetamine",,,0,1
PA166131388,4-hydroxycyclophosphamide,,,0,1
PA166127652,4-hydroxytamoxifen,,,0,1
PA166131394,6-hydroxy r-warfarin,,,0,1
PA166131393,6-hydroxy s-warfarin,,,0,1
PA448004,abacavir,J05AF06;J05AR02;J05AR04;J05AR13,Drug Hypersensitivity,1,0
PA448004,abacavir,J05AF06;J05AR02;J05AR04;J05AR13,HIV Infections,1,0
PA448004,abacavir,J05AF06;J05AR02;J05AR04;J05AR13,,1,0
PA166153471,abemaciclib,L01EF03,,0,1
PA166123407,abiraterone,L02BX03,,0,1
PA166123407,abiraterone,L02BX03,Prostatic Neoplasms,0,1
PA166272921,abrocitinib,,,0,1
PA166104276,ABT-751,,Neoplasms,0,1
PA166104276,ABT-751,,,0,1
PA10344,acamprosate,N07BB03,Alcoholism,0,1
PA10344,acamprosate,N07BB03,,0,1
PA448010,acarbose,A10BD17;A10BF01,,0,1
PA164712308,"Ace Inhibitors, Plain",,Cough,0,1
PA164712308,"Ace Inhibitors, Plain",,Angioedema,0,1
PA164712308,"Ace Inhibitors, Plain",,,0,1
PA164712308,"Ace Inhibitors, Plain",,Heart Failure,0,1
PA164712308,"Ace Inhibitors, Plain",,Coronary Artery Disease,0,1
PA164712308,"Ace Inhibitors, Plain",,Hypertension,0,1
PA452632,acenocoumarol,B01AA07,,0,1
PA452632,acenocoumarol,B01AA07,Hemorrhage,0,1
PA452632,acenocoumarol,B01AA07,over-anticoagulation,0,1
PA452632,acenocoumarol,B01AA07,venous thromboembolism,0,1
PA452632,acenocoumarol,B01AA07,Atrial Fibrillation,0,1
PA166186245,acetaldehyde,,,0,1
PA448015,acetaminophen,N02AJ01;N02AJ06;N02AJ13;N02AJ17;N02BE01;N02BE51;N02BE71,severe cutaneous adverse reactions,0,1
PA448015,acetaminophen,N02AJ01;N02AJ06;N02AJ13;N02AJ17;N02BE01;N02BE51;N02BE71,Pain,0,1
PA448015,acetaminophen,N02AJ01;N02AJ06;N02AJ13;N02AJ17;N02BE01;N02BE51;N02BE71,neuropathic pain,0,1
PA448015,acetaminophen,N02AJ01;N02AJ06;N02AJ13;N02AJ17;N02BE01;N02BE51;N02BE71,,0,1
PA448015,acetaminophen,N02AJ01;N02AJ06;N02AJ13;N02AJ17;N02BE01;N02BE51;N02BE71,"Liver Failure, Acute",0,1
PA166246281,acetaminophen / caffeine / dihydrocodeine,,,0,1
PA166184061,acetaminophen / codeine,,,0,1
PA166184496,acetaminophen / tramadol,,,0,1
PA165983956,acetaminophen sulfate,,,0,1
PA448018,acetazolamide,G01AE10;S01EC01,Stevens-Johnson Syndrome,0,1
PA448031,acetylcholine,S01EB09,,0,1
PA448033,acetylcysteine,R05CB01;S01XA08;V03AB23,,0,1
PA448033,acetylcysteine,R05CB01;S01XA08;V03AB23,Pulmonary Fibrosis,0,1
PA448039,acitretin,D05BB02,,0,1
PA448045,acyclovir,D06BB03;D06BB53;J05AB01;S01AD03,,1,0
PA10004,adalimumab,L04AB04,"Arthritis, Rheumatoid",0,1
PA10004,adalimumab,L04AB04,Psoriasis,0,1
PA10004,adalimumab,L04AB04,Inflammatory Bowel Diseases,0,1
PA10004,adalimumab,L04AB04,"Arthritis, Psoriatic",0,1
PA10004,adalimumab,L04AB04,Crohn Disease,0,1
PA10004,adalimumab,L04AB04,,0,1
PA10005,adefovir dipivoxil,J05AF08,,1,0
PA10405,"adrenergics, inhalants",,,0,1
PA10405,"adrenergics, inhalants",,Asthma,0,1
PA165981154,afatinib,L01EB03,,0,1
PA166122586,afutuzumab,,,0,1
PA165958363,agomelatine,N06AX22,,0,1
PA165958363,agomelatine,N06AX22,Depressive Disorder,0,1
PA164712326,Aldosterone antagonists,,,0,1
PA166160050,alectinib,L01ED03,,0,1
PA164783958,alemtuzumab,L04AA34,"Leukemia, Lymphocytic, Chronic, B-Cell",0,1
PA164783958,alemtuzumab,L04AA34,,0,1
PA448082,alendronate,M05BA04;M05BB03;M05BB05;M05BB06,Osteoporosis,0,1
PA448082,alendronate,M05BA04;M05BB03;M05BB05;M05BB06,Bone Diseases,0,1
PA448082,alendronate,M05BA04;M05BB03;M05BB05;M05BB06,,0,1
PA448084,alfentanil,N01AH02,Pain,0,1
PA448084,alfentanil,N01AH02,,0,1
PA164754753,alglucosidase alfa,A16AB07,,0,1
PA166159961,alirocumab,,,0,1
PA143487910,aliskiren,C09DX02;C09XA02;C09XA52;C09XA53;C09XA54,,0,1
PA164712331,Alkylating Agents,,Neoplasms,0,1
PA164712331,Alkylating Agents,,,0,1
PA448320,allopurinol,M04AA01;M04AA51,,0,1
PA448320,allopurinol,M04AA01;M04AA51,Gout,0,1
PA448320,allopurinol,M04AA01;M04AA51,Drug Hypersensitivity,0,1
PA448320,allopurinol,M04AA01;M04AA51,Exanthema,0,1
PA448320,allopurinol,M04AA01;M04AA51,severe cutaneous adverse reactions,0,1
PA448320,allopurinol,M04AA01;M04AA51,Stevens-Johnson Syndrome,0,1
PA448320,allopurinol,M04AA01;M04AA51,drug reaction with eosinophilia and systemic symptoms,0,1
PA448320,allopurinol,M04AA01;M04AA51,"Epidermal Necrolysis, Toxic",0,1
C520853,Alogliptin,,,0,1
PA166184523,alpelisib,,,0,1
PA166177865,alpha-hydroxymetoprolol,,,0,1
PA448333,alprazolam,N05BA12,Alcoholism,0,1
PA448333,alprazolam,N05BA12,,0,1
PA448333,alprazolam,N05BA12,adverse events,0,1
PA448333,alprazolam,N05BA12,Anxiety Disorders,0,1
PA448360,amantadine,N04BB01,Parkinson Disease,0,1
PA448360,amantadine,N04BB01,,0,1
PA165860521,ambrisentan,C02KX02;C02KX52,,0,1
PA166185150,amifampridine,,,0,1
PA166182002,amifampridine phosphate,,,0,1
PA164744372,amikacin,D06AX12;J01GB06;J01RA06;S01AA21,Ototoxicity,1,0
PA448368,amiloride,C03DB01,Hypertension,0,1
PA448368,amiloride,C03DB01,,0,1
PA452167,aminoglycoside antibacterials,,Ototoxicity,1,0
PA452167,aminoglycoside antibacterials,,,1,0
PA448383,amiodarone,C01BD01,Long QT Syndrome,0,1
PA448383,amiodarone,C01BD01,Torsades de Pointes,0,1
PA448383,amiodarone,C01BD01,,0,1
PA162565877,amisulpride,N05AL05,schizoaffective disorder,0,1
PA162565877,amisulpride,N05AL05,Hypertriglyceridemia,0,1
PA162565877,amisulpride,N05AL05,Weight gain,0,1
PA162565877,amisulpride,N05AL05,,0,1
PA162565877,amisulpride,N05AL05,Schizophrenia,0,1
PA162565877,amisulpride,N05AL05,Bipolar Disorder,0,1
PA162565877,amisulpride,N05AL05,Psychotic Disorders,0,1
PA162565877,amisulpride,N05AL05,Depressive Disorder,0,1
PA448385,amitriptyline,N06AA09;N06CA01,Depressive Disorder,0,1
PA448385,amitriptyline,N06AA09;N06CA01,Depression,0,1
PA448385,amitriptyline,N06AA09;N06CA01,Mental Disorders,0,1
PA448385,amitriptyline,N06AA09;N06CA01,"Depressive Disorder, Major",0,1
PA448385,amitriptyline,N06AA09;N06CA01,,0,1
PA448388,amlodipine,C07FB07;C07FB12;C07FB13;C08CA01;C08CA51;C08GA02;C09BB03;C09BB04;C09BB07;C09BB13;C09BX01;C09BX03;C09BX04;C09DB01;C09DB02;C09DB04;C09DB05;C09DB06;C09DB07;C09DB09;C09DX01;C09DX03;C09DX06;C09DX07;C09DX08;C09XA53;C09XA54;C10BX03;C10BX07;C10BX09;C10BX11;C10BX14;C10BX18;C10BX19,Stroke,0,1
PA448388,amlodipine,C07FB07;C07FB12;C07FB13;C08CA01;C08CA51;C08GA02;C09BB03;C09BB04;C09BB07;C09BB13;C09BX01;C09BX03;C09BX04;C09DB01;C09DB02;C09DB04;C09DB05;C09DB06;C09DB07;C09DB09;C09DX01;C09DX03;C09DX06;C09DX07;C09DX08;C09XA53;C09XA54;C10BX03;C10BX07;C10BX09;C10BX11;C10BX14;C10BX18;C10BX19,Cardiovascular Diseases,0,1
PA448388,amlodipine,C07FB07;C07FB12;C07FB13;C08CA01;C08CA51;C08GA02;C09BB03;C09BB04;C09BB07;C09BB13;C09BX01;C09BX03;C09BX04;C09DB01;C09DB02;C09DB04;C09DB05;C09DB06;C09DB07;C09DB09;C09DX01;C09DX03;C09DX06;C09DX07;C09DX08;C09XA53;C09XA54;C10BX03;C10BX07;C10BX09;C10BX11;C10BX14;C10BX18;C10BX19,,0,1
PA448388,amlodipine,C07FB07;C07FB12;C07FB13;C08CA01;C08CA51;C08GA02;C09BB03;C09BB04;C09BB07;C09BB13;C09BX01;C09BX03;C09BX04;C09DB01;C09DB02;C09DB04;C09DB05;C09DB06;C09DB07;C09DB09;C09DX01;C09DX03;C09DX06;C09DX07;C09DX08;C09XA53;C09XA54;C10BX03;C10BX07;C10BX09;C10BX11;C10BX14;C10BX18;C10BX19,Coronary Disease,0,1
PA448388,amlodipine,C07FB07;C07FB12;C07FB13;C08CA01;C08CA51;C08GA02;C09BB03;C09BB04;C09BB07;C09BB13;C09BX01;C09BX03;C09BX04;C09DB01;C09DB02;C09DB04;C09DB05;C09DB06;C09DB07;C09DB09;C09DX01;C09DX03;C09DX06;C09DX07;C09DX08;C09XA53;C09XA54;C10BX03;C10BX07;C10BX09;C10BX11;C10BX14;C10BX18;C10BX19,Hypertension,0,1
PA166183785,amlodipine / atorvastatin / perindopril arginine,,,0,1
PA448404,amodiaquine,P01BA06;P01BF03,,1,0
PA448404,amodiaquine,P01BA06;P01BF03,"Malaria, Falciparum",1,0
PA448404,amodiaquine,P01BA06;P01BF03,Malaria,1,0
PA448405,amoxapine,N06AA17,,0,1
PA448406,amoxicillin,A02BD01;A02BD03;A02BD04;A02BD05;A02BD06;A02BD07;A02BD10;A02BD11;A02BD12;A02BD13;A02BD14;A02BD15;A02BD16;J01CA04;J01CR50,,1,0
PA448406,amoxicillin,A02BD01;A02BD03;A02BD04;A02BD05;A02BD06;A02BD07;A02BD10;A02BD11;A02BD12;A02BD13;A02BD14;A02BD15;A02BD16;J01CA04;J01CR50,Drug Toxicity,1,0
PA448408,amphetamine,N06BA01,Substance-Related Disorders,0,1
PA448408,amphetamine,N06BA01,,0,1
PA448419,ampicillin,J01CA01;J01CA51;J01CR50;S01AA19,,1,0
PA448422,amprenavir,J05AE05,HIV Infections,1,0
PA448422,amprenavir,J05AE05,,1,0
PA10799,anakinra,L04AC03,,0,1
PA164712362,Analgesics,,Pain,0,1
PA164712362,Analgesics,,Substance Withdrawal Syndrome,0,1
PA164712362,Analgesics,,,0,1
PA164712363,Analgesics and anesthetics,,,0,1
PA448432,anastrozole,L02BG03,,0,1
PA448432,anastrozole,L02BG03,Arthralgia,0,1
PA448432,anastrozole,L02BG03,Breast Neoplasms,0,1
PA448432,anastrozole,L02BG03,Neoplasms,0,1
PA166109554,angiotensin II,,,0,1
PA164712372,Angiotensin II Antagonists,,Heart Failure,0,1
PA164712372,Angiotensin II Antagonists,,,0,1
PA166277641,anifrolumab,,,0,1
PA130620651,anthracyclines and related substances,,,0,1
PA130620651,anthracyclines and related substances,,Neoplasms,0,1
PA130620651,anthracyclines and related substances,,Heart Failure,0,1
PA130620651,anthracyclines and related substances,,Ovarian Neoplasms,0,1
PA130620651,anthracyclines and related substances,,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0,1
PA130620651,anthracyclines and related substances,,Stomach Neoplasms,0,1
PA130620651,anthracyclines and related substances,,Cardiomyopathies,0,1
PA130620651,anthracyclines and related substances,,Breast Neoplasms,0,1
PA130620651,anthracyclines and related substances,,cardiotoxicity,0,1
PA164712397,Antiandrogens,,,0,1
PA452249,"antiarrhythmics, class i and iii",,,0,1
PA164712406,Antibiotics,,Hypersensitivity,1,0
PA164712406,Antibiotics,,,1,0
PA164712419,Anticholinergic Agents,,,0,1
PA164712420,Anticholinergics,,,0,1
PA164712420,Anticholinergics,,Parkinson Disease,0,1
PA452229,antidepressants,,Bipolar Disorder,0,1
PA452229,antidepressants,,Respiratory Insufficiency,0,1
PA452229,antidepressants,,Migraine with Aura,0,1
PA452229,antidepressants,,Overdose,0,1
PA452229,antidepressants,,Headache Disorders,0,1
PA452229,antidepressants,,Depressive Disorder,0,1
PA452229,antidepressants,,,0,1
PA452229,antidepressants,,adverse events,0,1
PA452229,antidepressants,,Depression,0,1
PA452229,antidepressants,,Mood Disorders,0,1
PA452229,antidepressants,,Heart Arrest,0,1
PA452229,antidepressants,,"Depressive Disorder, Major",0,1
PA452229,antidepressants,,Migraine without Aura,0,1
PA143485705,antiepileptics,,Maculopapular Exanthema,0,1
PA143485705,antiepileptics,,severe cutaneous adverse reactions,0,1
PA143485705,antiepileptics,,"Epilepsy, Generalized",0,1
PA143485705,antiepileptics,,Epilepsy,0,1
PA143485705,antiepileptics,,Schizophrenia,0,1
PA143485705,antiepileptics,,"Epidermal Necrolysis, Toxic",0,1
PA143485705,antiepileptics,,Psychotic Disorders,0,1
PA143485705,antiepileptics,,Headache Disorders,0,1
PA143485705,antiepileptics,,Migraine with Aura,0,1
PA143485705,antiepileptics,,"Epilepsies, Partial",0,1
PA143485705,antiepileptics,,Stevens-Johnson Syndrome,0,1
PA143485705,antiepileptics,,Migraine without Aura,0,1
PA143485705,antiepileptics,,,0,1
PA164712435,Antifungals For Systemic Use,,,1,0
PA164712445,Antihypertensives,,Coronary Artery Disease,0,1
PA164712445,Antihypertensives,,Heart Diseases,0,1
PA164712445,Antihypertensives,,Hypertension,0,1
PA164712445,Antihypertensives,,,0,1
PA164712446,Antihypertensives And Diuretics In Combination,,Hypertension,0,1
PA164712446,Antihypertensives And Diuretics In Combination,,,0,1
PA164712462,"Antiinflammatory agents, non-steroids",,Substance Withdrawal Syndrome,0,1
PA164712462,"Antiinflammatory agents, non-steroids",,anaphylactoid reaction,0,1
PA164712462,"Antiinflammatory agents, non-steroids",,Colorectal Neoplasms,0,1
PA164712462,"Antiinflammatory agents, non-steroids",,Acute coronary syndrome,0,1
PA164712462,"Antiinflammatory agents, non-steroids",,,0,1
PA10384,"antiinflammatory and antirheumatic products, non-steroids",,,0,1
PA164712471,Antimycobacterials,,,1,0
PA452621,antineoplastic agents,,Pancreatic Neoplasms,0,1
PA452621,antineoplastic agents,,Breast Neoplasms,0,1
PA452621,antineoplastic agents,,Neoplasms,0,1
PA452621,antineoplastic agents,,Drug Toxicity,0,1
PA452621,antineoplastic agents,,,0,1
PA452233,antipsychotics,,Overdose,0,1
PA452233,antipsychotics,,Weight gain,0,1
PA452233,antipsychotics,,Heart Arrest,0,1
PA452233,antipsychotics,,,0,1
PA452233,antipsychotics,,tardive dyskinesia,0,1
PA452233,antipsychotics,,Schizophrenia,0,1
PA452233,antipsychotics,,Respiratory Insufficiency,0,1
PA452233,antipsychotics,,Psychotic Disorders,0,1
PA452233,antipsychotics,,Autism Spectrum Disorder,0,1
PA452233,antipsychotics,,Mood Disorders,0,1
PA452233,antipsychotics,,Mental Disorders,0,1
PA452233,antipsychotics,,Dystonia,0,1
PA452200,antithrombotic agents,,,0,1
PA164743704,antithymocyte globulin,L04AA04,,0,1
PA164743704,antithymocyte globulin,L04AA04,Kidney Transplantation,0,1
PA164712499,Antithyroid Preparations,,,0,1
PA164712499,Antithyroid Preparations,,Agranulocytosis,0,1
PA164712499,Antithyroid Preparations,,Graves Disease,0,1
PA164712505,"Antivirals for treatment of HIV infections, combinations",,Hypertriglyceridemia,1,0
PA164712505,"Antivirals for treatment of HIV infections, combinations",,Hyperlipidemias,1,0
PA164712505,"Antivirals for treatment of HIV infections, combinations",,drug-induced liver injury,1,0
PA164712505,"Antivirals for treatment of HIV infections, combinations",,HIV Infections,1,0
PA164712505,"Antivirals for treatment of HIV infections, combinations",,Tuberculosis,1,0
PA164712505,"Antivirals for treatment of HIV infections, combinations",,,1,0
PA166163740,apixaban,B01AF02,,0,1
PA166163740,apixaban,B01AF02,Atrial Fibrillation,0,1
PA164781163,apomorphine,G04BE07;N04BC07,,0,1
PA166180985,ara-CTP,,,0,1
PA164743977,arformoterol,,,0,1
PA10026,aripiprazole,N05AX12,Bipolar Disorder,0,1
PA10026,aripiprazole,N05AX12,Depressive Disorder,0,1
PA10026,aripiprazole,N05AX12,schizoaffective disorder,0,1
PA10026,aripiprazole,N05AX12,Weight gain,0,1
PA10026,aripiprazole,N05AX12,Schizophrenia,0,1
PA10026,aripiprazole,N05AX12,Psychomotor Agitation,0,1
PA10026,aripiprazole,N05AX12,Psychotic Disorders,0,1
PA10026,aripiprazole,N05AX12,Autism Spectrum Disorder,0,1
PA10026,aripiprazole,N05AX12,,0,1
PA166161216,aripiprazole lauroxil,,,0,1
PA164712509,Arsenic compounds,,,0,1
PA448486,arsenic trioxide,L01XX27,,0,1
PA452638,arsenite,,,0,1
PA165111698,artemether,P01BE02;P01BF01,,1,0
PA165111696,artemisinin,P01BE01;P01BF07;P01BF08,,1,0
PA165111697,artesunate,,,1,0
PA165111697,artesunate,,Malaria,1,0
PA166182783,articaine / epinephrine,,,0,1
PA166268841,asciminib,L01EA06,,0,1
PA448492,asparaginase,L01XX02,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0,1
PA448492,asparaginase,L01XX02,Pancreatitis,0,1
PA448492,asparaginase,L01XX02,,0,1
PA448497,aspirin,A01AD05;B01AC06;B01AC56;C07FX02;C07FX03;C07FX04;C10BX01;C10BX02;C10BX04;C10BX05;C10BX06;C10BX08;C10BX12;M01BA03;N02AJ02;N02AJ07;N02AJ18;N02BA01;N02BA51;N02BA71,Colonic Neoplasms,0,1
PA448497,aspirin,A01AD05;B01AC06;B01AC56;C07FX02;C07FX03;C07FX04;C10BX01;C10BX02;C10BX04;C10BX05;C10BX06;C10BX08;C10BX12;M01BA03;N02AJ02;N02AJ07;N02AJ18;N02BA01;N02BA51;N02BA71,major adverse cardiac events (mace),0,1
PA448497,aspirin,A01AD05;B01AC06;B01AC56;C07FX02;C07FX03;C07FX04;C10BX01;C10BX02;C10BX04;C10BX05;C10BX06;C10BX08;C10BX12;M01BA03;N02AJ02;N02AJ07;N02AJ18;N02BA01;N02BA51;N02BA71,adverse events,0,1
PA448497,aspirin,A01AD05;B01AC06;B01AC56;C07FX02;C07FX03;C07FX04;C10BX01;C10BX02;C10BX04;C10BX05;C10BX06;C10BX08;C10BX12;M01BA03;N02AJ02;N02AJ07;N02AJ18;N02BA01;N02BA51;N02BA71,Coronary Artery Disease,0,1
PA448497,aspirin,A01AD05;B01AC06;B01AC56;C07FX02;C07FX03;C07FX04;C10BX01;C10BX02;C10BX04;C10BX05;C10BX06;C10BX08;C10BX12;M01BA03;N02AJ02;N02AJ07;N02AJ18;N02BA01;N02BA51;N02BA71,Acute coronary syndrome,0,1
PA448497,aspirin,A01AD05;B01AC06;B01AC56;C07FX02;C07FX03;C07FX04;C10BX01;C10BX02;C10BX04;C10BX05;C10BX06;C10BX08;C10BX12;M01BA03;N02AJ02;N02AJ07;N02AJ18;N02BA01;N02BA51;N02BA71,"Diabetes Mellitus, Type 2",0,1
PA448497,aspirin,A01AD05;B01AC06;B01AC56;C07FX02;C07FX03;C07FX04;C10BX01;C10BX02;C10BX04;C10BX05;C10BX06;C10BX08;C10BX12;M01BA03;N02AJ02;N02AJ07;N02AJ18;N02BA01;N02BA51;N02BA71,Asthma,0,1
PA448497,aspirin,A01AD05;B01AC06;B01AC56;C07FX02;C07FX03;C07FX04;C10BX01;C10BX02;C10BX04;C10BX05;C10BX06;C10BX08;C10BX12;M01BA03;N02AJ02;N02AJ07;N02AJ18;N02BA01;N02BA51;N02BA71,Urticaria,0,1
PA448497,aspirin,A01AD05;B01AC06;B01AC56;C07FX02;C07FX03;C07FX04;C10BX01;C10BX02;C10BX04;C10BX05;C10BX06;C10BX08;C10BX12;M01BA03;N02AJ02;N02AJ07;N02AJ18;N02BA01;N02BA51;N02BA71,,0,1
PA448497,aspirin,A01AD05;B01AC06;B01AC56;C07FX02;C07FX03;C07FX04;C10BX01;C10BX02;C10BX04;C10BX05;C10BX06;C10BX08;C10BX12;M01BA03;N02AJ02;N02AJ07;N02AJ18;N02BA01;N02BA51;N02BA71,Hemolysis,0,1
PA448497,aspirin,A01AD05;B01AC06;B01AC56;C07FX02;C07FX03;C07FX04;C10BX01;C10BX02;C10BX04;C10BX05;C10BX06;C10BX08;C10BX12;M01BA03;N02AJ02;N02AJ07;N02AJ18;N02BA01;N02BA51;N02BA71,Prostatic Neoplasms,0,1
PA448497,aspirin,A01AD05;B01AC06;B01AC56;C07FX02;C07FX03;C07FX04;C10BX01;C10BX02;C10BX04;C10BX05;C10BX06;C10BX08;C10BX12;M01BA03;N02AJ02;N02AJ07;N02AJ18;N02BA01;N02BA51;N02BA71,Myocardial Infarction,0,1
PA448497,aspirin,A01AD05;B01AC06;B01AC56;C07FX02;C07FX03;C07FX04;C10BX01;C10BX02;C10BX04;C10BX05;C10BX06;C10BX08;C10BX12;M01BA03;N02AJ02;N02AJ07;N02AJ18;N02BA01;N02BA51;N02BA71,aspirin-induced asthma,0,1
PA448497,aspirin,A01AD05;B01AC06;B01AC56;C07FX02;C07FX03;C07FX04;C10BX01;C10BX02;C10BX04;C10BX05;C10BX06;C10BX08;C10BX12;M01BA03;N02AJ02;N02AJ07;N02AJ18;N02BA01;N02BA51;N02BA71,Colorectal Neoplasms,0,1
PA448497,aspirin,A01AD05;B01AC06;B01AC56;C07FX02;C07FX03;C07FX04;C10BX01;C10BX02;C10BX04;C10BX05;C10BX06;C10BX08;C10BX12;M01BA03;N02AJ02;N02AJ07;N02AJ18;N02BA01;N02BA51;N02BA71,Coronary Disease,0,1
PA448497,aspirin,A01AD05;B01AC06;B01AC56;C07FX02;C07FX03;C07FX04;C10BX01;C10BX02;C10BX04;C10BX05;C10BX06;C10BX08;C10BX12;M01BA03;N02AJ02;N02AJ07;N02AJ18;N02BA01;N02BA51;N02BA71,Peptic Ulcer,0,1
PA166128168,asunaprevir,J05AP06;J05AP58,,1,0
PA166151864,ataluren,M09AX03,Cystic Fibrosis,0,1
PA166151864,ataluren,M09AX03,,0,1
PA10251,atazanavir,J05AE08;J05AR15;J05AR23,,1,0
PA10251,atazanavir,J05AE08;J05AR15;J05AR23,HIV Infections,1,0
PA10251,atazanavir,J05AE08;J05AR15;J05AR23,nephrolithiasis,1,0
PA10251,atazanavir,J05AE08;J05AR15;J05AR23,Acquired Immunodeficiency Syndrome,1,0
PA10251,atazanavir,J05AE08;J05AR15;J05AR23,Hyperbilirubinemia,1,0
PA166182624,atazanavir / ritonavir,,,1,0
PA166182624,atazanavir / ritonavir,,Hyperbilirubinemia,1,0
PA166182624,atazanavir / ritonavir,,HIV Infections,1,0
PA448499,atenolol,C07AB03;C07BB03;C07CB03;C07CB53;C07DB01;C07FB03,Tachycardia,0,1
PA448499,atenolol,C07AB03;C07BB03;C07CB03;C07CB53;C07DB01;C07FB03,,0,1
PA448499,atenolol,C07AB03;C07BB03;C07CB03;C07CB53;C07DB01;C07FB03,Coronary Artery Disease,0,1
PA448499,atenolol,C07AB03;C07BB03;C07CB03;C07CB53;C07DB01;C07FB03,Diabetes Mellitus,0,1
PA448499,atenolol,C07AB03;C07BB03;C07CB03;C07CB53;C07DB01;C07FB03,Essential hypertension,0,1
PA448499,atenolol,C07AB03;C07BB03;C07CB03;C07CB53;C07DB01;C07FB03,"Hypertrophy, Left Ventricular",0,1
PA448499,atenolol,C07AB03;C07BB03;C07CB03;C07CB53;C07DB01;C07FB03,Hyperglycemia,0,1
PA448499,atenolol,C07AB03;C07BB03;C07CB03;C07CB53;C07DB01;C07FB03,Hypertension,0,1
PA166129523,atezolizumab,,,0,1
PA134688071,atomoxetine,N06BA09,,0,1
PA134688071,atomoxetine,N06BA09,Attention Deficit Disorder with Hyperactivity,0,1
PA448500,atorvastatin,C10AA05;C10BA05;C10BX03;C10BX06;C10BX08;C10BX11;C10BX12;C10BX15;C10BX18;C10BX19,Hyperlipidemias,0,1
PA448500,atorvastatin,C10AA05;C10BA05;C10BX03;C10BX06;C10BX08;C10BX11;C10BX12;C10BX15;C10BX18;C10BX19,Coronary Artery Disease,0,1
PA448500,atorvastatin,C10AA05;C10BA05;C10BX03;C10BX06;C10BX08;C10BX11;C10BX12;C10BX15;C10BX18;C10BX19,Myocardial Infarction,0,1
PA448500,atorvastatin,C10AA05;C10BA05;C10BX03;C10BX06;C10BX08;C10BX11;C10BX12;C10BX15;C10BX18;C10BX19,statin-related myopathy,0,1
PA448500,atorvastatin,C10AA05;C10BA05;C10BX03;C10BX06;C10BX08;C10BX11;C10BX12;C10BX15;C10BX18;C10BX19,Hypercholesterolemia,0,1
PA448500,atorvastatin,C10AA05;C10BA05;C10BX03;C10BX06;C10BX08;C10BX11;C10BX12;C10BX15;C10BX18;C10BX19,familial hypercholesterolemia,0,1
PA448500,atorvastatin,C10AA05;C10BA05;C10BX03;C10BX06;C10BX08;C10BX11;C10BX12;C10BX15;C10BX18;C10BX19,Myalgia unspecified,0,1
PA448500,atorvastatin,C10AA05;C10BA05;C10BX03;C10BX06;C10BX08;C10BX11;C10BX12;C10BX15;C10BX18;C10BX19,Acute coronary syndrome,0,1
PA448500,atorvastatin,C10AA05;C10BA05;C10BX03;C10BX06;C10BX08;C10BX11;C10BX12;C10BX15;C10BX18;C10BX19,Osteoporosis,0,1
PA448500,atorvastatin,C10AA05;C10BA05;C10BX03;C10BX06;C10BX08;C10BX11;C10BX12;C10BX15;C10BX18;C10BX19,Cardiovascular Diseases,0,1
PA448500,atorvastatin,C10AA05;C10BA05;C10BX03;C10BX06;C10BX08;C10BX11;C10BX12;C10BX15;C10BX18;C10BX19,Coronary Disease,0,1
PA448500,atorvastatin,C10AA05;C10BA05;C10BX03;C10BX06;C10BX08;C10BX11;C10BX12;C10BX15;C10BX18;C10BX19,Hyperlipoproteinemia Type II,0,1
PA448500,atorvastatin,C10AA05;C10BA05;C10BX03;C10BX06;C10BX08;C10BX11;C10BX12;C10BX15;C10BX18;C10BX19,Muscular Diseases,0,1
PA448500,atorvastatin,C10AA05;C10BA05;C10BX03;C10BX06;C10BX08;C10BX11;C10BX12;C10BX15;C10BX18;C10BX19,,0,1
PA448502,atovaquone,P01AX06;P01BB51,,1,0
PA143414738,atrasentan,,,0,1
PA448505,atropine,A03BA01;A03CB03;S01FA01,,0,1
PA166223903,avapritinib,,,0,1
PA166179849,avatrombopag,,,0,1
PA166169875,avelumab,,,0,1
PA164924493,axitinib,L01EK01,,0,1
PA451996,azacitidine,L01BC07,,0,1
PA448515,azathioprine,L04AX01,Crohn Disease,0,1
PA448515,azathioprine,L04AX01,Pancytopenia,0,1
PA448515,azathioprine,L04AX01,Drug Toxicity,0,1
PA448515,azathioprine,L04AX01,Myelosuppression,0,1
PA448515,azathioprine,L04AX01,"Colitis, Ulcerative",0,1
PA448515,azathioprine,L04AX01,,0,1
PA448515,azathioprine,L04AX01,Neutropenia,0,1
PA448515,azathioprine,L04AX01,Pancreatitis,0,1
PA448515,azathioprine,L04AX01,Irritable Bowel Syndrome,0,1
PA448515,azathioprine,L04AX01,Inflammatory Bowel Diseases,0,1
PA448515,azathioprine,L04AX01,Transplantation,0,1
PA448515,azathioprine,L04AX01,Leukopenia,0,1
PA448515,azathioprine,L04AX01,"Lupus Erythematosus, Systemic",0,1
PA448515,azathioprine,L04AX01,Thrombocytopenia,0,1
PA448515,azathioprine,L04AX01,dose reduction,0,1
PA448519,azithromycin,J01FA10;J01RA07;J01RA16;S01AA26,,1,0
PA164745461,bacampicillin,J01CA06;J01CR50,,1,0
PA166220606,bazedoxifene,,,0,1
PA448547,beclomethasone,A07EA07;D07AC15;D07CC04;R01AD01;R03AK08;R03AK13;R03AL09;R03BA01,,0,1
PA166114904,belimumab,,,0,1
PA165971474,belinostat,,,0,1
PA166268761,belzutifan,L01XX74,,0,1
PA448561,benazepril,C09AA07;C09BA07;C09BB13,Diabetes Mellitus,0,1
PA448561,benazepril,C09AA07;C09BA07;C09BB13,Hypertension,0,1
PA448561,benazepril,C09AA07;C09BA07;C09BB13,,0,1
PA448561,benazepril,C09AA07;C09BA07;C09BB13,Essential hypertension,0,1
PA134852920,benzbromarone,,,0,1
PA451991,benzene,,,0,1
PA10402,benzodiazepine derivatives,,Respiratory Insufficiency,0,1
PA10402,benzodiazepine derivatives,,Overdose,0,1
PA10402,benzodiazepine derivatives,,Heart Arrest,0,1
PA10402,benzodiazepine derivatives,,"Depressive Disorder, Major",0,1
PA10402,benzodiazepine derivatives,,,0,1
PA164754755,bepridil,C08EA02,,0,1
PA165860812,berberine,,,0,1
PA164712535,Beta Blocking Agents,,Coronary Artery Disease,0,1
PA164712535,Beta Blocking Agents,,Heart Diseases,0,1
PA164712535,Beta Blocking Agents,,Coronary Disease,0,1
PA164712535,Beta Blocking Agents,,,0,1
PA164712535,Beta Blocking Agents,,major adverse cardiac events (mace),0,1
PA164712535,Beta Blocking Agents,,Migraine with Aura,0,1
PA164712535,Beta Blocking Agents,,Death,0,1
PA164712535,Beta Blocking Agents,,Migraine without Aura,0,1
PA164712535,Beta Blocking Agents,,"Cardiomyopathy, Dilated",0,1
PA164712535,Beta Blocking Agents,,Headache Disorders,0,1
PA164712535,Beta Blocking Agents,,Heart Failure,0,1
PA164712547,"Beta blocking agents, selective",,,0,1
PA164712547,"Beta blocking agents, selective",,Hypertension,0,1
PA164754818,betamethasone,A07EA04;C05AA05;D07AC01;D07BC01;D07CC01;D07XC01;H02AB01;R01AD06;R03BA04;S01BA06;S01BB04;S01CA05;S01CB04;S02BA07;S03BA03;S03CA06,,0,1
PA130232992,bevacizumab,L01FG01;S01LA08,Breast Neoplasms,0,1
PA130232992,bevacizumab,L01FG01;S01LA08,Neoplasms,0,1
PA130232992,bevacizumab,L01FG01;S01LA08,Hypertension,0,1
PA130232992,bevacizumab,L01FG01;S01LA08,"Carcinoma, Non-Small-Cell Lung",0,1
PA130232992,bevacizumab,L01FG01;S01LA08,,0,1
PA130232992,bevacizumab,L01FG01;S01LA08,Colorectal Neoplasms,0,1
PA130232992,bevacizumab,L01FG01;S01LA08,Macular Degeneration,0,1
PA130232992,bevacizumab,L01FG01;S01LA08,Choroidal Neovascularization,0,1
PA162364313,bezafibrate,C10AB02,,0,1
C000620396,Bictegravir,,,1,0
PA166123346,bilirubin,,Colorectal Neoplasms,0,1
PA166123346,bilirubin,,,0,1
PA166179867,binimetinib,L01EE03,,0,1
PA448641,bisoprolol,C07AB07;C07BB07;C07FB07;C07FX04;C09BX02;C09BX04;C09BX05,Hypertension,0,1
PA448641,bisoprolol,C07AB07;C07BB07;C07FB07;C07FX04;C09BX02;C09BX04;C09BX05,,0,1
PA166184057,bisoprolol fumarate / perindopril arginine,,,0,1
PA164712563,Bisphosphonates,,Osteoporosis,0,1
PA164712563,Bisphosphonates,,Osteonecrosis,0,1
PA164712563,Bisphosphonates,,,0,1
PA164712563,Bisphosphonates,,Multiple Myeloma,0,1
PA164712563,Bisphosphonates,,"Osteoporosis, Postmenopausal",0,1
PA164712563,Bisphosphonates,,osteonecrosis of jaw caused by drug,0,1
PA164712563,Bisphosphonates,,Osteitis Deformans,0,1
PA164712563,Bisphosphonates,,Coronary Disease,0,1
PA448645,bleomycin,L01DC01,"Lymphoma, Non-Hodgkin",0,1
PA448645,bleomycin,L01DC01,Leukopenia,0,1
PA448645,bleomycin,L01DC01,Pain,0,1
PA448645,bleomycin,L01DC01,,0,1
PA448645,bleomycin,L01DC01,Infection,0,1
PA448645,bleomycin,L01DC01,Nausea,0,1
PA448645,bleomycin,L01DC01,Vomiting,0,1
PA448645,bleomycin,L01DC01,febrile neutropenia,0,1
PA448645,bleomycin,L01DC01,Anemia,0,1
PA448645,bleomycin,L01DC01,Testicular Neoplasms,0,1
PA448645,bleomycin,L01DC01,Alopecia,0,1
PA166129524,blinatumomab,,,0,1
PA165948902,boceprevir,J05AP03,,1,0
PA165948902,boceprevir,J05AP03,"Hepatitis C, Chronic",1,0
PA10252,bortezomib,L01XG01,,0,1
PA10034,bosentan,C02KX01;G01AE10,,0,1
PA166114906,bosutinib,,,0,1
PA164754825,botulinum toxin type a,M03AX01,,0,1
PA164754825,botulinum toxin type a,M03AX01,Migraine NOS,0,1
PA165948903,brentuximab vedotin,,,0,1
PA166160053,brexpiprazole,N05AX16,,0,1
PA166163482,brigatinib,L01ED04,,0,1
PA166153491,brivaracetam,N03AX23,,0,1
PA165282097,bromperidol,,,0,1
PA165282097,bromperidol,,Schizophrenia,0,1
PA166123566,bucillamine,M01CC02,,0,1
PA165945764,bucindolol,,Heart Failure,0,1
PA165945764,bucindolol,,,0,1
PA448681,budesonide,A07EA06;D07AC09;R01AD05;R03AK07;R03AK12;R03AL11;R03BA02,Asthma,0,1
PA448681,budesonide,A07EA06;D07AC09;R01AD05;R03AK07;R03AK12;R03AL11;R03BA02,,0,1
PA166110256,bufuralol,,,0,1
PA448682,bumetanide,C03CA02;C03CB02;C03EB02;G01AE10,,0,1
PA135057240,bupivacaine,N01BB01;N01BB51;N01BB59,,0,1
PA448685,buprenorphine,N02AE01;N07BC01;N07BC51,Neonatal Abstinence Syndrome,0,1
PA448685,buprenorphine,N02AE01;N07BC01;N07BC51,,0,1
PA448685,buprenorphine,N02AE01;N07BC01;N07BC51,Exanthema,0,1
PA448685,buprenorphine,N02AE01;N07BC01;N07BC51,"Sexual Dysfunctions, Psychological",0,1
PA448685,buprenorphine,N02AE01;N07BC01;N07BC51,adverse events,0,1
PA448685,buprenorphine,N02AE01;N07BC01;N07BC51,Pain,0,1
PA448685,buprenorphine,N02AE01;N07BC01;N07BC51,Opioid-Related Disorders,0,1
PA166182641,buprenorphine / naloxone,,Opioid-Related Disorders,0,1
PA448687,bupropion,A08AA62;N06AX12,"Depressive Disorder, Major",0,1
PA448687,bupropion,A08AA62;N06AX12,,0,1
PA448687,bupropion,A08AA62;N06AX12,Obesity,0,1
PA448687,bupropion,A08AA62;N06AX12,Tobacco Use Disorder,0,1
PA448691,busulfan,L01AB01,Transplantation,0,1
PA448691,busulfan,L01AB01,,0,1
PA448691,busulfan,L01AB01,"Leukemia, Myeloid, Acute",0,1
PA448691,busulfan,L01AB01,hemopoietic stem cell transplant,0,1
PA164745398,butorphanol,N02AF01,,0,1
PA165958401,cabazitaxel,L01CD04,,0,1
PA166251381,cabotegravir / rilpivirine,,,1,0
PA165906891,cabozantinib,,,0,1
PA448710,caffeine,D11AX26;N06BC01;R03DA20;V04CG30,insomnia,0,1
PA448710,caffeine,D11AX26;N06BC01;R03DA20;V04CG30,Anxiety Disorders,0,1
PA448710,caffeine,D11AX26;N06BC01;R03DA20;V04CG30,Malignant Hyperthermia,0,1
PA448710,caffeine,D11AX26;N06BC01;R03DA20;V04CG30,"Abortion, Spontaneous",0,1
PA448710,caffeine,D11AX26;N06BC01;R03DA20;V04CG30,Myocardial Infarction,0,1
PA448710,caffeine,D11AX26;N06BC01;R03DA20;V04CG30,,0,1
PA132595336,calcein,,,0,1
PA164712580,Calcineurin inhibitors,,,0,1
PA448717,calcitriol,A11CC04;D05AX03,,0,1
PA164712582,calcium,A11AA02;A11GB01;M05BB01;M05BB02;M05BB04;M05BB05;M05BB08,,0,1
PA10407,calcium channel blockers,,Headache Disorders,0,1
PA10407,calcium channel blockers,,Migraine without Aura,0,1
PA10407,calcium channel blockers,,Hypertension,0,1
PA10407,calcium channel blockers,,,0,1
PA10407,calcium channel blockers,,Essential hypertension,0,1
PA10407,calcium channel blockers,,Migraine with Aura,0,1
D000068896,Canagliflozin,,,0,1
PA165958358,canakinumab,,,0,1
PA448765,candesartan,C09CA06;C09DA06;C09DB07;C09DX06;C10BX19,Hypertension,0,1
PA448765,candesartan,C09CA06;C09DA06;C09DB07;C09DX06;C10BX19,,0,1
PA448765,candesartan,C09CA06;C09DA06;C09DB07;C09DX06;C10BX19,Heart Failure,0,1
PA448765,candesartan,C09CA06;C09DA06;C09DB07;C09DX06;C10BX19,Essential hypertension,0,1
PA165945763,cangrelor,B01AC25,,0,1
PA166175791,cannabidiol,,,0,1
PA131890620,cannabinoids,,Marijuana Abuse,0,1
PA131890620,cannabinoids,,Substance-Related Disorders,0,1
PA131890620,cannabinoids,,,0,1
PA448771,capecitabine,L01BC06,Drug Toxicity,0,1
PA448771,capecitabine,L01BC06,Diarrhea,0,1
PA448771,capecitabine,L01BC06,Vomiting,0,1
PA448771,capecitabine,L01BC06,Nausea,0,1
PA448771,capecitabine,L01BC06,Asthenia,0,1
PA448771,capecitabine,L01BC06,Hyperbilirubinemia,0,1
PA448771,capecitabine,L01BC06,,0,1
PA448771,capecitabine,L01BC06,Rectal Neoplasms,0,1
PA448771,capecitabine,L01BC06,Breast Neoplasms,0,1
PA448771,capecitabine,L01BC06,Neoplasm Metastasis,0,1
PA448771,capecitabine,L01BC06,Colonic Neoplasms,0,1
PA448771,capecitabine,L01BC06,Neoplasms,0,1
PA448771,capecitabine,L01BC06,hand-foot syndrome,0,1
PA448771,capecitabine,L01BC06,Colorectal Neoplasms,0,1
PA166224201,capmatinib,,,0,1
PA448780,captopril,C09AA01;C09BA01,"Diabetes Mellitus, Type 2",0,1
PA448780,captopril,C09AA01;C09BA01,Hypertension,0,1
PA448780,captopril,C09AA01;C09BA01,Heart Failure,0,1
PA448780,captopril,C09AA01;C09BA01,"Pulmonary Disease, Chronic Obstructive",0,1
PA448780,captopril,C09AA01;C09BA01,Alzheimer Disease,0,1
PA448780,captopril,C09AA01;C09BA01,,0,1
PA448785,carbamazepine,N03AF01,"Epidermal Necrolysis, Toxic",0,1
PA448785,carbamazepine,N03AF01,Drug Hypersensitivity,0,1
PA448785,carbamazepine,N03AF01,Hypersensitivity,0,1
PA448785,carbamazepine,N03AF01,Epilepsy,0,1
PA448785,carbamazepine,N03AF01,Maculopapular Exanthema,0,1
PA448785,carbamazepine,N03AF01,,0,1
PA448785,carbamazepine,N03AF01,Stevens-Johnson Syndrome,0,1
PA448785,carbamazepine,N03AF01,erythema exudativum multiforme,0,1
PA448785,carbamazepine,N03AF01,drug reaction with eosinophilia and systemic symptoms,0,1
PA448785,carbamazepine,N03AF01,severe cutaneous adverse reactions,0,1
PA166184059,carbasalate calcium,,,0,1
PA448794,carbidopa,,,0,1
PA164742970,carbimazole,H03BB01,,0,1
PA164742970,carbimazole,H03BB01,Graves Disease,0,1
PA166184060,carbocisteine,,,0,1
PA448803,carboplatin,L01XA02,Neoplasms,0,1
PA448803,carboplatin,L01XA02,,0,1
PA448803,carboplatin,L01XA02,Thrombocytopenia,0,1
PA448803,carboplatin,L01XA02,Ovarian Neoplasms,0,1
PA448803,carboplatin,L01XA02,"Carcinoma, Non-Small-Cell Lung",0,1
PA448803,carboplatin,L01XA02,Neutropenia,0,1
PA448803,carboplatin,L01XA02,Leukopenia,0,1
PA448803,carboplatin,L01XA02,Breast Neoplasms,0,1
PA448803,carboplatin,L01XA02,Uterine Cervical Neoplasms,0,1
PA448803,carboplatin,L01XA02,Lung Neoplasms,0,1
PA166165203,carfilzomib,L01XG02,,0,1
PA165958402,carglumic acid,A16AA05,,0,1
PA166177476,cariprazine,,,0,1
PA448809,carisoprodol,M03BA02;M03BA52;M03BA72,,0,1
PA448817,carvedilol,C07AG02;C07FX06,Heart Failure,0,1
PA448817,carvedilol,C07AG02;C07FX06,,0,1
PA448817,carvedilol,C07AG02;C07FX06,Angina Pectoris,0,1
PA448817,carvedilol,C07AG02;C07FX06,Heart Diseases,0,1
PA166251541,casimersen,,,0,1
PA133822447,catecholamines,,,0,1
PA133822447,catecholamines,,Coronary Artery Disease,0,1
PA166163226,cavosonstat,,Cystic Fibrosis,0,1
PA166163226,cavosonstat,,,0,1
PA448852,cefotaxime,J01DD01,,1,0
PA448866,ceftriaxone,J01DD04;J01DD54,,1,0
PA448866,ceftriaxone,J01DD04;J01DD54,Central Nervous System Infections,1,0
PA448871,celecoxib,C08CA51;G01AE10;L01XX33;M01AH01;N02AJ16,Colorectal Neoplasms,0,1
PA448871,celecoxib,C08CA51;G01AE10;L01XX33;M01AH01;N02AJ16,,0,1
PA164924561,celiprolol,,,0,1
PA166251401,cemiplimab-rwlc,,,0,1
PA448883,cephalexin,J01DB01,,1,0
PA448883,cephalexin,J01DB01,adverse events,1,0
PA166124616,ceritinib,,,0,1
PA448897,cerivastatin,C10AA06,,0,1
PA448897,cerivastatin,C10AA06,Rhabdomyolysis,0,1
PA166169879,cerliponase alfa,,,0,1
PA165107055,certolizumab pegol,L04AB05,"Arthritis, Rheumatoid",0,1
PA165107055,certolizumab pegol,L04AB05,,0,1
PA10040,cetuximab,L01FE01,Neoplasms,0,1
PA10040,cetuximab,L01FE01,Head and Neck Neoplasms,0,1
PA10040,cetuximab,L01FE01,Rectal Neoplasms,0,1
PA10040,cetuximab,L01FE01,Colorectal Neoplasms,0,1
PA10040,cetuximab,L01FE01,,0,1
PA164754754,cevimeline,N07AX03,,0,1
PA165958403,chenodeoxycholic acid,A05AA01,,0,1
PA448926,chlorambucil,L01AA02,"Leukemia, Lymphocytic, Chronic, B-Cell",0,1
PA448926,chlorambucil,L01AA02,,0,1
PA448927,chloramphenicol,D06AX02;D10AF03;G01AA05;J01BA01;S01AA01;S02AA01;S03AA08,Hemolysis,1,0
PA448927,chloramphenicol,D06AX02;D10AF03;G01AA05;J01BA01;S01AA01;S02AA01;S03AA08,"Anemia, Hemolytic",1,0
PA448927,chloramphenicol,D06AX02;D10AF03;G01AA05;J01BA01;S01AA01;S02AA01;S03AA08,,1,0
PA166122627,chlorocresol,,Malignant Hyperthermia,0,1
PA448946,chloroprocaine,N01BA04,,0,1
PA448948,chloroquine,P01BA01;P01BB52,"Anemia, Hemolytic",1,0
PA448948,chloroquine,P01BA01;P01BB52,,1,0
PA448953,chlorothiazide,C03AA04;C03AB04;C03AH01;G01AE10,Hypertension,0,1
PA448953,chlorothiazide,C03AA04;C03AB04;C03AH01;G01AE10,Hyperglycemia,0,1
PA448953,chlorothiazide,C03AA04;C03AB04;C03AH01;G01AE10,,0,1
PA165857067,chlorproguanil,,Malaria,1,0
PA448964,chlorpromazine,N05AA01,,0,1
PA448964,chlorpromazine,N05AA01,Schizophrenia,0,1
PA448966,chlorpropamide,A10BB02;G01AE10,,0,1
PA448970,chlorthalidone,C03BA04;C03BB04;C03EA06;G01AE10,Cardiovascular Diseases,0,1
PA448970,chlorthalidone,C03BA04;C03BB04;C03EA06;G01AE10,,0,1
PA448970,chlorthalidone,C03BA04;C03BB04;C03EA06;G01AE10,Stroke,0,1
PA448970,chlorthalidone,C03BA04;C03BB04;C03EA06;G01AE10,Hypertension,0,1
PA448970,chlorthalidone,C03BA04;C03BB04;C03EA06;G01AE10,Coronary Disease,0,1
PA166160055,cholic acid,A05AA03,,0,1
PA448997,cidofovir,J05AB12,,1,0
PA164746334,cilostazol,B01AC23,,0,1
PA449001,cimetidine,A02BA01;A02BA51,,0,1
PA164776671,cinacalcet,H05BX01,,0,1
PA449009,ciprofloxacin,J01MA02;J01RA10;J01RA11;J01RA12;S01AE03;S02AA15;S03AA07,,1,0
PA449009,ciprofloxacin,J01MA02;J01RA10;J01RA11;J01RA12;S01AE03;S02AA15;S03AA07,"Anemia, Hemolytic",1,0
PA449014,cisplatin,L01XA01,febrile neutropenia,0,1
PA449014,cisplatin,L01XA01,Testicular Neoplasms,0,1
PA449014,cisplatin,L01XA01,nephrotoxicity,0,1
PA449014,cisplatin,L01XA01,Ototoxicity,0,1
PA449014,cisplatin,L01XA01,Brain Neoplasms,0,1
PA449014,cisplatin,L01XA01,Drug Toxicity,0,1
PA449014,cisplatin,L01XA01,cardiotoxicity,0,1
PA449014,cisplatin,L01XA01,Medulloblastoma,0,1
PA449014,cisplatin,L01XA01,progression-free survival,0,1
PA449014,cisplatin,L01XA01,Leukopenia,0,1
PA449014,cisplatin,L01XA01,Lung Neoplasms,0,1
PA449014,cisplatin,L01XA01,,0,1
PA449014,cisplatin,L01XA01,Vomiting,0,1
PA449014,cisplatin,L01XA01,Urinary Bladder Neoplasms,0,1
PA449014,cisplatin,L01XA01,Infection,0,1
PA449014,cisplatin,L01XA01,Uterine Cervical Neoplasms,0,1
PA449014,cisplatin,L01XA01,Mesothelioma,0,1
PA449014,cisplatin,L01XA01,Liver Neoplasms,0,1
PA449014,cisplatin,L01XA01,Osteosarcoma,0,1
PA449014,cisplatin,L01XA01,Deafness,0,1
PA449014,cisplatin,L01XA01,Neutropenia,0,1
PA449014,cisplatin,L01XA01,Thrombocytopenia,0,1
PA449014,cisplatin,L01XA01,Esophageal Neoplasms,0,1
PA449014,cisplatin,L01XA01,Neoplasms,0,1
PA449014,cisplatin,L01XA01,mucositis,0,1
PA449014,cisplatin,L01XA01,Pancreatic Neoplasms,0,1
PA449014,cisplatin,L01XA01,Colorectal Neoplasms,0,1
PA449014,cisplatin,L01XA01,Ovarian Neoplasms,0,1
PA449014,cisplatin,L01XA01,Alopecia,0,1
PA449014,cisplatin,L01XA01,Anemia,0,1
PA449014,cisplatin,L01XA01,overall survival,0,1
PA449014,cisplatin,L01XA01,Stomach Neoplasms,0,1
PA449014,cisplatin,L01XA01,Nausea,0,1
PA449014,cisplatin,L01XA01,"Carcinoma, Non-Small-Cell Lung",0,1
PA449014,cisplatin,L01XA01,"Carcinoma, Hepatocellular",0,1
PA449014,cisplatin,L01XA01,"Carcinoma, Small Cell",0,1
PA449014,cisplatin,L01XA01,"Carcinoma, Squamous Cell",0,1
PA449014,cisplatin,L01XA01,Pain,0,1
PA449014,cisplatin,L01XA01,Gastrointestinal Neoplasms,0,1
PA449015,citalopram,N06AB04,suicide,0,1
PA449015,citalopram,N06AB04,Depressive Disorder,0,1
PA449015,citalopram,N06AB04,Vomiting,0,1
PA449015,citalopram,N06AB04,"Sexual Dysfunctions, Psychological",0,1
PA449015,citalopram,N06AB04,Anxiety Disorders,0,1
PA449015,citalopram,N06AB04,"Depressive Disorder, Major",0,1
PA449015,citalopram,N06AB04,Depression,0,1
PA449015,citalopram,N06AB04,Nausea,0,1
PA449015,citalopram,N06AB04,,0,1
PA449015,citalopram,N06AB04,Obsessive-Compulsive Disorder,0,1
PA449027,cladribine,L01BB04;L04AA40,,0,1
PA449027,cladribine,L01BB04;L04AA40,"Leukemia, Myeloid, Acute",0,1
PA449028,clarithromycin,A02BD04;A02BD05;A02BD06;A02BD07;A02BD09;A02BD11;A02BD12;A02BD14;J01FA09,,1,0
PA164742987,clavulanate,,,1,0
PA164742987,clavulanate,,Drug Toxicity,1,0
PA449035,clindamycin,D10AF01;D10AF51;G01AA10;J01FF01,,1,0
PA10888,clobazam,N05BA09,Epilepsy,0,1
PA10888,clobazam,N05BA09,,0,1
PA10239,clodronate,M05BA02,,0,1
PA10239,clodronate,M05BA02,Osteitis Deformans,0,1
PA449048,clomipramine,N06AA04,,0,1
PA449048,clomipramine,N06AA04,Depression,0,1
PA449048,clomipramine,N06AA04,"Depressive Disorder, Major",0,1
PA449048,clomipramine,N06AA04,Mental Disorders,0,1
PA449050,clonazepam,N03AE01,,0,1
PA449051,clonidine,C02AC01;C02LC01;C02LC51;N02CX02;S01EA04,,0,1
PA449051,clonidine,C02AC01;C02LC01;C02LC51;N02CX02;S01EA04,Liver Cirrhosis,0,1
PA449053,clopidogrel,B01AC04,Angina Pectoris,0,1
PA449053,clopidogrel,B01AC04,Stroke,0,1
PA449053,clopidogrel,B01AC04,,0,1
PA449053,clopidogrel,B01AC04,"Ischemic Attack, Transient",0,1
PA449053,clopidogrel,B01AC04,"Constriction, Pathologic",0,1
PA449053,clopidogrel,B01AC04,Myocardial Ischemia,0,1
PA449053,clopidogrel,B01AC04,Hemorrhage,0,1
PA449053,clopidogrel,B01AC04,major adverse cardiac events (mace),0,1
PA449053,clopidogrel,B01AC04,Thrombosis,0,1
PA449053,clopidogrel,B01AC04,Myocardial Infarction,0,1
PA449053,clopidogrel,B01AC04,Cardiovascular Diseases,0,1
PA449053,clopidogrel,B01AC04,Acute coronary syndrome,0,1
PA449053,clopidogrel,B01AC04,"Diabetes Mellitus, Type 2",0,1
PA449053,clopidogrel,B01AC04,platelet reactivity,0,1
PA449053,clopidogrel,B01AC04,Coronary Artery Disease,0,1
PA449053,clopidogrel,B01AC04,Coronary Disease,0,1
PA166131260,clopidogrel thiol metabolite H4,,,0,1
PA449061,clozapine,N05AH02,Schizophrenia,0,1
PA449061,clozapine,N05AH02,Psychotic Disorders,0,1
PA449061,clozapine,N05AH02,Bipolar Disorder,0,1
PA449061,clozapine,N05AH02,Tachycardia,0,1
PA449061,clozapine,N05AH02,Seizures,0,1
PA449061,clozapine,N05AH02,Headache,0,1
PA449061,clozapine,N05AH02,Muscle Rigidity,0,1
PA449061,clozapine,N05AH02,Drug Toxicity,0,1
PA449061,clozapine,N05AH02,Confusion,0,1
PA449061,clozapine,N05AH02,,0,1
PA449061,clozapine,N05AH02,Depressive Disorder,0,1
PA449061,clozapine,N05AH02,Mental Disorders,0,1
PA449061,clozapine,N05AH02,sedation,0,1
PA449061,clozapine,N05AH02,Metabolic Syndrome,0,1
PA449061,clozapine,N05AH02,Weight gain,0,1
PA449061,clozapine,N05AH02,schizoaffective disorder,0,1
PA449061,clozapine,N05AH02,Neutropenia,0,1
PA449061,clozapine,N05AH02,Autism Spectrum Disorder,0,1
PA449061,clozapine,N05AH02,Agranulocytosis,0,1
PA166160044,cobimetinib,L01EE02,,0,1
PA449072,cocaine,N01BC01;R02AD03;S01HA01;S02DA02,Cocaine-Related Disorders,0,1
PA449072,cocaine,N01BC01;R02AD03;S01HA01;S02DA02,Heroin Dependence,0,1
PA449072,cocaine,N01BC01;R02AD03;S01HA01;S02DA02,,0,1
PA449072,cocaine,N01BC01;R02AD03;S01HA01;S02DA02,Substance-Related Disorders,0,1
PA449088,codeine,N02AA59;N02AA79;N02AJ06;N02AJ07;N02AJ08;R05DA04,Pain,0,1
PA449088,codeine,N02AA59;N02AA79;N02AJ06;N02AJ07;N02AJ08;R05DA04,,0,1
PA449088,codeine,N02AA59;N02AA79;N02AJ06;N02AJ07;N02AJ08;R05DA04,Opioid-Related Disorders,0,1
PA449088,codeine,N02AA59;N02AA79;N02AJ06;N02AJ07;N02AJ08;R05DA04,adverse events,0,1
PA449095,colesevelam,C10AC04,,0,1
PA166230961,combination nicotine replacement therapy,,,0,1
PA164754789,conjugated estrogens,G03CA57;G03CC07,,0,1
PA164754789,conjugated estrogens,G03CA57;G03CC07,Endometrial Neoplasms,0,1
PA166153416,coptisine,,,1,0
PA10832,corticosteroids,,,0,1
PA10832,corticosteroids,,Crohn Disease,0,1
PA10832,corticosteroids,,Asthma,0,1
PA10832,corticosteroids,,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0,1
PA164712636,Corticosteroids For Systemic Use,,,0,1
PA449130,cortisone acetate,,,0,1
PA166114414,cotinine,,Tobacco Use Disorder,0,1
PA166114414,cotinine,,,0,1
PA166131561,cotinine glucuronide,,,0,1
PA134521193,coumarin,,,0,1
PA164712669,Coxibs,,,0,1
PA164778930,creatine,,,0,1
PA164778930,creatine,,Amyotrophic Lateral Sclerosis,0,1
PA166189801,crizanlizumab-tmca,,,0,1
PA165946122,crizotinib,L01ED01,,0,1
PA151958596,curcumin,,Cystic Fibrosis,0,1
PA151958596,curcumin,,,0,1
PA451892,cyanocobalamin,B03AE01;B03BA01;B03BA51,Neoplasms,0,1
PA451892,cyanocobalamin,B03AE01;B03BA01;B03BA51,,0,1
PA165107357,cycloguanil,,,1,0
PA449165,cyclophosphamide,L01AA01,,0,1
PA449165,cyclophosphamide,L01AA01,Lupus Nephritis,0,1
PA449165,cyclophosphamide,L01AA01,"Lymphoma, Large B-Cell, Diffuse",0,1
PA449165,cyclophosphamide,L01AA01,Neoplasms,0,1
PA449165,cyclophosphamide,L01AA01,Stomach Neoplasms,0,1
PA449165,cyclophosphamide,L01AA01,Hepatic Veno-Occlusive Disease,0,1
PA449165,cyclophosphamide,L01AA01,Osteosarcoma,0,1
PA449165,cyclophosphamide,L01AA01,Ovarian Neoplasms,0,1
PA449165,cyclophosphamide,L01AA01,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0,1
PA449165,cyclophosphamide,L01AA01,Cystitis,0,1
PA449165,cyclophosphamide,L01AA01,"Leukemia, Lymphocytic, Chronic, B-Cell",0,1
PA449165,cyclophosphamide,L01AA01,Lupus erythematosus,0,1
PA449165,cyclophosphamide,L01AA01,"Lymphoma, Non-Hodgkin",0,1
PA449165,cyclophosphamide,L01AA01,Anemia,0,1
PA449165,cyclophosphamide,L01AA01,Leukopenia,0,1
PA449165,cyclophosphamide,L01AA01,Neutropenia,0,1
PA449165,cyclophosphamide,L01AA01,Drug Toxicity,0,1
PA449165,cyclophosphamide,L01AA01,Prostatic Neoplasms,0,1
PA449165,cyclophosphamide,L01AA01,Osteonecrosis,0,1
PA449165,cyclophosphamide,L01AA01,hemopoietic stem cell transplant,0,1
PA449165,cyclophosphamide,L01AA01,Transplantation,0,1
PA449165,cyclophosphamide,L01AA01,Breast Neoplasms,0,1
PA449165,cyclophosphamide,L01AA01,"Lymphoma, B-Cell",0,1
PA449165,cyclophosphamide,L01AA01,Multiple Myeloma,0,1
PA449165,cyclophosphamide,L01AA01,"Lupus Erythematosus, Systemic",0,1
PA449167,cyclosporine,L04AD01;S01XA18,Organ Transplantation,0,1
PA449167,cyclosporine,L04AD01;S01XA18,transplant rejection,0,1
PA449167,cyclosporine,L04AD01;S01XA18,Transplantation,0,1
PA449167,cyclosporine,L04AD01;S01XA18,Myasthenia Gravis,0,1
PA449167,cyclosporine,L04AD01;S01XA18,hematopoietic stem cell transplantation,0,1
PA449167,cyclosporine,L04AD01;S01XA18,Cystic Fibrosis,0,1
PA449167,cyclosporine,L04AD01;S01XA18,Neurotoxicity Syndromes,0,1
PA449167,cyclosporine,L04AD01;S01XA18,"Colitis, Ulcerative",0,1
PA449167,cyclosporine,L04AD01;S01XA18,Kidney Transplantation,0,1
PA449167,cyclosporine,L04AD01;S01XA18,liver transplantation,0,1
PA449167,cyclosporine,L04AD01;S01XA18,,0,1
PA449171,cysteamine,A16AA04;S01XA21,Cystic Fibrosis,0,1
PA449171,cysteamine,A16AA04;S01XA21,,0,1
PA449177,cytarabine,L01BC01;L01XY01,Lymphoma,0,1
PA449177,cytarabine,L01BC01;L01XY01,,0,1
PA449177,cytarabine,L01BC01;L01XY01,Neoplasms,0,1
PA449177,cytarabine,L01BC01;L01XY01,Leukemia,0,1
PA449177,cytarabine,L01BC01;L01XY01,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0,1
PA449177,cytarabine,L01BC01;L01XY01,Osteonecrosis,0,1
PA449177,cytarabine,L01BC01;L01XY01,"Leukemia, Myeloid",0,1
PA449177,cytarabine,L01BC01;L01XY01,"Leukemia, Myeloid, Acute",0,1
PA165110351,dabigatran,,,0,1
PA165110351,dabigatran,,Atrial Fibrillation,0,1
PA165958369,dabigatran etexilate,B01AE07,,0,1
PA166114911,dabrafenib,,,0,1
PA449197,dacarbazine,L01AX04,,0,1
PA166128167,daclatasvir,J05AP07;J05AP58,"Hepatitis C, Chronic",1,0
PA166128167,daclatasvir,J05AP07;J05AP58,,1,0
PA166182279,dacomitinib,,,0,1
PA151917012,dactinomycin,L01DA01,,0,1
PA166131581,dalcetrapib,,Acute coronary syndrome,0,1
PA166131581,dalcetrapib,,,0,1
PA166151992,dapoxetine,G04BX14,,0,1
PA449211,dapsone,D10AX05;J04BA02;J04BA50;J04BA51,Malaria,1,0
PA449211,dapsone,D10AX05;J04BA02;J04BA50;J04BA51,Drug Hypersensitivity,1,0
PA449211,dapsone,D10AX05;J04BA02;J04BA50;J04BA51,Maculopapular Exanthema,1,0
PA449211,dapsone,D10AX05;J04BA02;J04BA50;J04BA51,Leprosy,1,0
PA449211,dapsone,D10AX05;J04BA02;J04BA50;J04BA51,,1,0
PA449211,dapsone,D10AX05;J04BA02;J04BA50;J04BA51,Stevens-Johnson Syndrome,1,0
PA449211,dapsone,D10AX05;J04BA02;J04BA50;J04BA51,severe cutaneous adverse reactions,1,0
PA449211,dapsone,D10AX05;J04BA02;J04BA50;J04BA51,drug reaction with eosinophilia and systemic symptoms,1,0
PA164768820,daptomycin,J01XX09,,1,0
PA164774901,darifenacin,G04BD10,,0,1
PA163522472,darunavir,G01AE10;J05AE10;J05AR14;J05AR22;J05AR26,,1,0
PA166163411,dasabuvir,J05AP09;J05AP52,,1,0
PA166160002,dasabuvir / ombitasvir / paritaprevir / ritonavir,,,1,0
PA162372878,dasatinib,L01EA02,,0,1
PA449212,daunorubicin,L01DB02;L01XY01,"Leukemia, Myeloid, Acute",0,1
PA449212,daunorubicin,L01DB02;L01XY01,Osteonecrosis,0,1
PA449212,daunorubicin,L01DB02;L01XY01,,0,1
PA449212,daunorubicin,L01DB02;L01XY01,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0,1
PA449212,daunorubicin,L01DB02;L01XY01,Drug Toxicity,0,1
PA452616,debrisoquine,C02CC04,,0,1
PA164749631,decitabine,L01BC08,,0,1
PA164760843,deferasirox,V03AC03,beta-Thalassemia,0,1
PA164760843,deferasirox,V03AC03,Drug Toxicity,0,1
PA164760843,deferasirox,V03AC03,Thalassemia,0,1
PA164760843,deferasirox,V03AC03,,0,1
PA166118041,deferiprone,V03AC02,,0,1
PA166118041,deferiprone,V03AC02,beta-Thalassemia,0,1
PA166128130,deleobuvir,,,1,0
PA166128130,deleobuvir,,"Hepatitis C, Chronic",1,0
PA164750594,denileukin diftitox,L01XX29,,0,1
PA166197521,desethyl hydroxychloroquine,,,1,0
PA164749136,desflurane,N01AB07,Malignant Hyperthermia,0,1
PA164749136,desflurane,N01AB07,,0,1
PA449233,desipramine,N06AA01,Depression,0,1
PA449233,desipramine,N06AA01,"Depressive Disorder, Major",0,1
PA449233,desipramine,N06AA01,Mental Disorders,0,1
PA449233,desipramine,N06AA01,Depressive Disorder,0,1
PA449233,desipramine,N06AA01,,0,1
PA164776964,desloratadine,R06AX27,sedation,0,1
PA164776964,desloratadine,R06AX27,Urticaria,0,1
PA164776964,desloratadine,R06AX27,,0,1
PA166163690,desmethylnaproxen,,,0,1
PA165958374,desvenlafaxine,N06AX23,,0,1
PA166169881,deutetrabenazine,,,0,1
PA449247,dexamethasone,A01AC02;C05AA09;D07AB19;D07CB04;D07XB05;D10AA03;H02AB02;R01AD03;R01AD53;S01BA01;S01CA01;S01CB01;S02BA06;S02CA06;S03BA01;S03CA01,,0,1
PA449247,dexamethasone,A01AC02;C05AA09;D07AB19;D07CB04;D07XB05;D10AA03;H02AB02;R01AD03;R01AD53;S01BA01;S01CA01;S01CB01;S02BA06;S02CA06;S03BA01;S03CA01,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0,1
PA449247,dexamethasone,A01AC02;C05AA09;D07AB19;D07CB04;D07XB05;D10AA03;H02AB02;R01AD03;R01AD53;S01BA01;S01CA01;S01CB01;S02BA06;S02CA06;S03BA01;S03CA01,Multiple Myeloma,0,1
PA449247,dexamethasone,A01AC02;C05AA09;D07AB19;D07CB04;D07XB05;D10AA03;H02AB02;R01AD03;R01AD53;S01BA01;S01CA01;S01CB01;S02BA06;S02CA06;S03BA01;S03CA01,progression-free survival,0,1
PA449247,dexamethasone,A01AC02;C05AA09;D07AB19;D07CB04;D07XB05;D10AA03;H02AB02;R01AD03;R01AD53;S01BA01;S01CA01;S01CB01;S02BA06;S02CA06;S03BA01;S03CA01,Osteonecrosis,0,1
PA166110257,dexlansoprazole,A02BC06,,0,1
PA449256,dexmedetomidine,N05CM18,,0,1
PA449256,dexmedetomidine,N05CM18,"Pain, Postoperative",0,1
PA449259,dexrazoxane,V03AF02,"Leukemia, Myeloid, Acute",0,1
PA449269,dextroamphetamine,N06BA02,,0,1
PA449269,dextroamphetamine,N06BA02,Attention Deficit Disorder with Hyperactivity,0,1
PA449273,dextromethorphan,N07XX59;R05DA09,,0,1
PA166175998,dextromethorphan / quinidine,,,1,0
PA166278341,dextromethorphan hydrobromide / bupropion hydrochloride,,,0,1
PA166183939,dextropropoxyphene,,,0,1
PA449283,diazepam,N05BA01,,0,1
PA165947835,dichloroacetic acid,,,0,1
PA449293,diclofenac,D11AX18;M01AB05;M01AB55;M02AA15;S01BC03;S01CC01,,0,1
PA164749649,dicloxacillin,J01CF01;J01CR50,Cystic Fibrosis,1,0
PA164749649,dicloxacillin,J01CF01;J01CR50,,1,0
PA449301,didanosine,J05AF02,HIV Infections,1,0
PA449301,didanosine,J05AF02,,1,0
PA134653756,diflomotecan,,,0,1
PA166131569,difluorodeoxyuridine,,Neoplasms,0,1
PA449319,digoxin,C01AA05,,0,1
PA449319,digoxin,C01AA05,Heart Failure,0,1
PA449319,digoxin,C01AA05,Shortened QT interval,0,1
PA166176885,dihydrocodeine,,,0,1
PA164712688,Dihydropyridine derivatives,,,0,1
PA166242461,dihydrostreptomycin,,Ototoxicity,1,0
PA449334,diltiazem,C05AE03;C08DB01,Hypertension,0,1
PA449334,diltiazem,C05AE03;C08DB01,,0,1
PA165958406,dimercaprol,V03AB09,"Lead Poisoning, Nervous System, Childhood",0,1
PA165958406,dimercaprol,V03AB09,Hemolysis,0,1
PA166152838,dimethyl fumarate,L04AX07,Psoriasis,0,1
PA166152838,dimethyl fumarate,L04AX07,,0,1
PA166160060,dinutuximab,,,0,1
PA164712689,Dipeptidyl peptidase 4 (DPP-4) inhibitors,,Diabetes Mellitus,0,1
PA164712689,Dipeptidyl peptidase 4 (DPP-4) inhibitors,,,0,1
PA166128206,dipyrone,N02BB02;N02BB52;N02BB72,,0,1
PA166179660,direct acting antivirals,,,1,0
PA166179660,direct acting antivirals,,sustained virological response (svr),1,0
PA449373,disopyramide,C01BA03,short qt syndrome 1,0,1
PA449376,disulfiram,N07BB01;P03AA04;P03AA54,,0,1
PA449376,disulfiram,N07BB01;P03AA04;P03AA54,Cocaine-Related Disorders,0,1
PA151249535,diuretics,,Nephrosclerosis,0,1
PA151249535,diuretics,,Myocardial Infarction,0,1
PA151249535,diuretics,,,0,1
PA151249535,diuretics,,Hypertension,0,1
PA151249535,diuretics,,Heart Failure,0,1
PA164783479,divalproex sodium,,,0,1
PA449381,dobutamine,C01CA07,,0,1
PA449383,docetaxel,L01CD02,,0,1
PA449383,docetaxel,L01CD02,Neutropenia,0,1
PA449383,docetaxel,L01CD02,Amenorrhea,0,1
PA449383,docetaxel,L01CD02,Nasopharyngeal Neoplasms,0,1
PA449383,docetaxel,L01CD02,Anemia,0,1
PA449383,docetaxel,L01CD02,Neoplasms,0,1
PA449383,docetaxel,L01CD02,Breast Neoplasms,0,1
PA449383,docetaxel,L01CD02,Ovarian Neoplasms,0,1
PA449383,docetaxel,L01CD02,"Carcinoma, Non-Small-Cell Lung",0,1
PA449383,docetaxel,L01CD02,Prostatic Neoplasms,0,1
PA449390,dolasetron,A04AA04,Postoperative Nausea and Vomiting,0,1
PA449390,dolasetron,A04AA04,,0,1
PA166114961,dolutegravir,J05AJ03;J05AR13;J05AR21;J05AR25;J05AR27,HIV Infections,1,0
PA166114961,dolutegravir,J05AJ03;J05AR13;J05AR21;J05AR25;J05AR27,,1,0
PA166184505,dolutegravir / abacavir / lamivudine,,,1,0
PA449394,donepezil,N06DA02;N06DA52;N06DA53,cognitive dysfunction,0,1
PA449394,donepezil,N06DA02;N06DA52;N06DA53,Alzheimer Disease,0,1
PA449394,donepezil,N06DA02;N06DA52;N06DA53,,0,1
PA164712697,Dopamine agonists,,,0,1
PA164712697,Dopamine agonists,,Parkinson Disease,0,1
PA449407,doxazosin,C02CA04;G04CA55,,0,1
PA449409,doxepin,D04AX01;N06AA12,,0,1
PA449412,doxorubicin,L01DB01,,0,1
PA449412,doxorubicin,L01DB01,Anemia,0,1
PA449412,doxorubicin,L01DB01,"Lymphoma, Large B-Cell, Diffuse",0,1
PA449412,doxorubicin,L01DB01,mucositis,0,1
PA449412,doxorubicin,L01DB01,nephrotoxicity,0,1
PA449412,doxorubicin,L01DB01,Sarcoma,0,1
PA449412,doxorubicin,L01DB01,cardiotoxicity,0,1
PA449412,doxorubicin,L01DB01,Ovarian Neoplasms,0,1
PA449412,doxorubicin,L01DB01,"Arrhythmias, Cardiac",0,1
PA449412,doxorubicin,L01DB01,Breast Neoplasms,0,1
PA449412,doxorubicin,L01DB01,"Lymphoma, Non-Hodgkin",0,1
PA449412,doxorubicin,L01DB01,Neutropenia,0,1
PA449412,doxorubicin,L01DB01,Multiple Myeloma,0,1
PA449412,doxorubicin,L01DB01,Neoplasms,0,1
PA449412,doxorubicin,L01DB01,Osteosarcoma,0,1
PA449412,doxorubicin,L01DB01,Drug Toxicity,0,1
PA449412,doxorubicin,L01DB01,Stomach Neoplasms,0,1
PA449412,doxorubicin,L01DB01,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0,1
PA449412,doxorubicin,L01DB01,Osteonecrosis,0,1
PA449412,doxorubicin,L01DB01,Leukopenia,0,1
PA165291922,doxorubicinol,,Breast Neoplasms,0,1
PA449421,dronabinol,A04AD10,,0,1
PA153619853,dronedarone,C01BD07,,0,1
PA165290928,drospirenone / ethinyl estradiol,,,0,1
PA164712704,Drugs For Obstructive Airway Diseases,,,0,1
PA164712708,Drugs For Treatment Of Tuberculosis,,Tuberculosis,1,0
PA164712708,Drugs For Treatment Of Tuberculosis,,drug-induced liver injury,1,0
PA164712708,Drugs For Treatment Of Tuberculosis,,Drug Toxicity,1,0
PA164712708,Drugs For Treatment Of Tuberculosis,,Toxic liver disease,1,0
PA164712708,Drugs For Treatment Of Tuberculosis,,HIV Infections,1,0
PA164712708,Drugs For Treatment Of Tuberculosis,,"Hepatitis, Toxic",1,0
PA164712708,Drugs For Treatment Of Tuberculosis,,,1,0
PA164712718,Drugs used in alcohol dependence,,,0,1
PA164712718,Drugs used in alcohol dependence,,Alcoholism,0,1
PA164712711,Drugs Used In Diabetes,,,0,1
PA164712711,Drugs Used In Diabetes,,"Diabetes Mellitus, Type 2",0,1
PA164712720,Drugs used in nicotine dependence,,Tobacco Use Disorder,0,1
PA164712720,Drugs used in nicotine dependence,,,0,1
PA10066,duloxetine,N06AX21,Anxiety Disorders,0,1
PA10066,duloxetine,N06AX21,,0,1
PA10066,duloxetine,N06AX21,"Depressive Disorder, Major",0,1
PA166169883,durvalumab,,,0,1
PA164776637,eculizumab,L04AA25,paroxysmal nocturnal hemoglobinuria,0,1
PA164776637,eculizumab,L04AA25,,0,1
PA166128806,edoxaban,B01AF03,,0,1
PA449441,efavirenz,J05AG03;J05AR06;J05AR11,,1,0
PA449441,efavirenz,J05AG03;J05AR06;J05AR11,HIV Infections,1,0
PA449441,efavirenz,J05AG03;J05AR06;J05AR11,Tuberculosis,1,0
PA166176033,efavirenz / emtricitabine / tenofovir disoproxil,,,1,0
PA166268781,efgartigimod alfa,,,0,1
PA153561371,egfr inhibitors,,"Carcinoma, Non-Small-Cell Lung",0,1
PA153561371,egfr inhibitors,,Neoplasms,0,1
PA153561371,egfr inhibitors,,Pancreatic Neoplasms,0,1
PA153561371,egfr inhibitors,,,0,1
PA153561371,egfr inhibitors,,Colorectal Neoplasms,0,1
PA166182348,elagolix,,,0,1
PA166163438,elbasvir / grazoprevir,,,1,0
PA134687947,eletriptan,N02CC06,,0,1
PA166190041,elexacaftor / tezacaftor / ivacaftor,,,0,1
PA166123486,eliglustat,A16AX10,,0,1
PA166159062,elosulfase alfa,,,0,1
PA165981594,eltrombopag,,,0,1
PA166182763,emapalumab,,,0,1
PA10069,emtricitabine,J05AF09;J05AR03;J05AR06;J05AR08;J05AR09;J05AR17;J05AR18;J05AR19;J05AR20;J05AR22,,1,0
PA449456,enalapril,C09AA02;C09BA02;C09BB02;C09BB06,"Glomerulonephritis, IGA",0,1
PA449456,enalapril,C09AA02;C09BA02;C09BB02;C09BB06,Arteriosclerosis,0,1
PA449456,enalapril,C09AA02;C09BA02;C09BB02;C09BB06,,0,1
PA449456,enalapril,C09AA02;C09BA02;C09BB02;C09BB06,Hypertension,0,1
PA449456,enalapril,C09AA02;C09BA02;C09BB02;C09BB06,glomerular disease,0,1
PA449456,enalapril,C09AA02;C09BA02;C09BB02;C09BB06,Essential hypertension,0,1
PA449456,enalapril,C09AA02;C09BA02;C09BB02;C09BB06,Cough,0,1
PA449456,enalapril,C09AA02;C09BA02;C09BB02;C09BB06,Kidney Diseases,0,1
PA449456,enalapril,C09AA02;C09BA02;C09BB02;C09BB06,"Hypertrophy, Left Ventricular",0,1
PA449456,enalapril,C09AA02;C09BA02;C09BB02;C09BB06,Coronary Disease,0,1
PA166177484,enasidenib,,,0,1
PA166179872,encorafenib,L01EC03,,0,1
PA166124478,endoxifen,,,0,1
PA449461,enflurane,N01AB04,Malignant Hyperthermia,0,1
PA449461,enflurane,N01AB04,,0,1
PA166190121,enfortumab vedotin,,,0,1
PA164748726,entacapone,N04BX02,Parkinson Disease,0,1
PA164748726,entacapone,N04BX02,,0,1
PA164784025,entecavir,J05AF10,,1,0
PA166190161,entrectinib,,,0,1
PA164712732,Enzyme inhibitors,,,0,1
PA164712734,Enzymes,,Stroke,0,1
PA164712734,Enzymes,,,0,1
PA449466,ephedrine,A08AA56;C01CA26;R01AA03;R01AB05;R03CA02;S01FB02,,0,1
PA449470,epinephrine,A01AD01;B02BC09;C01CA24;R01AA14;R03AA01;R03AK01;S01EA01;S01EA51,,0,1
PA449476,epirubicin,L01DB03,Ovarian Neoplasms,0,1
PA449476,epirubicin,L01DB03,Neoplasm Metastasis,0,1
PA449476,epirubicin,L01DB03,Leukopenia,0,1
PA449476,epirubicin,L01DB03,Stomach Neoplasms,0,1
PA449476,epirubicin,L01DB03,,0,1
PA449476,epirubicin,L01DB03,Drug Toxicity,0,1
PA449476,epirubicin,L01DB03,Neoplasms,0,1
PA449476,epirubicin,L01DB03,Neutropenia,0,1
PA449476,epirubicin,L01DB03,Breast Neoplasms,0,1
PA449476,epirubicin,L01DB03,Colorectal Neoplasms,0,1
PA10072,epoetin alfa,B03XA01,,0,1
PA166182720,erdafitinib,,,0,1
PA164712741,Ergot alkaloids,,Substance Withdrawal Syndrome,0,1
PA164712741,Ergot alkaloids,,,0,1
PA166182723,eribulin,,,0,1
PA134687924,erlotinib,L01EB02,Drug Resistance,0,1
PA134687924,erlotinib,L01EB02,Lung Neoplasms,0,1
PA134687924,erlotinib,L01EB02,,0,1
PA134687924,erlotinib,L01EB02,Adenocarcinoma,0,1
PA134687924,erlotinib,L01EB02,"Carcinoma, Non-Small-Cell Lung",0,1
PA134687924,erlotinib,L01EB02,Neoplasms,0,1
PA449493,erythromycin,D10AF02;D10AF52;J01FA01;S01AA17,,1,0
PA449493,erythromycin,D10AF02;D10AF52;J01FA01;S01AA17,Neoplasms,1,0
PA166176008,erythromycin ethylsuccinate / sulfisoxazole acetyl,,,1,0
PA10074,escitalopram,N06AB10,neuropathic pain,0,1
PA10074,escitalopram,N06AB10,Anxiety Disorders,0,1
PA10074,escitalopram,N06AB10,,0,1
PA10074,escitalopram,N06AB10,"Depressive Disorder, Major",0,1
PA10074,escitalopram,N06AB10,Mental Disorders,0,1
PA10074,escitalopram,N06AB10,Depressive Disorder,0,1
PA10074,escitalopram,N06AB10,Depression,0,1
PA10075,esomeprazole,A02BC01;A02BD01;A02BD05;A02BD16;A02BC05;A02BD06;M01AE52,eosinophilic esophagitis,0,1
PA10075,esomeprazole,A02BC01;A02BD01;A02BD05;A02BD16;A02BC05;A02BD06;M01AE52,eosinophilic esophagitis,0,1
PA10075,esomeprazole,A02BC01;A02BD01;A02BD05;A02BD16;A02BC05;A02BD06;M01AE52,,0,1
PA10075,esomeprazole,A02BC01;A02BD01;A02BD05;A02BD16;A02BC05;A02BD06;M01AE52,Helicobacter Infections,0,1
PA10075,esomeprazole,A02BC01;A02BD01;A02BD05;A02BD16;A02BC05;A02BD06;M01AE52,Gastroesophageal Reflux,0,1
PA10075,esomeprazole,A02BC01;A02BD01;A02BD05;A02BD16;A02BC05;A02BD06;M01AE52,Helicobacter Infections,0,1
PA10075,esomeprazole,A02BC01;A02BD01;A02BD05;A02BD16;A02BC05;A02BD06;M01AE52,Gastroesophageal Reflux,0,1
PA10075,esomeprazole,A02BC01;A02BD01;A02BD05;A02BD16;A02BC05;A02BD06;M01AE52,,0,1
PA449503,estradiol,G02BB01;G03AA14;G03AA17;G03AB08;G03CA03;G03CA53;G03EA01;G03EA02;G03EA03;G03FA01;G03FA02;G03FA03;G03FA04;G03FA05;G03FA06;G03FA07;G03FA08;G03FA09;G03FA10;G03FA11;G03FA12;G03FA13;G03FA14;G03FA15;G03FA16;G03FA17;G03FB01;G03FB02;G03FB03;G03FB04;G03FB05;G03FB06;G03FB07;G03FB08;G03FB09;G03FB10;G03FB11;G03FB12;G03HB01;H01CC53;H01CC54,,0,1
PA166190221,estradiol / progesterone,,,0,1
D004958,Estradiol valerate,,,0,1
PA449512,estrone,G03CA07;G03CC04,,0,1
PA166185957,estrone sulfate,,,0,1
PA449515,etanercept,L04AB01,"Arthritis, Rheumatoid",0,1
PA449515,etanercept,L04AB01,,0,1
PA449515,etanercept,L04AB01,"Spondylitis, Ankylosing",0,1
PA449515,etanercept,L04AB01,Crohn Disease,0,1
PA449515,etanercept,L04AB01,Inflammation,0,1
PA449515,etanercept,L04AB01,"Arthritis, Psoriatic",0,1
PA449515,etanercept,L04AB01,Psoriasis,0,1
PA166163432,eteplirsen,,,0,1
PA164784021,ethambutol,J04AK02;J04AM03;J04AM06;J04AM07,Tuberculosis,1,0
PA164784021,ethambutol,J04AK02;J04AM03;J04AM06;J04AM07,,1,0
PA164784021,ethambutol,J04AK02;J04AM03;J04AM06;J04AM07,Toxic liver disease,1,0
PA164784021,ethambutol,J04AK02;J04AM03;J04AM06;J04AM07,Maculopapular Exanthema,1,0
PA448073,ethanol,D08AX08;V03AB16;V03AZ01,Substance-Related Disorders,0,1
PA448073,ethanol,D08AX08;V03AB16;V03AZ01,Bipolar Disorder,0,1
PA448073,ethanol,D08AX08;V03AB16;V03AZ01,Attention Deficit Disorder with Hyperactivity,0,1
PA448073,ethanol,D08AX08;V03AB16;V03AZ01,,0,1
PA448073,ethanol,D08AX08;V03AB16;V03AZ01,Death,0,1
PA448073,ethanol,D08AX08;V03AB16;V03AZ01,Alcoholism,0,1
PA165290929,ethinyl estradiol / norelgestromin,,,0,1
PA164768738,ethionamide,J04AD03,,1,0
PA449533,ethosuximide,N03AD01;N03AD51,Epilepsy,0,1
PA449533,ethosuximide,N03AD01;N03AD51,,0,1
PA166210801,ethylmorphine,,,0,1
PA449548,etidronic acid,M05BA01;M05BB01,,0,1
PA449548,etidronic acid,M05BA01;M05BB01,Osteitis Deformans,0,1
PA449552,etoposide,L01CB01,Leukopenia,0,1
PA449552,etoposide,L01CB01,Alopecia,0,1
PA449552,etoposide,L01CB01,Pain,0,1
PA449552,etoposide,L01CB01,Testicular Neoplasms,0,1
PA449552,etoposide,L01CB01,Anemia,0,1
PA449552,etoposide,L01CB01,Vomiting,0,1
PA449552,etoposide,L01CB01,febrile neutropenia,0,1
PA449552,etoposide,L01CB01,Nausea,0,1
PA449552,etoposide,L01CB01,,0,1
PA449552,etoposide,L01CB01,"Leukemia, Myeloid, Acute",0,1
PA449552,etoposide,L01CB01,Infection,0,1
PA449552,etoposide,L01CB01,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0,1
PA166014703,etravirine,J05AG04,HIV Infections,1,0
PA166014703,etravirine,J05AG04,,1,0
PA164746311,everolimus,L01EG02;L04AA18,Breast Neoplasms,0,1
PA164746311,everolimus,L01EG02;L04AA18,Lymphopenia,0,1
PA164746311,everolimus,L01EG02;L04AA18,heart transplantation,0,1
PA164746311,everolimus,L01EG02;L04AA18,discontinuation,0,1
PA164746311,everolimus,L01EG02;L04AA18,Neuroendocrine Tumors,0,1
PA164746311,everolimus,L01EG02;L04AA18,progression-free survival,0,1
PA164746311,everolimus,L01EG02;L04AA18,Hyperglycemia,0,1
PA164746311,everolimus,L01EG02;L04AA18,,0,1
PA164746311,everolimus,L01EG02;L04AA18,Leukopenia,0,1
PA164746311,everolimus,L01EG02;L04AA18,mucositis,0,1
PA164746311,everolimus,L01EG02;L04AA18,pneumonitis,0,1
PA164746311,everolimus,L01EG02;L04AA18,Kidney Transplantation,0,1
PA164746311,everolimus,L01EG02;L04AA18,Kidney Neoplasms,0,1
PA164746311,everolimus,L01EG02;L04AA18,lung transplantation,0,1
PA166222281,evinacumab,,,0,1
PA166160027,evolocumab,,,0,1
PA449563,exemestane,L02BG06,,0,1
PA449563,exemestane,L02BG06,Breast Neoplasms,0,1
PA164749238,exenatide,A10BJ01,,0,1
PA10816,ezetimibe,C10AX09;C10BA02;C10BA05;C10BA06;C10BA10;C10BA11;C10BA12,,0,1
PA166184498,ezetimibe / rosuvastatin,,,0,1
PA166184495,ezetimibe / simvastatin,,,0,1
PA166128132,faldaprevir,J05AP04,,1,0
PA166128132,faldaprevir,J05AP04,"Hepatitis C, Chronic",1,0
PA449586,famotidine,A02BA03;A02BA53,,0,1
PA166123389,fampridine,N07XX07,,0,1
PA165815771,Farglitazar,,"Diabetes Mellitus, Type 2",0,1
PA165815771,Farglitazar,,,0,1
PA165958521,febuxostat,M04AA03,,0,1
PA165958521,febuxostat,M04AA03,Gout,0,1
PA166185677,FEC100,,,0,1
PA166185677,FEC100,,Amenorrhea,0,1
PA449591,felodipine,C07FB02;C08CA02;C09BB05,,0,1
PA449594,fenofibrate,C10AB05;C10BA03;C10BA04;C10BA09;C10BA12,,0,1
PA449594,fenofibrate,C10AB05;C10BA03;C10BA04;C10BA09;C10BA12,Hypertriglyceridemia,0,1
PA449594,fenofibrate,C10AB05;C10BA03;C10BA04;C10BA09;C10BA12,Metabolic Syndrome,0,1
PA449594,fenofibrate,C10AB05;C10BA03;C10BA04;C10BA09;C10BA12,Diabetes Mellitus,0,1
PA449594,fenofibrate,C10AB05;C10BA03;C10BA04;C10BA09;C10BA12,Cardiovascular Diseases,0,1
C006012,Fenofibric acid,,,0,1
PA10079,fenoterol,G02CA03;R03AC04;R03AL01;R03CC04,,0,1
PA449599,fentanyl,N01AH01;N01AH51;N02AB03,"Sexual Dysfunctions, Psychological",0,1
PA449599,fentanyl,N01AH01;N01AH51;N02AB03,Nausea,0,1
PA449599,fentanyl,N01AH01;N01AH51;N02AB03,Neoplasms,0,1
PA449599,fentanyl,N01AH01;N01AH51;N02AB03,"Pain, Postoperative",0,1
PA449599,fentanyl,N01AH01;N01AH51;N02AB03,Pain,0,1
PA449599,fentanyl,N01AH01;N01AH51;N02AB03,Respiratory Insufficiency,0,1
PA449599,fentanyl,N01AH01;N01AH51;N02AB03,Opioid-Related Disorders,0,1
PA449599,fentanyl,N01AH01;N01AH51;N02AB03,Exanthema,0,1
PA449599,fentanyl,N01AH01;N01AH51;N02AB03,adverse events,0,1
PA449599,fentanyl,N01AH01;N01AH51;N02AB03,Vomiting,0,1
PA449599,fentanyl,N01AH01;N01AH51;N02AB03,,0,1
PA449599,fentanyl,N01AH01;N01AH51;N02AB03,Hypotension,0,1
PA449599,fentanyl,N01AH01;N01AH51;N02AB03,somnolence,0,1
PA165958376,fesoterodine,G04BD11,,0,1
PA449621,fexofenadine,R06AX26,,0,1
PA449627,finasteride,D11AX10;G04CA51;G04CA55;G04CB01;G04CB51,,0,1
D000068876,Fingolimod,,,0,1
PA449646,flecainide,C01BC04,,0,1
PA449646,flecainide,C01BC04,Myotonic Disorders,0,1
PA449646,flecainide,C01BC04,"Arrhythmias, Cardiac",0,1
PA449646,flecainide,C01BC04,Myotonia,0,1
PA166153431,flibanserin,G02CX02,,0,1
PA164781042,flucloxacillin,J01CF05;J01CR50,Toxic liver disease,1,0
PA164781042,flucloxacillin,J01CF05;J01CR50,drug-induced liver injury,1,0
PA164781042,flucloxacillin,J01CF05;J01CR50,,1,0
PA449653,fluconazole,D01AC15;J01RA07;J02AC01,,1,0
PA449654,flucytosine,D01AE21;J02AX01,,1,0
PA449655,fludarabine,L01BB05,,0,1
PA449655,fludarabine,L01BB05,"Leukemia, Myeloid, Acute",0,1
PA449655,fludarabine,L01BB05,"Leukemia, Lymphocytic, Chronic, B-Cell",0,1
PA165980614,fluindione,,Thromboembolism,0,1
PA165980614,fluindione,,,0,1
PA449661,flunisolide,R01AD04;R03BA03,Asthma,0,1
PA449661,flunisolide,R01AD04;R03BA03,,0,1
PA128406956,fluorouracil,L01BC02;L01BC52,Neutropenia,0,1
PA128406956,fluorouracil,L01BC02;L01BC52,Stomach Neoplasms,0,1
PA128406956,fluorouracil,L01BC02;L01BC52,Uterine Cervical Neoplasms,0,1
PA128406956,fluorouracil,L01BC02;L01BC52,Leukopenia,0,1
PA128406956,fluorouracil,L01BC02;L01BC52,Colorectal Neoplasms,0,1
PA128406956,fluorouracil,L01BC02;L01BC52,progression-free survival,0,1
PA128406956,fluorouracil,L01BC02;L01BC52,Neoplasms,0,1
PA128406956,fluorouracil,L01BC02;L01BC52,Rectal Neoplasms,0,1
PA128406956,fluorouracil,L01BC02;L01BC52,Colonic Neoplasms,0,1
PA128406956,fluorouracil,L01BC02;L01BC52,"Carcinoma, Squamous Cell",0,1
PA128406956,fluorouracil,L01BC02;L01BC52,,0,1
PA128406956,fluorouracil,L01BC02;L01BC52,Neoplasm Metastasis,0,1
PA128406956,fluorouracil,L01BC02;L01BC52,"Carcinoma, Hepatocellular",0,1
PA128406956,fluorouracil,L01BC02;L01BC52,Liver Neoplasms,0,1
PA128406956,fluorouracil,L01BC02;L01BC52,Pancreatic Neoplasms,0,1
PA128406956,fluorouracil,L01BC02;L01BC52,overall survival,0,1
PA128406956,fluorouracil,L01BC02;L01BC52,Breast Neoplasms,0,1
PA128406956,fluorouracil,L01BC02;L01BC52,Drug Toxicity,0,1
PA128406956,fluorouracil,L01BC02;L01BC52,Ovarian Neoplasms,0,1
PA128406956,fluorouracil,L01BC02;L01BC52,Esophageal Neoplasms,0,1
PA166183787,fluorouracil / salicylic acid,,,0,1
PA449673,fluoxetine,N06AB03;N06CA03,"Depressive Disorder, Major",0,1
PA449673,fluoxetine,N06AB03;N06CA03,Mental Disorders,0,1
PA449673,fluoxetine,N06AB03;N06CA03,,0,1
PA449673,fluoxetine,N06AB03;N06CA03,Depression,0,1
PA449673,fluoxetine,N06AB03;N06CA03,Anxiety Disorders,0,1
PA449673,fluoxetine,N06AB03;N06CA03,Depressive Disorder,0,1
PA449673,fluoxetine,N06AB03;N06CA03,Mood Disorders,0,1
PA166176027,fluoxetine / olanzapine,,,0,1
PA10268,flupenthixol,N05AF01,,0,1
PA449676,fluphenazine,N05AB02,,0,1
PA449676,fluphenazine,N05AB02,Schizophrenia,0,1
PA166152829,flupirtine,N02BG07,,0,1
PA166152829,flupirtine,N02BG07,drug-induced liver injury,0,1
PA449683,flurbiprofen,M01AE09;M02AA19;R02AX01;S01BC04,,0,1
PA449685,flutamide,L02BB01,,0,1
PA449686,fluticasone propionate,,Asthma,0,1
PA449686,fluticasone propionate,,,0,1
PA165290926,fluticasone/salmeterol,,,0,1
PA449688,fluvastatin,C10AA04,Hypercholesterolemia,0,1
PA449688,fluvastatin,C10AA04,Coronary Artery Disease,0,1
PA449688,fluvastatin,C10AA04,,0,1
PA449688,fluvastatin,C10AA04,statin-related myopathy,0,1
PA449690,fluvoxamine,N06AB08,"Depressive Disorder, Major",0,1
PA449690,fluvoxamine,N06AB08,Depressive Disorder,0,1
PA449690,fluvoxamine,N06AB08,Depression,0,1
PA449690,fluvoxamine,N06AB08,,0,1
PA166182863,FOLFIRI,,overall survival,0,1
PA166182863,FOLFIRI,,Diarrhea,0,1
PA166182863,FOLFIRI,,Neutropenia,0,1
PA166182863,FOLFIRI,,progression-free survival,0,1
PA166182863,FOLFIRI,,,0,1
PA166240141,FOLFIRINOX,,Thrombocytopenia,0,1
PA166240141,FOLFIRINOX,,,0,1
PA166240141,FOLFIRINOX,,Pancreatic Neoplasms,0,1
PA166182862,FOLFOX,,Neoplasms,0,1
PA166182862,FOLFOX,,,0,1
PA166182862,FOLFOX,,progression-free survival,0,1
PA166182862,FOLFOX,,overall survival,0,1
PA449692,folic acid,B03AD01;B03AD02;B03AD03;B03AD04;B03AD05;B03AE01;B03AE02;B03BB01;B03BB51;V04CX02,Neoplasms,0,1
PA449692,folic acid,B03AD01;B03AD02;B03AD03;B03AD04;B03AD05;B03AE01;B03AE02;B03BB01;B03BB51;V04CX02,Migraine with Aura,0,1
PA449692,folic acid,B03AD01;B03AD02;B03AD03;B03AD04;B03AD05;B03AE01;B03AE02;B03BB01;B03BB51;V04CX02,"Arthritis, Rheumatoid",0,1
PA449692,folic acid,B03AD01;B03AD02;B03AD03;B03AD04;B03AD05;B03AE01;B03AE02;B03BB01;B03BB51;V04CX02,,0,1
PA449693,follitropin beta,G03GA05;G03GA06;G03GA10,Ovarian hyperstimulation syndrome,0,1
PA449693,follitropin beta,G03GA05;G03GA06;G03GA10,"Infertility, Female",0,1
PA449693,follitropin beta,G03GA05;G03GA06;G03GA10,,0,1
PA134687907,formoterol,R03AC13;R03AK07;R03AK08;R03AK09;R03AK11;R03AL05;R03AL07;R03AL09;R03AL10;R03AL11;R03CC15,,0,1
PA10084,fosamprenavir,J05AE07,,1,0
PA166252761,fosdenopterin,,,0,1
PA164746820,fosphenytoin,N03AB05,,0,1
PA164747170,fulvestrant,L02BA03,,0,1
PA449719,furosemide,C03CA01;C03CB01;C03EB01;G01AE10,,0,1
PA449719,furosemide,C03CA01;C03CB01;C03EB01;G01AE10,Heart Failure,0,1
PA449719,furosemide,C03CA01;C03CB01;C03EB01;G01AE10,Liver Cirrhosis,0,1
PA449720,gabapentin,N02BF01,,0,1
PA449720,gabapentin,N02BF01,adverse events,0,1
PA449720,gabapentin,N02BF01,neuropathic pain,0,1
PA165985534,Gadoxetic acid,V08CA10,,0,1
PA449726,galantamine,N06DA04,Dementia,0,1
PA449726,galantamine,N06DA04,Alzheimer Disease,0,1
PA449726,galantamine,N06DA04,,0,1
PA166278301,ganaxolone,N03AX27,,0,1
PA131301952,gefitinib,L01EB01,"Carcinoma, Non-Small-Cell Lung",0,1
PA131301952,gefitinib,L01EB01,Drug Resistance,0,1
PA131301952,gefitinib,L01EB01,Lung Neoplasms,0,1
PA131301952,gefitinib,L01EB01,Adenocarcinoma,0,1
PA131301952,gefitinib,L01EB01,Drug Toxicity,0,1
PA131301952,gefitinib,L01EB01,,0,1
PA131301952,gefitinib,L01EB01,Exanthema,0,1
PA131301952,gefitinib,L01EB01,Diarrhea,0,1
PA131301952,gefitinib,L01EB01,Neoplasms,0,1
PA131301952,gefitinib,L01EB01,Toxic liver disease,0,1
PA152031327,geldanamycin,,Neoplasms,0,1
PA449748,gemcitabine,L01BC05,,0,1
PA449748,gemcitabine,L01BC05,Amenorrhea,0,1
PA449748,gemcitabine,L01BC05,Mesothelioma,0,1
PA449748,gemcitabine,L01BC05,Neutropenia,0,1
PA449748,gemcitabine,L01BC05,"Carcinoma, Non-Small-Cell Lung",0,1
PA449748,gemcitabine,L01BC05,Thrombocytopenia,0,1
PA449748,gemcitabine,L01BC05,Nausea,0,1
PA449748,gemcitabine,L01BC05,Breast Neoplasms,0,1
PA449748,gemcitabine,L01BC05,Neoplasms,0,1
PA449748,gemcitabine,L01BC05,Pancreatic Neoplasms,0,1
PA449748,gemcitabine,L01BC05,Leukopenia,0,1
PA449750,gemfibrozil,C10AB04,,0,1
PA164749431,gemtuzumab ozogamicin,L01FX02,"Leukemia, Myeloid, Acute",0,1
PA164749431,gemtuzumab ozogamicin,L01FX02,,0,1
PA449753,gentamicin,D06AX07;J01GB03;S01AA11;S02AA14;S03AA06,,1,0
PA449753,gentamicin,D06AX07;J01GB03;S01AA11;S02AA14;S03AA06,Ototoxicity,1,0
PA166182767,gilteritinib,,,0,1
PA166190681,givosiran,,,0,1
PA449760,glatiramer acetate,L03AX13,,0,1
PA10892,gliclazide,A10BB09;G01AE10,Diabetes Mellitus,0,1
PA10892,gliclazide,A10BB09;G01AE10,,0,1
PA449761,glimepiride,A10BB12;A10BD04;A10BD06,,0,1
PA449761,glimepiride,A10BB12;A10BD04;A10BD06,"Diabetes Mellitus, Type 2",0,1
PA449761,glimepiride,A10BB12;A10BD04;A10BD06,Hypoglycemia,0,1
PA449762,glipizide,A10BB07,Hypoglycemia,0,1
PA449762,glipizide,A10BB07,"Diabetes Mellitus, Type 2",0,1
PA449762,glipizide,A10BB07,,0,1
PA164744895,gliquidone,A10BB08,,0,1
PA164779052,glucagon recombinant,H04AA01,,0,1
PA165949771,Glucarpidase,,nephrotoxicity,0,1
PA165949771,Glucarpidase,,,0,1
PA452347,glucocorticoids,,Asthma,0,1
PA452347,glucocorticoids,,"Arthritis, Rheumatoid",0,1
PA452347,glucocorticoids,,,0,1
PA449773,glucose,,,0,1
PA449782,glyburide,A10BB01,,0,1
PA449782,glyburide,A10BB01,"Anemia, Hemolytic",0,1
PA449782,glyburide,A10BB01,Hypoglycemia,0,1
PA449782,glyburide,A10BB01,"Diabetes Mellitus, Type 2",0,1
PA166268801,glycerol phenylbutyrate,,,0,1
D001622,Glycine betaine,,,0,1
PA166190721,golodirsen,,,0,1
PA164747674,goserelin,L02AE03,,0,1
PA449809,granisetron,A04AA02,Nausea,0,1
PA449809,granisetron,A04AA02,Neoplasms,0,1
PA449809,granisetron,A04AA02,Vomiting,0,1
PA449809,granisetron,A04AA02,,0,1
PA449809,granisetron,A04AA02,Postoperative Nausea and Vomiting,0,1
PA166163437,grazoprevir,J05AP11;J05AP54,,1,0
PA449841,haloperidol,N05AD01,Psychotic Disorders,0,1
PA449841,haloperidol,N05AD01,Weight gain,0,1
PA449841,haloperidol,N05AD01,,0,1
PA449841,haloperidol,N05AD01,Hypertriglyceridemia,0,1
PA449841,haloperidol,N05AD01,Schizophrenia,0,1
PA449841,haloperidol,N05AD01,schizoaffective disorder,0,1
PA449841,haloperidol,N05AD01,Autism Spectrum Disorder,0,1
PA449845,halothane,N01AB01,,0,1
PA449845,halothane,N01AB01,Malignant Hyperthermia,0,1
PA166129559,hdl cholesterol,,,0,1
PA166129559,hdl cholesterol,,Menopause,0,1
PA166129559,hdl cholesterol,,Breast Neoplasms,0,1
PA449855,heparin,B01AB01;B01AB51;C05BA03;C05BA53;S01XA14,heparin-induced thrombocytopenia,0,1
PA449855,heparin,B01AB01;B01AB51;C05BA03;C05BA53;S01XA14,,0,1
PA164712789,Hepatitis vaccines,,,1,0
PA452619,heroin,N07BC06,Heroin Dependence,0,1
PA452619,heroin,N07BC06,Cocaine-Related Disorders,0,1
PA452619,heroin,N07BC06,Memory Disorders,0,1
PA452619,heroin,N07BC06,,0,1
PA452619,heroin,N07BC06,Opioid-Related Disorders,0,1
PA452619,heroin,N07BC06,Substance-Related Disorders,0,1
PA166177229,highly active antiretroviral therapy (haart),,,1,0
PA166177229,highly active antiretroviral therapy (haart),,HIV Infections,1,0
PA133950441,hmg coa reductase inhibitors,,Myalgia unspecified,0,1
PA133950441,hmg coa reductase inhibitors,,Myocardial Infarction,0,1
PA133950441,hmg coa reductase inhibitors,,Colonic Neoplasms,0,1
PA133950441,hmg coa reductase inhibitors,,Schizophrenia,0,1
PA133950441,hmg coa reductase inhibitors,,Acute coronary syndrome,0,1
PA133950441,hmg coa reductase inhibitors,,Hypercholesterolemia,0,1
PA133950441,hmg coa reductase inhibitors,,Diabetes Mellitus,0,1
PA133950441,hmg coa reductase inhibitors,,Neoplasms,0,1
PA133950441,hmg coa reductase inhibitors,,Breast Neoplasms,0,1
PA133950441,hmg coa reductase inhibitors,,Menopause,0,1
PA133950441,hmg coa reductase inhibitors,,Asthma,0,1
PA133950441,hmg coa reductase inhibitors,,,0,1
PA133950441,hmg coa reductase inhibitors,,Hyperlipidemias,0,1
PA133950441,hmg coa reductase inhibitors,,statin-related myopathy,0,1
PA133950441,hmg coa reductase inhibitors,,Rhabdomyolysis,0,1
PA133950441,hmg coa reductase inhibitors,,Alzheimer Disease,0,1
PA133950441,hmg coa reductase inhibitors,,Muscular Diseases,0,1
PA133950441,hmg coa reductase inhibitors,,Coronary Artery Disease,0,1
PA164712781,"HMG CoA reductase inhibitors, other combinations",,Cardiovascular Diseases,0,1
PA164712781,"HMG CoA reductase inhibitors, other combinations",,,0,1
PA164712781,"HMG CoA reductase inhibitors, other combinations",,Rhabdomyolysis,0,1
PA166114929,homoharringtonine,,,0,1
PA452637,hormonal contraceptives for systemic use,,Thrombosis,0,1
PA452637,hormonal contraceptives for systemic use,,,0,1
PA452637,hormonal contraceptives for systemic use,,Stroke,0,1
PA452637,hormonal contraceptives for systemic use,,Venous Thrombosis,0,1
PA449894,hydralazine,C02DB02;C02LG02,Hypertension,0,1
PA449894,hydralazine,C02DB02;C02LG02,,0,1
PA166176017,hydralazine / isosorbide dinitrate,,Heart Failure,0,1
PA166176017,hydralazine / isosorbide dinitrate,,,0,1
PA449899,hydrochlorothiazide,C03AA03;C03AB03;C03AX01;C03EA01;C09BX03;C09DX01;C09DX03;C09DX06;C09DX07;C09DX08;C09XA52;C09XA54;G01AE10,Essential hypertension,0,1
PA449899,hydrochlorothiazide,C03AA03;C03AB03;C03AX01;C03EA01;C09BX03;C09DX01;C09DX03;C09DX06;C09DX07;C09DX08;C09XA52;C09XA54;G01AE10,Diabetes Mellitus,0,1
PA449899,hydrochlorothiazide,C03AA03;C03AB03;C03AX01;C03EA01;C09BX03;C09DX01;C09DX03;C09DX06;C09DX07;C09DX08;C09XA52;C09XA54;G01AE10,Hyperglycemia,0,1
PA449899,hydrochlorothiazide,C03AA03;C03AB03;C03AX01;C03EA01;C09BX03;C09DX01;C09DX03;C09DX06;C09DX07;C09DX08;C09XA52;C09XA54;G01AE10,,0,1
PA449899,hydrochlorothiazide,C03AA03;C03AB03;C03AX01;C03EA01;C09BX03;C09DX01;C09DX03;C09DX06;C09DX07;C09DX08;C09XA52;C09XA54;G01AE10,Hypertension,0,1
PA449900,hydrocodone,R05DA03,Opioid-Related Disorders,0,1
PA449900,hydrocodone,R05DA03,Pain,0,1
PA449900,hydrocodone,R05DA03,adverse events,0,1
PA449900,hydrocodone,R05DA03,Constipation,0,1
PA449900,hydrocodone,R05DA03,dry mouth,0,1
PA449900,hydrocodone,R05DA03,Respiratory Insufficiency,0,1
PA449900,hydrocodone,R05DA03,,0,1
PA449900,hydrocodone,R05DA03,Drug Toxicity,0,1
PA449905,hydrocortisone,A01AC03;A07EA02;C05AA01;D07AA02;D07BA04;D07CA01;D07XA01;H02AB09;R01AD60;S01BA02;S01BB01;S01CA03;S01CB03;S02BA01;S02CA03;S03CA04,,0,1
PA449918,hydromorphone,N02AA03;N02AA53;N02AG04,,0,1
PA449924,hydroquinone,D11AX11,,0,1
PA165946747,hydroxyamitriptyline,,,0,1
PA166226561,hydroxybupropion,,,0,1
PA164777036,hydroxychloroquine,P01BA02,"Arthritis, Rheumatoid",1,0
PA164777036,hydroxychloroquine,P01BA02,,1,0
PA165823907,hydroxyphenytoin,,,0,1
PA449942,hydroxyurea,L01XX05,,0,1
PA449942,hydroxyurea,L01XX05,Thalassemia,0,1
PA164781375,ibritumomab,V10XX02,,0,1
PA166121346,ibrutinib,L01EL01,,0,1
PA449957,ibuprofen,C01EB16;G02CC01;M01AE01;M01AE51;M02AA13;N02AJ08;N02AJ19;R02AX02,"Pain, Postoperative",0,1
PA449957,ibuprofen,C01EB16;G02CC01;M01AE01;M01AE51;M02AA13;N02AJ08;N02AJ19;R02AX02,,0,1
PA449958,ibutilide,C01BD05,,0,1
PA166114460,icotinib,L01EB08,,0,1
PA449961,idarubicin,L01DB06,Neoplasms,0,1
PA449961,idarubicin,L01DB06,"Leukemia, Myeloid, Acute",0,1
PA449961,idarubicin,L01DB06,,0,1
PA449964,ifosfamide,L01AA06,,0,1
PA166178387,iguratimod,,,0,1
PA161199368,iloperidone,N05AX14,,0,1
PA161199368,iloperidone,N05AX14,Acquired Long QT Syndrome (aLQTS),0,1
PA161199368,iloperidone,N05AX14,Schizophrenia,0,1
PA10804,imatinib,L01EA01,,0,1
PA10804,imatinib,L01EA01,Neoplasms,0,1
PA10804,imatinib,L01EA01,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",0,1
PA10804,imatinib,L01EA01,Gastrointestinal Stromal Tumors,0,1
PA10804,imatinib,L01EA01,Drug Toxicity,0,1
PA452640,imidapril,C09AA16,Essential hypertension,0,1
PA452640,imidapril,C09AA16,Cough,0,1
PA452640,imidapril,C09AA16,Hypertension,0,1
PA452640,imidapril,C09AA16,,0,1
PA449969,imipramine,N06AA02,Depressive Disorder,0,1
PA449969,imipramine,N06AA02,,0,1
PA449969,imipramine,N06AA02,Mental Disorders,0,1
PA449969,imipramine,N06AA02,"Depressive Disorder, Major",0,1
PA449972,imiquimod,D06BB10,,0,1
PA449972,imiquimod,D06BB10,"Carcinoma, Basal Cell",0,1
PA164712817,Immunoglobulins,,,0,1
PA166268802,inclisiran,,,0,1
PA165958348,indacaterol,R03AC18;R03AK14;R03AL04;R03AL12,,0,1
PA449977,indinavir,J05AE02,HIV Infections,1,0
PA449977,indinavir,J05AE02,,1,0
PA449982,indomethacin,C01EB03;M01AB01;M01AB51;M02AA23;S01BC01;S01CC02,,0,1
PA166224921,inebilizumab-cdon,,,0,1
PA166252061,infigratinib,,,0,1
PA452639,infliximab,L04AB02,Psoriasis,0,1
PA452639,infliximab,L04AB02,"Arthritis, Rheumatoid",0,1
PA452639,infliximab,L04AB02,"Arthritis, Psoriatic",0,1
PA452639,infliximab,L04AB02,,0,1
PA452639,infliximab,L04AB02,Crohn Disease,0,1
PA452639,infliximab,L04AB02,drug-induced liver injury,0,1
PA164712830,Influenza vaccines,,,1,0
PA164712830,Influenza vaccines,,Narcolepsy,1,0
C486592,Ingenol mebutate,,,0,1
PA166182756,inotersen,,,0,1
PA166177510,inotuzumab ozogamicin,,,0,1
PA164744571,insulin recombinant,A10AB01;A10AC01;A10AD01;A10AE01;A10AF01,,0,1
PA164712832,Insulins And Analogues,,,0,1
PA164779048,"interferon alfa-2a, recombinant",L03AB04,,0,1
PA164779048,"interferon alfa-2a, recombinant",L03AB04,"Hepatitis C, Chronic",0,1
PA164779048,"interferon alfa-2a, recombinant",L03AB04,Hepatitis C,0,1
PA164779048,"interferon alfa-2a, recombinant",L03AB04,HIV Infections,0,1
PA164783990,"interferon alfa-2b, recombinant",L03AB05,"Hepatitis C, Chronic",0,1
PA164783990,"interferon alfa-2b, recombinant",L03AB05,,0,1
PA164783990,"interferon alfa-2b, recombinant",L03AB05,HIV Infections,0,1
PA164746538,interferon alfa-n1,L03AB06,,0,1
PA450037,interferon beta-1a,L03AB07,Multiple Sclerosis,0,1
PA450037,interferon beta-1a,L03AB07,drug-induced liver injury,0,1
PA450037,interferon beta-1a,L03AB07,,0,1
PA450039,interferon beta-1b,L03AB08,drug-induced liver injury,0,1
PA450039,interferon beta-1b,L03AB08,Multiple Sclerosis,0,1
PA450039,interferon beta-1b,L03AB08,,0,1
PA451999,interferons,,"Carcinoma, Renal Cell",0,1
PA451999,interferons,,Hepatitis C,0,1
PA451999,interferons,,"Hepatitis C, Chronic",0,1
PA451999,interferons,,,0,1
PA164712848,Iodine (131I) compounds,,,0,1
PA166182718,ipilimumab,,,0,1
PA450084,irbesartan,C09CA04;C09DA04;C09DB05;C09DX07,Hypertension,0,1
PA450084,irbesartan,C09CA04;C09DA04;C09DB05;C09DX07,,0,1
PA450084,irbesartan,C09CA04;C09DA04;C09DB05;C09DX07,Essential hypertension,0,1
PA450084,irbesartan,C09CA04;C09DA04;C09DB05;C09DX07,"Hypertrophy, Left Ventricular",0,1
PA450085,irinotecan,L01CE02,Colonic Neoplasms,0,1
PA450085,irinotecan,L01CE02,Lymphoma,0,1
PA450085,irinotecan,L01CE02,Colorectal Neoplasms,0,1
PA450085,irinotecan,L01CE02,"Carcinoma, Non-Small-Cell Lung",0,1
PA450085,irinotecan,L01CE02,Neoplasms,0,1
PA450085,irinotecan,L01CE02,Neutropenia,0,1
PA450085,irinotecan,L01CE02,Diarrhea,0,1
PA450085,irinotecan,L01CE02,,0,1
PA450085,irinotecan,L01CE02,"Carcinoma, Small Cell",0,1
PA166224941,isatuximab,,,0,1
PA166241781,isepamicin,,Ototoxicity,1,0
PA450106,isoflurane,N01AB06,,0,1
PA450106,isoflurane,N01AB06,Malignant Hyperthermia,0,1
PA450112,isoniazid,J04AC01;J04AC51;J04AM01;J04AM02;J04AM03;J04AM04;J04AM05;J04AM06;J04AM07;J04AM08,"Hepatitis, Toxic",1,0
PA450112,isoniazid,J04AC01;J04AC51;J04AM01;J04AM02;J04AM03;J04AM04;J04AM05;J04AM06;J04AM07;J04AM08,Drug Toxicity,1,0
PA450112,isoniazid,J04AC01;J04AC51;J04AM01;J04AM02;J04AM03;J04AM04;J04AM05;J04AM06;J04AM07;J04AM08,Drug interaction with drug,1,0
PA450112,isoniazid,J04AC01;J04AC51;J04AM01;J04AM02;J04AM03;J04AM04;J04AM05;J04AM06;J04AM07;J04AM08,Maculopapular Exanthema,1,0
PA450112,isoniazid,J04AC01;J04AC51;J04AM01;J04AM02;J04AM03;J04AM04;J04AM05;J04AM06;J04AM07;J04AM08,,1,0
PA450112,isoniazid,J04AC01;J04AC51;J04AM01;J04AM02;J04AM03;J04AM04;J04AM05;J04AM06;J04AM07;J04AM08,drug-induced liver injury,1,0
PA450112,isoniazid,J04AC01;J04AC51;J04AM01;J04AM02;J04AM03;J04AM04;J04AM05;J04AM06;J04AM07;J04AM08,Toxic liver disease,1,0
PA450112,isoniazid,J04AC01;J04AC51;J04AM01;J04AM02;J04AM03;J04AM04;J04AM05;J04AM06;J04AM07;J04AM08,Tuberculosis,1,0
PA166176022,isoniazid / pyrazinamide / rifampin,,,1,0
PA450121,isoproterenol,C01CA02;R03AB02;R03AK02;R03CB01;R03CB51,,0,1
PA450125,isosorbide dinitrate,C01DA08;C01DA58;C05AE02,,0,1
PA450126,isosorbide mononitrate,C01DA14,,0,1
PA450128,isotretinoin,D10AD04;D10AD54;D10BA01,,0,1
PA152432599,itopride,A03FA07,,0,1
PA450132,itraconazole,J02AC02,,1,0
PA166123415,ivabradine,C01EB17;C07FX05;C07FX06,,0,1
PA165950341,ivacaftor,R07AX02;R07AX30;R07AX31;R07AX32,,0,1
PA165950341,ivacaftor,R07AX02;R07AX30;R07AX31;R07AX32,Cystic Fibrosis,0,1
PA166152935,ivacaftor / lumacaftor,,Cystic Fibrosis,0,1
PA166152935,ivacaftor / lumacaftor,,,0,1
PA166179845,ivacaftor / tezacaftor,,Cystic Fibrosis,0,1
PA166179845,ivacaftor / tezacaftor,,,0,1
PA450133,ivermectin,D11AX22;P02CF01,,1,0
PA166182707,ivosidenib,,,0,1
PA165110439,ixabepilone,,,0,1
PA450137,kanamycin,A07AA08;J01GB04;S01AA24,Ototoxicity,1,0
PA450144,ketamine,N01AX03,,0,1
PA450144,ketamine,N01AX03,Neoplasms,0,1
PA450144,ketamine,N01AX03,Pain,0,1
PA450146,ketoconazole,D01AC08;G01AF11;G01AF20;H02CA03;J02AB02;H02CA04,,1,0
PA450149,ketoprofen,M01AE03;M01AE53;M02AA10,,0,1
PA450149,ketoprofen,M01AE03;M01AE53;M02AA10,"Pain, Postoperative",0,1
PA450149,ketoprofen,M01AE03;M01AE53;M02AA10,Dyspepsia,0,1
PA450150,ketorolac,M01AB15;S01BC05;S01FB51,,0,1
PA450150,ketorolac,M01AB15;S01BC05;S01FB51,"Pain, Postoperative",0,1
PA166182939,l-methylfolate,,"Depressive Disorder, Major",0,1
PA450931,l-phenylalanine,,,0,1
PA10323,l-tryptophan,N06AX02,,0,1
PA164743150,labetalol,C07AG01;C07BG01;C07CG01,,0,1
PA166187141,lacidipine,,,0,1
PA166160048,lacosamide,N03AX18,,0,1
PA450163,lamivudine,J05AF05;J05AR01;J05AR02;J05AR04;J05AR05;J05AR07;J05AR11;J05AR12;J05AR13;J05AR16;J05AR24;J05AR25;J05AR27,HIV Infections,1,0
PA450163,lamivudine,J05AF05;J05AR01;J05AR02;J05AR04;J05AR05;J05AR07;J05AR11;J05AR12;J05AR13;J05AR16;J05AR24;J05AR25;J05AR27,,1,0
PA166184501,lamivudine / abacavir,,,1,0
PA450164,lamotrigine,N03AX09,,0,1
PA450164,lamotrigine,N03AX09,"Epidermal Necrolysis, Toxic",0,1
PA450164,lamotrigine,N03AX09,Maculopapular Exanthema,0,1
PA450164,lamotrigine,N03AX09,severe cutaneous adverse reactions,0,1
PA450164,lamotrigine,N03AX09,Stevens-Johnson Syndrome,0,1
PA450164,lamotrigine,N03AX09,Epilepsy,0,1
PA450180,lansoprazole,A02BC03;A02BC53;A02BD02;A02BD03;A02BD07;A02BD09;A02BD10,Transplantation,0,1
PA450180,lansoprazole,A02BC03;A02BC53;A02BD02;A02BD03;A02BD07;A02BD09;A02BD10,Helicobacter Infections,0,1
PA450180,lansoprazole,A02BC03;A02BC53;A02BD02;A02BD03;A02BD07;A02BD09;A02BD10,,0,1
PA450180,lansoprazole,A02BC03;A02BC53;A02BD02;A02BD03;A02BD07;A02BD09;A02BD10,Gastroesophageal Reflux,0,1
PA152241907,lapatinib,L01EH01,Toxic liver disease,0,1
PA152241907,lapatinib,L01EH01,,0,1
PA166182733,larotrectinib sulfate,,,0,1
PA164774763,latanoprost,S01EE01;S01EE51,,0,1
PA164774763,latanoprost,S01EE01;S01EE51,"Glaucoma, Open-Angle",0,1
PA166128166,ledipasvir,J05AP51,,1,0
PA166128166,ledipasvir,J05AP51,"Hepatitis C, Chronic",1,0
PA166128166,ledipasvir,J05AP51,Recurrence,1,0
PA166163427,ledipasvir / sofosbuvir,,,1,0
PA450192,leflunomide,L04AA13,,0,1
PA450192,leflunomide,L04AA13,"Arthritis, Rheumatoid",0,1
PA162363968,lenalidomide,L04AX04,Multiple Myeloma,0,1
PA162363968,lenalidomide,L04AX04,,0,1
PA162363968,lenalidomide,L04AX04,progression-free survival,0,1
PA166153472,lenvatinib,L01EX08,,0,1
PA166160006,lesinurad,M04AB05,,0,1
PA166184379,letermovir,,,1,0
PA450196,letrozole,L02BG04,Breast Neoplasms,0,1
PA450196,letrozole,L02BG04,Menopause,0,1
PA450196,letrozole,L02BG04,,0,1
PA450196,letrozole,L02BG04,Neoplasms,0,1
PA450198,leucovorin,V03AF03;V03AF06;V03AF04;V03AF10,,0,1
PA450198,leucovorin,V03AF03;V03AF06;V03AF04;V03AF10,Neoplasms,0,1
PA450198,leucovorin,V03AF03;V03AF06;V03AF04;V03AF10,Neoplasms,0,1
PA450198,leucovorin,V03AF03;V03AF06;V03AF04;V03AF10,Colonic Neoplasms,0,1
PA450198,leucovorin,V03AF03;V03AF06;V03AF04;V03AF10,Colorectal Neoplasms,0,1
PA450198,leucovorin,V03AF03;V03AF06;V03AF04;V03AF10,Colorectal Neoplasms,0,1
PA450198,leucovorin,V03AF03;V03AF06;V03AF04;V03AF10,,0,1
PA450198,leucovorin,V03AF03;V03AF06;V03AF04;V03AF10,Colonic Neoplasms,0,1
PA450205,levamisole,P02CE01,,1,0
PA450206,levetiracetam,N03AX14,,0,1
PA450206,levetiracetam,N03AX14,Epilepsy,0,1
PA450206,levetiracetam,N03AX14,adverse events,0,1
PA450213,levodopa,N04BA01;N04BA02;N04BA03,Hallucinations,0,1
PA450213,levodopa,N04BA01;N04BA02;N04BA03,Cocaine-Related Disorders,0,1
PA450213,levodopa,N04BA01;N04BA02;N04BA03,Parkinson Disease,0,1
PA450213,levodopa,N04BA01;N04BA02;N04BA03,gastrointestinal toxicity,0,1
PA450213,levodopa,N04BA01;N04BA02;N04BA03,,0,1
PA450214,levofloxacin,A02BD10;J01MA12;J01RA05;S01AE05,,1,0
PA134687942,levomepromazine,,,0,1
PA450218,levonorgestrel,G03AA07;G03AB03;G03AC03;G03AD01;G03FA11;G03FB09,,0,1
PA450226,lidocaine,C01BB01;C05AD01;D04AB01;N01BB02;N01BB52;R02AD02;S01HA07;S02DA01,,0,1
PA166176018,lidocaine / prilocaine,,,0,1
PA166182735,lidocaine and tetracaine,,,0,1
D000069476,Linagliptin,,,0,1
PA164778866,liothyronine,H03AA02;H03AA03,Depression,0,1
PA164778866,liothyronine,H03AA02;H03AA03,,0,1
PA165958364,liraglutide,A10AE56;A10BJ02,Polycystic Ovary Syndrome,0,1
PA165958364,liraglutide,A10AE56;A10BJ02,,0,1
PA165958364,liraglutide,A10AE56;A10BJ02,Obesity,0,1
PA450242,lisinopril,C09AA03;C09BA03;C09BB03;C10BX07,Heart Failure,0,1
PA450242,lisinopril,C09AA03;C09BA03;C09BB03;C10BX07,"Diabetes Mellitus, Type 1",0,1
PA450242,lisinopril,C09AA03;C09BA03;C09BB03;C10BX07,Hypertension,0,1
PA450242,lisinopril,C09AA03;C09BA03;C09BB03;C10BX07,Cough,0,1
PA450242,lisinopril,C09AA03;C09BA03;C09BB03;C10BX07,Essential hypertension,0,1
PA450242,lisinopril,C09AA03;C09BA03;C09BB03;C10BX07,,0,1
PA450243,lithium,,Depression,0,1
PA450243,lithium,,Bipolar Disorder,0,1
PA450243,lithium,,Depressive Disorder,0,1
PA450243,lithium,,,0,1
PA450243,lithium,,schizoaffective disorder,0,1
PA450243,lithium,,Psychotic Disorders,0,1
PA164744510,lofexidine,N07BC04,,0,1
PA166114922,lomitapide,C10AX12,,0,1
PA166129466,lonafarnib,A16AX20,,0,1
PA166129466,lonafarnib,A16AX20,Ovarian Neoplasms,0,1
PA450262,loperamide,A07DA03;A07DA53,,0,1
PA450264,lopinavir,J05AR10,,1,0
PA450264,lopinavir,J05AR10,HIV Infections,1,0
PA450266,loratadine,R06AX13,,0,1
PA450267,lorazepam,N05BA06;N05BA56,,0,1
PA166182743,lorlatinib,,,0,1
PA165958395,lornoxicam,M01AC05,,0,1
PA450268,losartan,C09CA01;C09DA01;C09DB06,,0,1
PA450268,losartan,C09CA01;C09DA01;C09DB06,Essential hypertension,0,1
PA450268,losartan,C09CA01;C09DA01;C09DB06,Liver Cirrhosis,0,1
PA450268,losartan,C09CA01;C09DA01;C09DB06,Hypertension,0,1
PA450272,lovastatin,C10AA02;C10BA01,Arteriosclerosis,0,1
PA450272,lovastatin,C10AA02;C10BA01,,0,1
PA450272,lovastatin,C10AA02;C10BA01,statin-related myopathy,0,1
PA450272,lovastatin,C10AA02;C10BA01,Hyperlipidemias,0,1
PA166163161,lovastatin acid,,,0,1
PA166165399,low density lipoprotein,,,0,1
PA166049180,loxoprofen,M02AA31,,0,1
PA166114483,lumacaftor,R07AX30,Cystic Fibrosis,0,1
PA166114483,lumacaftor,R07AX30,,0,1
PA166235281,lumasiran,,,0,1
PA165111722,lumefantrine,P01BF01,,1,0
PA165111722,lumefantrine,P01BF01,Malaria,1,0
PA164769031,lumiracoxib,M01AH06,,0,1
PA166129557,lurasidone,N05AE05,,0,1
PA166129557,lurasidone,N05AE05,Schizophrenia,0,1
PA166190001,luspatercept-aamt,,,0,1
PA166182748,lusutrombopag,,,0,1
PA166224981,lutetium (177Lu) oxodotreotide,,,0,1
PA166278141,lutetium (177lu) vipivotide tetraxetan,,,0,1
PA166114925,mafenide,,,1,0
PA450322,maprotiline,N06AA21,,0,1
PA450322,maprotiline,N06AA21,Depression,0,1
PA166268803,maralixibat,A05AX04,,0,1
PA164768835,maraviroc,J05AX09,HIV Infections,1,0
PA164768835,maraviroc,J05AX09,,1,0
PA166235241,margetuximab,,,0,1
PA166272922,mavacamten,C01EB24,,0,1
PA164712887,Measles vaccines,,,1,0
PA450338,meclizine,R06AE05;R06AE55,,0,1
PA450344,medroxyprogesterone,G03AA08;G03AA17;G03AC06;G03DA02;G03FA12;G03FB06;L02AB02,,0,1
PA450348,mefloquine,P01BC02;P01BF02,Malaria,1,0
PA450348,mefloquine,P01BC02;P01BF02,,1,0
PA164712893,Melatonin receptor agonists,,,0,1
PA450353,meloxicam,M01AC06;M01AC56;N01BB59,,0,1
PA450354,melphalan,L01AA03,,0,1
PA450354,melphalan,L01AA03,Multiple Myeloma,0,1
PA10364,memantine,N06DA52;N06DA53;N06DX01,,0,1
PA10364,memantine,N06DA52;N06DA53;N06DX01,Dementia,0,1
PA450369,meperidine,N02AB02;N02AB52;N02AB72;N02AG03,adverse events,0,1
PA450369,meperidine,N02AB02;N02AB52;N02AB72;N02AG03,,0,1
PA166184711,mephedrone,,,0,1
PA450373,mephenytoin,N03AB04;N03AB54,,0,1
PA164748741,mepivacaine,N01BB03;N01BB53,,0,1
PA450379,mercaptopurine,L01BB02;R03DA20,Leukopenia,0,1
PA450379,mercaptopurine,L01BB02;R03DA20,Pancreatitis,0,1
PA450379,mercaptopurine,L01BB02;R03DA20,Myelosuppression,0,1
PA450379,mercaptopurine,L01BB02;R03DA20,Crohn Disease,0,1
PA450379,mercaptopurine,L01BB02;R03DA20,gastrointestinal toxicity,0,1
PA450379,mercaptopurine,L01BB02;R03DA20,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0,1
PA450379,mercaptopurine,L01BB02;R03DA20,"Lupus Erythematosus, Systemic",0,1
PA450379,mercaptopurine,L01BB02;R03DA20,"Colitis, Ulcerative",0,1
PA450379,mercaptopurine,L01BB02;R03DA20,Irritable Bowel Syndrome,0,1
PA450379,mercaptopurine,L01BB02;R03DA20,Inflammatory Bowel Diseases,0,1
PA450379,mercaptopurine,L01BB02;R03DA20,Pancytopenia,0,1
PA450379,mercaptopurine,L01BB02;R03DA20,Thrombocytopenia,0,1
PA450379,mercaptopurine,L01BB02;R03DA20,dose reduction,0,1
PA450379,mercaptopurine,L01BB02;R03DA20,Neutropenia,0,1
PA450379,mercaptopurine,L01BB02;R03DA20,,0,1
PA450379,mercaptopurine,L01BB02;R03DA20,Drug Toxicity,0,1
PA450384,mesalazine,A07EC02,,0,1
PA166183788,metabutethamine,,,0,1
PA450395,metformin,A10BA02;A10BD02;A10BD03;A10BD05;A10BD07;A10BD08;A10BD10;A10BD11;A10BD13;A10BD14;A10BD15;A10BD16;A10BD17;A10BD18;A10BD20;A10BD22;A10BD23;A10BD25;A10BD26;A10BD27,Polycystic Ovary Syndrome,0,1
PA450395,metformin,A10BA02;A10BD02;A10BD03;A10BD05;A10BD07;A10BD08;A10BD10;A10BD11;A10BD13;A10BD14;A10BD15;A10BD16;A10BD17;A10BD18;A10BD20;A10BD22;A10BD23;A10BD25;A10BD26;A10BD27,,0,1
PA450395,metformin,A10BA02;A10BD02;A10BD03;A10BD05;A10BD07;A10BD08;A10BD10;A10BD11;A10BD13;A10BD14;A10BD15;A10BD16;A10BD17;A10BD18;A10BD20;A10BD22;A10BD23;A10BD25;A10BD26;A10BD27,"Diabetes Mellitus, Type 2",0,1
PA450395,metformin,A10BA02;A10BD02;A10BD03;A10BD05;A10BD07;A10BD08;A10BD10;A10BD11;A10BD13;A10BD14;A10BD15;A10BD16;A10BD17;A10BD18;A10BD20;A10BD22;A10BD23;A10BD25;A10BD26;A10BD27,Diabetes Mellitus,0,1
PA165958382,methacholine,V04CX03,Asthma,0,1
PA165958382,methacholine,V04CX03,,0,1
PA450398,methacholine chloride,,,0,1
PA450401,methadone,N02AC52;N07BC02,Sleep Disorders,0,1
PA450401,methadone,N02AC52;N07BC02,Heroin Dependence,0,1
PA450401,methadone,N02AC52;N07BC02,,0,1
PA450401,methadone,N02AC52;N07BC02,Pain,0,1
PA450401,methadone,N02AC52;N07BC02,Substance-Related Disorders,0,1
PA450401,methadone,N02AC52;N07BC02,Opioid-Related Disorders,0,1
PA450401,methadone,N02AC52;N07BC02,Pruritus,0,1
PA450401,methadone,N02AC52;N07BC02,Neonatal Abstinence Syndrome,0,1
PA450403,methamphetamine,N06BA03,,0,1
PA450403,methamphetamine,N06BA03,HIV Infections,0,1
PA450403,methamphetamine,N06BA03,Psychotic Disorders,0,1
PA450403,methamphetamine,N06BA03,Substance-Related Disorders,0,1
PA450403,methamphetamine,N06BA03,methamphetamine dependence,0,1
PA450413,methazolamide,G01AE10;S01EC05,,0,1
PA450413,methazolamide,G01AE10;S01EC05,Stevens-Johnson Syndrome,0,1
PA450413,methazolamide,G01AE10;S01EC05,"Epidermal Necrolysis, Toxic",0,1
PA450422,methimazole,H03BB02;H03BB52,Graves Disease,0,1
PA450422,methimazole,H03BB02;H03BB52,,0,1
PA450428,methotrexate,L01BA01;L04AX03,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0,1
PA450428,methotrexate,L01BA01;L04AX03,"Leukemia, Lymphoid",0,1
PA450428,methotrexate,L01BA01;L04AX03,cardiotoxicity,0,1
PA450428,methotrexate,L01BA01;L04AX03,Ovarian Neoplasms,0,1
PA450428,methotrexate,L01BA01;L04AX03,Stomach Neoplasms,0,1
PA450428,methotrexate,L01BA01;L04AX03,Anemia,0,1
PA450428,methotrexate,L01BA01;L04AX03,nephrotoxicity,0,1
PA450428,methotrexate,L01BA01;L04AX03,"Carcinoma, Non-Small-Cell Lung",0,1
PA450428,methotrexate,L01BA01;L04AX03,Agranulocytosis,0,1
PA450428,methotrexate,L01BA01;L04AX03,gastrointestinal toxicity,0,1
PA450428,methotrexate,L01BA01;L04AX03,"Arthritis, Rheumatoid",0,1
PA450428,methotrexate,L01BA01;L04AX03,Hematologic Neoplasms,0,1
PA450428,methotrexate,L01BA01;L04AX03,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",0,1
PA450428,methotrexate,L01BA01;L04AX03,Brain Diseases,0,1
PA450428,methotrexate,L01BA01;L04AX03,Burkitt Lymphoma,0,1
PA450428,methotrexate,L01BA01;L04AX03,Leukemia,0,1
PA450428,methotrexate,L01BA01;L04AX03,"Lymphoma, T-Cell",0,1
PA450428,methotrexate,L01BA01;L04AX03,Graft vs Host Disease,0,1
PA450428,methotrexate,L01BA01;L04AX03,Osteonecrosis,0,1
PA450428,methotrexate,L01BA01;L04AX03,"Leukemia, B-Cell, Acute",0,1
PA450428,methotrexate,L01BA01;L04AX03,Toxic liver disease,0,1
PA450428,methotrexate,L01BA01;L04AX03,Thrombocytopenia,0,1
PA450428,methotrexate,L01BA01;L04AX03,primary central nervous system lymphoma,0,1
PA450428,methotrexate,L01BA01;L04AX03,Osteosarcoma,0,1
PA450428,methotrexate,L01BA01;L04AX03,Psoriasis,0,1
PA450428,methotrexate,L01BA01;L04AX03,Neutropenia,0,1
PA450428,methotrexate,L01BA01;L04AX03,mucositis,0,1
PA450428,methotrexate,L01BA01;L04AX03,Breast Neoplasms,0,1
PA450428,methotrexate,L01BA01;L04AX03,"Lymphoma, Non-Hodgkin",0,1
PA450428,methotrexate,L01BA01;L04AX03,,0,1
PA450428,methotrexate,L01BA01;L04AX03,adverse events,0,1
PA450428,methotrexate,L01BA01;L04AX03,drug-induced liver injury,0,1
PA450428,methotrexate,L01BA01;L04AX03,Neoplasms,0,1
PA450428,methotrexate,L01BA01;L04AX03,Mesothelioma,0,1
PA450428,methotrexate,L01BA01;L04AX03,hematopoietic stem cell transplantation,0,1
PA450428,methotrexate,L01BA01;L04AX03,Drug Toxicity,0,1
PA450428,methotrexate,L01BA01;L04AX03,hematotoxicity,0,1
PA450428,methotrexate,L01BA01;L04AX03,Leukopenia,0,1
PA450428,methotrexate,L01BA01;L04AX03,Lymphoma,0,1
PA450428,methotrexate,L01BA01;L04AX03,"Arthritis, Juvenile Rheumatoid",0,1
PA450428,methotrexate,L01BA01;L04AX03,"Arthritis, Psoriatic",0,1
PA450428,methotrexate,L01BA01;L04AX03,"Neoplasm, Residual",0,1
PA450433,methoxsalen,D05AD02;D05BA02,,0,1
PA450434,methoxyflurane,N02BG09,Malignant Hyperthermia,0,1
PA450434,methoxyflurane,N02BG09,,0,1
PA164712898,Methyldopa,,,0,1
PA450457,methylene blue,,"Anemia, Hemolytic",0,1
PA450457,methylene blue,,,0,1
PA450457,methylene blue,,Protein Deficiency,0,1
PA450457,methylene blue,,Hemolysis,0,1
PA450464,methylphenidate,,Attention Deficit Disorder with Hyperactivity,0,1
PA450464,methylphenidate,,Autism Spectrum Disorder,0,1
PA450464,methylphenidate,,,0,1
PA450374,methylphenobarbital,N03AA01;N05CB01,,0,1
PA450466,methylprednisolone,D07AA01;D07CA02;D10AA02;H02AB04;H02BX01;S01CA08;S03CA07,,0,1
PA450466,methylprednisolone,D07AA01;D07CA02;D10AA02;H02AB04;H02BX01;S01CA08;S03CA07,Kidney Transplantation,0,1
PA450475,metoclopramide,A03FA01,,0,1
PA450480,metoprolol,C07AB02;C07BB02;C07BB52;C07CB02;C07FB02;C07FB13;C07FX03;C07FX05,,0,1
PA450480,metoprolol,C07AB02;C07BB02;C07BB52;C07CB02;C07FB02;C07FB13;C07FX03;C07FX05,Nephrosclerosis,0,1
PA450480,metoprolol,C07AB02;C07BB02;C07BB52;C07CB02;C07FB02;C07FB13;C07FX03;C07FX05,Heart Failure,0,1
PA450480,metoprolol,C07AB02;C07BB02;C07BB52;C07CB02;C07FB02;C07FB13;C07FX03;C07FX05,Kidney Diseases,0,1
PA450480,metoprolol,C07AB02;C07BB02;C07BB52;C07CB02;C07FB02;C07FB13;C07FX03;C07FX05,hypertensive nephrosclerosis,0,1
PA450480,metoprolol,C07AB02;C07BB02;C07BB52;C07CB02;C07FB02;C07FB13;C07FX03;C07FX05,Hypertension,0,1
PA450480,metoprolol,C07AB02;C07BB02;C07BB52;C07CB02;C07FB02;C07FB13;C07FX03;C07FX05,Tachycardia,0,1
PA166235301,metreleptin,,,0,1
PA450484,metronidazole,A01AB17;A02BD01;A02BD02;A02BD03;A02BD08;A02BD11;A02BD13;A02BD15;D06BX01;G01AF01;G01AF20;J01RA03;J01RA04;J01RA10;J01RA14;J01XD01;P01AB01;P01AB51;P01AB52,,1,0
PA450488,mexiletine,C01BB02,Myotonia,0,1
PA450488,mexiletine,C01BB02,Myotonic Disorders,0,1
PA450488,mexiletine,C01BB02,,0,1
PA134687937,mianserin,N06AX03,Depression,0,1
PA134687937,mianserin,N06AX03,,0,1
PA166241801,micronomicin,,Ototoxicity,1,0
PA450496,midazolam,N05CD08,Neoplasms,0,1
PA450496,midazolam,N05CD08,,0,1
PA166169917,midostaurin,,,0,1
PA166182881,migalastat,,Fabry Disease,0,1
PA166182881,migalastat,,,0,1
PA164752812,milnacipran,N06AX17,Depressive Disorder,0,1
PA164752812,milnacipran,N06AX17,,0,1
PA164752812,milnacipran,N06AX17,"Depressive Disorder, Major",0,1
PA450519,minocycline,A01AB23;D10AF07;J01AA08;J01AA20,drug-induced liver injury,1,0
PA450519,minocycline,A01AB23;D10AF07;J01AA08;J01AA20,,1,0
PA166114927,mipomersen,,,0,1
PA166177513,mirabegron,,,0,1
PA450522,mirtazapine,N06AX11,"Depressive Disorder, Major",0,1
PA450522,mirtazapine,N06AX11,Depression,0,1
PA450522,mirtazapine,N06AX11,,0,1
PA450522,mirtazapine,N06AX11,Psychotic Disorders,0,1
PA450522,mirtazapine,N06AX11,schizoaffective disorder,0,1
PA450522,mirtazapine,N06AX11,Depressive Disorder,0,1
PA450522,mirtazapine,N06AX11,Mood Disorders,0,1
PA450522,mirtazapine,N06AX11,Bipolar Disorder,0,1
PA450523,misoprostol,A02BB01;G02AD06;M01AE56,,0,1
PA166278021,mitapivat,,,0,1
PA450524,mitomycin,L01DC03,,0,1
PA164746157,mitotane,L01XX23,,0,1
PA164746157,mitotane,L01XX23,Adrenocortical Carcinoma,0,1
PA450526,mitoxantrone,L01DB07,,0,1
PA450526,mitoxantrone,L01DB07,"Leukemia, Myeloid, Acute",0,1
PA450526,mitoxantrone,L01DB07,Liver Neoplasms,0,1
PA450526,mitoxantrone,L01DB07,"Carcinoma, Hepatocellular",0,1
PA450528,mivacurium,M03AC10,,0,1
PA166129535,mizolastine,R06AX25,Urticaria,0,1
PA166129535,mizolastine,R06AX25,,0,1
PA166268804,mobocertinib,,,0,1
PA452615,moclobemide,N06AG02,,0,1
PA450530,modafinil,N06BA07,,0,1
PA450530,modafinil,N06BA07,methamphetamine dependence,0,1
PA450530,modafinil,N06BA07,Narcolepsy,0,1
PA450546,montelukast,R03DC03;R03DC53,Asthma,0,1
PA450546,montelukast,R03DC03;R03DC53,,0,1
PA450550,morphine,A07DA52;N02AA01;N02AA51;N02AG01,Neonatal Abstinence Syndrome,0,1
PA450550,morphine,A07DA52;N02AA01;N02AA51;N02AG01,Pain,0,1
PA450550,morphine,A07DA52;N02AA01;N02AA51;N02AG01,Sleep Apnea Syndromes,0,1
PA450550,morphine,A07DA52;N02AA01;N02AA51;N02AG01,Lung Neoplasms,0,1
PA450550,morphine,A07DA52;N02AA01;N02AA51;N02AG01,Constipation,0,1
PA450550,morphine,A07DA52;N02AA01;N02AA51;N02AG01,"Anemia, Sickle Cell",0,1
PA450550,morphine,A07DA52;N02AA01;N02AA51;N02AG01,Neoplasms,0,1
PA450550,morphine,A07DA52;N02AA01;N02AA51;N02AG01,Vomiting,0,1
PA450550,morphine,A07DA52;N02AA01;N02AA51;N02AG01,adverse events,0,1
PA450550,morphine,A07DA52;N02AA01;N02AA51;N02AG01,Urinary Retention,0,1
PA450550,morphine,A07DA52;N02AA01;N02AA51;N02AG01,somnolence,0,1
PA450550,morphine,A07DA52;N02AA01;N02AA51;N02AG01,,0,1
PA450550,morphine,A07DA52;N02AA01;N02AA51;N02AG01,Delirium,0,1
PA450550,morphine,A07DA52;N02AA01;N02AA51;N02AG01,Dizziness,0,1
PA450550,morphine,A07DA52;N02AA01;N02AA51;N02AG01,"Pain, Postoperative",0,1
PA450550,morphine,A07DA52;N02AA01;N02AA51;N02AG01,Nausea,0,1
PA450550,morphine,A07DA52;N02AA01;N02AA51;N02AG01,Pruritus,0,1
PA450550,morphine,A07DA52;N02AA01;N02AA51;N02AG01,Postoperative Nausea and Vomiting,0,1
PA450550,morphine,A07DA52;N02AA01;N02AA51;N02AG01,Respiratory Insufficiency,0,1
PA166131340,morphine-3-glucuronide,,,0,1
PA452633,morphine-6-glucuronide,,,0,1
PA166163260,moviprep,,,0,1
PA450555,moxifloxacin,J01MA14;S01AE07,,1,0
PA162356187,muraglitazar,,,0,1
PA162356187,muraglitazar,,Edema,0,1
PA162356187,muraglitazar,,Diabetes Mellitus,0,1
PA162356187,muraglitazar,,Hyperlipidemias,0,1
PA450566,mycophenolate mofetil,,Leukopenia,0,1
PA450566,mycophenolate mofetil,,,0,1
PA450566,mycophenolate mofetil,,Kidney Transplantation,0,1
PA450566,mycophenolate mofetil,,Organ Transplantation,0,1
PA164748728,mycophenolic acid,L04AA06,overall survival,0,1
PA164748728,mycophenolic acid,L04AA06,Kidney Transplantation,0,1
PA164748728,mycophenolic acid,L04AA06,chronic lung allograft dysfunction,0,1
PA164748728,mycophenolic acid,L04AA06,Organ Transplantation,0,1
PA164748728,mycophenolic acid,L04AA06,lung transplantation,0,1
PA164748728,mycophenolic acid,L04AA06,,0,1
PA164748728,mycophenolic acid,L04AA06,transplant rejection,0,1
PA166163659,n-desmethylclozapine,,,0,1
PA166127651,n-desmethyltamoxifen,,,0,1
PA166131493,n-desmethyltramadol,,,0,1
PA450576,nafcillin,J01CF06;J01CR50,,1,0
PA164746384,nalidixic acid,J01MB02,,1,0
PA450586,naloxone,A06AH04;N02AA53;N02AA55;N02AX51;V03AB15,Erythema,0,1
PA450586,naloxone,A06AH04;N02AA53;N02AA55;N02AX51;V03AB15,,0,1
PA450586,naloxone,A06AH04;N02AA53;N02AA55;N02AX51;V03AB15,Vomiting,0,1
PA450588,naltrexone,A08AA62;N02AA56;N07BB04,Alcoholism,0,1
PA450588,naltrexone,A08AA62;N02AA56;N07BB04,hypersexuality state,0,1
PA450588,naltrexone,A08AA62;N02AA56;N07BB04,,0,1
PA450588,naltrexone,A08AA62;N02AA56;N07BB04,Tobacco Use Disorder,0,1
PA450588,naltrexone,A08AA62;N02AA56;N07BB04,Obesity,0,1
PA450595,naproxen,G02CC02;M01AE02;M01AE52;M01AE56;M02AA12,,0,1
PA164747191,natalizumab,L04AA23,,0,1
PA450600,nateglinide,A10BX03,,0,1
PA151958426,nebivolol,C07AB12;C07BB12;C07FB12;C09DX05,,0,1
PA450601,nedocromil,R01AC07;R03BC03;S01GX04,Asthma,0,1
PA450603,nefazodone,N06AX06,,0,1
PA450603,nefazodone,N06AX06,Depression,0,1
PA164752425,nelarabine,L01BB07,,0,1
PA450606,nelfinavir,J05AE04,HIV Infections,1,0
PA450606,nelfinavir,J05AE04,Pancreatic Neoplasms,1,0
PA450606,nelfinavir,J05AE04,,1,0
PA151186253,nemonapride,,,0,1
PA151186253,nemonapride,,Schizophrenia,0,1
PA450608,neomycin,A01AB08;A07AA01;A07AA51;B05CA09;D06AX04;J01GB05;R02AB01;S01AA03;S02AA07;S03AA01;D09AA01;R01AX08;S01AA07,,1,0
PA450608,neomycin,A01AB08;A07AA01;A07AA51;B05CA09;D06AX04;J01GB05;R02AB01;S01AA03;S02AA07;S03AA01;D09AA01;R01AX08;S01AA07,,1,0
PA450608,neomycin,A01AB08;A07AA01;A07AA51;B05CA09;D06AX04;J01GB05;R02AB01;S01AA03;S02AA07;S03AA01;D09AA01;R01AX08;S01AA07,Ototoxicity,1,0
PA450608,neomycin,A01AB08;A07AA01;A07AA51;B05CA09;D06AX04;J01GB05;R02AB01;S01AA03;S02AA07;S03AA01;D09AA01;R01AX08;S01AA07,Ototoxicity,1,0
PA165291472,neratinib,,,0,1
PA450616,nevirapine,J05AG01;J05AR05;J05AR07,Hypersensitivity,1,0
PA450616,nevirapine,J05AG01;J05AR05;J05AR07,Toxic liver disease,1,0
PA450616,nevirapine,J05AG01;J05AR05;J05AR07,,1,0
PA450616,nevirapine,J05AG01;J05AR05;J05AR07,Exanthema,1,0
PA450616,nevirapine,J05AG01;J05AR05;J05AR07,Drug Hypersensitivity,1,0
PA450616,nevirapine,J05AG01;J05AR05;J05AR07,drug reaction with eosinophilia and systemic symptoms,1,0
PA450616,nevirapine,J05AG01;J05AR05;J05AR07,"Epidermal Necrolysis, Toxic",1,0
PA450616,nevirapine,J05AG01;J05AR05;J05AR07,HIV Infections,1,0
PA450616,nevirapine,J05AG01;J05AR05;J05AR07,Stevens-Johnson Syndrome,1,0
PA450616,nevirapine,J05AG01;J05AR05;J05AR07,Acquired Immunodeficiency Syndrome,1,0
PA450617,niacin,C04AC01;C10AD02;C10AD52;C10BA01,,0,1
PA166184081,nicorandil,,,0,1
PA450626,nicotine,N07BA01,Pregnancy,0,1
PA450626,nicotine,N07BA01,Substance-Related Disorders,0,1
PA450626,nicotine,N07BA01,,0,1
PA450626,nicotine,N07BA01,Pain,0,1
PA450626,nicotine,N07BA01,Tobacco Use Disorder,0,1
PA450626,nicotine,N07BA01,cessation,0,1
PA450631,nifedipine,C07FB03;C08CA05;C08CA55;C08GA01,Pregnancy,0,1
PA450631,nifedipine,C07FB03;C08CA05;C08CA55;C08GA01,,0,1
PA450631,nifedipine,C07FB03;C08CA05;C08CA55;C08GA01,Hypertension,0,1
PA165958345,nilotinib,L01EA03,,0,1
PA165958345,nilotinib,L01EA03,Hyperbilirubinemia,0,1
PA450633,nimodipine,C08CA06,,0,1
PA166249521,nintedanib,,,0,1
PA166131610,niraparib,L01XK02,,0,1
PA146096020,nitrendipine,C08CA08;C09BB06,Essential hypertension,0,1
PA146096020,nitrendipine,C08CA08;C09BB06,,0,1
PA146096020,nitrendipine,C08CA08;C09BB06,Hypertension,0,1
PA450635,nitric oxide,R07AX01,,0,1
PA450640,nitrofurantoin,J01XE01;J01XE51,"Anemia, Hemolytic",1,0
PA450640,nitrofurantoin,J01XE01;J01XE51,Hemolysis,1,0
PA450640,nitrofurantoin,J01XE01;J01XE51,,1,0
PA450644,nitroglycerin,C01DA02;C01DA52;C05AE01,,0,1
PA451406,nitroprusside,C02DD01,,0,1
PA450645,nitrous oxide,N01AX13;N01AX63,,0,1
PA166129522,nivolumab,,,0,1
PA166277902,nivolumab / relatlimab,,,0,1
PA150047156,non-nucleoside reverse transcriptase inhibitors,,,1,0
PA450654,norfloxacin,J01MA06;J01RA13;J01RA14;S01AE02,,1,0
PA166131342,noroxycodone,,,0,1
PA166131548,noroxymorphone,,,0,1
PA450657,nortriptyline,N06AA10,Depressive Disorder,0,1
PA450657,nortriptyline,N06AA10,"Depressive Disorder, Major",0,1
PA450657,nortriptyline,N06AA10,Pain,0,1
PA450657,nortriptyline,N06AA10,Depression,0,1
PA450657,nortriptyline,N06AA10,Hypotension,0,1
PA450657,nortriptyline,N06AA10,,0,1
PA164712943,Nucleoside and nucleotide reverse transcriptase inhibitors,,,1,0
PA164712943,Nucleoside and nucleotide reverse transcriptase inhibitors,,HIV Infections,1,0
PA166182882,nusinersen,,,0,1
PA166131379,o-desmethyltramadol,,,0,1
PA166268805,odevixibat,A05AX05,,0,1
PA165291493,ofatumumab,,,0,1
PA450684,ofloxacin,J01MA01;J01RA09;S01AE01;S02AA16,,1,0
PA450688,olanzapine,N05AH03;N05AH53,,0,1
PA450688,olanzapine,N05AH03;N05AH53,Autism Spectrum Disorder,0,1
PA450688,olanzapine,N05AH03;N05AH53,Schizophrenia,0,1
PA450688,olanzapine,N05AH03;N05AH53,Psychotic Disorders,0,1
PA450688,olanzapine,N05AH03;N05AH53,somnolence,0,1
PA450688,olanzapine,N05AH03;N05AH53,Asthenia,0,1
PA450688,olanzapine,N05AH03;N05AH53,Depression,0,1
PA450688,olanzapine,N05AH03;N05AH53,Fatigue,0,1
PA450688,olanzapine,N05AH03;N05AH53,schizoaffective disorder,0,1
PA450688,olanzapine,N05AH03;N05AH53,Hypotension,0,1
PA450688,olanzapine,N05AH03;N05AH53,Depressive Disorder,0,1
PA450688,olanzapine,N05AH03;N05AH53,Bipolar Disorder,0,1
PA450688,olanzapine,N05AH03;N05AH53,Alzheimer Disease,0,1
PA450688,olanzapine,N05AH03;N05AH53,Weight gain,0,1
PA450688,olanzapine,N05AH03;N05AH53,Mental Disorders,0,1
PA450688,olanzapine,N05AH03;N05AH53,"Arrhythmias, Cardiac",0,1
PA164920420,olaparib,,,0,1
PA166163434,olaratumab,,,0,1
PA166223601,oliceridine,,,0,1
PA164742950,olmesartan,C09CA08;C09DA08;C09DB02;C09DX03,,0,1
PA166163408,ombitasvir / paritaprevir / ritonavir,,,1,0
PA450702,omega-3 polyunsaturated fatty acids,,,0,1
PA450704,omeprazole,,,0,1
PA450704,omeprazole,,Helicobacter Infections,0,1
PA450704,omeprazole,,Gastroesophageal Reflux,0,1
PA450704,omeprazole,,Esophagitis,0,1
PA450704,omeprazole,,Peptic Ulcer,0,1
PA450705,ondansetron,A04AA01,Alcoholism,0,1
PA450705,ondansetron,A04AA01,Postoperative Nausea and Vomiting,0,1
PA450705,ondansetron,A04AA01,Vomiting,0,1
PA450705,ondansetron,A04AA01,,0,1
PA164712948,Opioid anesthetics,,,0,1
PA452618,opioids,,Death,0,1
PA452618,opioids,,Sleep Disorders,0,1
PA452618,opioids,,adverse events,0,1
PA452618,opioids,,Overdose,0,1
PA452618,opioids,,Opioid-Related Disorders,0,1
PA452618,opioids,,Nausea,0,1
PA452618,opioids,,Vomiting,0,1
PA452618,opioids,,"Pain, Postoperative",0,1
PA452618,opioids,,Pain,0,1
PA452618,opioids,,Heroin Dependence,0,1
PA452618,opioids,,Substance-Related Disorders,0,1
PA452618,opioids,,Heart Arrest,0,1
PA452618,opioids,,,0,1
PA452618,opioids,,"Sexual Dysfunctions, Psychological",0,1
PA452618,opioids,,Dizziness,0,1
PA452618,opioids,,Low Back Pain,0,1
PA452618,opioids,,Respiratory Insufficiency,0,1
PA452618,opioids,,Hyperalgesia,0,1
PA452618,opioids,,Neoplasms,0,1
PA452618,opioids,,Substance Withdrawal Syndrome,0,1
PA144614922,opipramol,N06AA05,Depression,0,1
PA144614922,opipramol,N06AA05,,0,1
PA164712950,Opium alkaloids and derivatives,,Tobacco Use Disorder,0,1
PA164712950,Opium alkaloids and derivatives,,,0,1
PA164712950,Opium alkaloids and derivatives,,Pain,0,1
PA164712951,Opium derivatives and expectorants,,,0,1
PA450721,oseltamivir,J05AH02,,1,0
PA166131626,osimertinib,L01EB04,,0,1
PA166182883,ospemifene,,,0,1
PA164713083,Other general anesthetics,,,0,1
PA131285527,oxaliplatin,L01XA03,Esophageal Neoplasms,0,1
PA131285527,oxaliplatin,L01XA03,Colorectal Neoplasms,0,1
PA131285527,oxaliplatin,L01XA03,Colonic Neoplasms,0,1
PA131285527,oxaliplatin,L01XA03,Neoplasm Metastasis,0,1
PA131285527,oxaliplatin,L01XA03,Drug Toxicity,0,1
PA131285527,oxaliplatin,L01XA03,Gastrointestinal Neoplasms,0,1
PA131285527,oxaliplatin,L01XA03,"Carcinoma, Non-Small-Cell Lung",0,1
PA131285527,oxaliplatin,L01XA03,Stomach Neoplasms,0,1
PA131285527,oxaliplatin,L01XA03,,0,1
PA131285527,oxaliplatin,L01XA03,Ovarian Neoplasms,0,1
PA131285527,oxaliplatin,L01XA03,Neoplasms,0,1
PA131285527,oxaliplatin,L01XA03,Pancreatic Neoplasms,0,1
PA131285527,oxaliplatin,L01XA03,Osteosarcoma,0,1
PA450731,oxazepam,N05BA04,,0,1
PA450732,oxcarbazepine,N03AF02,Stevens-Johnson Syndrome,0,1
PA450732,oxcarbazepine,N03AF02,Epilepsy,0,1
PA450732,oxcarbazepine,N03AF02,Maculopapular Exanthema,0,1
PA450732,oxcarbazepine,N03AF02,,0,1
PA450732,oxcarbazepine,N03AF02,Seizures,0,1
PA450732,oxcarbazepine,N03AF02,drug reaction with eosinophilia and systemic symptoms,0,1
PA450741,oxycodone,N02AA05;N02AA55;N02AA56;N02AJ17;N02AJ18;N02AJ19,Neoplasms,0,1
PA450741,oxycodone,N02AA05;N02AA55;N02AA56;N02AJ17;N02AJ18;N02AJ19,adverse events,0,1
PA450741,oxycodone,N02AA05;N02AA55;N02AA56;N02AJ17;N02AJ18;N02AJ19,cns depression,0,1
PA450741,oxycodone,N02AA05;N02AA55;N02AA56;N02AJ17;N02AJ18;N02AJ19,Drug Toxicity,0,1
PA450741,oxycodone,N02AA05;N02AA55;N02AA56;N02AJ17;N02AJ18;N02AJ19,,0,1
PA450741,oxycodone,N02AA05;N02AA55;N02AA56;N02AJ17;N02AJ18;N02AJ19,Erythema,0,1
PA450741,oxycodone,N02AA05;N02AA55;N02AA56;N02AJ17;N02AJ18;N02AJ19,Opioid-Related Disorders,0,1
PA450741,oxycodone,N02AA05;N02AA55;N02AA56;N02AJ17;N02AJ18;N02AJ19,Pain,0,1
PA450741,oxycodone,N02AA05;N02AA55;N02AA56;N02AJ17;N02AJ18;N02AJ19,Vomiting,0,1
PA450741,oxycodone,N02AA05;N02AA55;N02AA56;N02AJ17;N02AJ18;N02AJ19,"Pain, Postoperative",0,1
PA450741,oxycodone,N02AA05;N02AA55;N02AA56;N02AJ17;N02AJ18;N02AJ19,Constipation,0,1
PA450741,oxycodone,N02AA05;N02AA55;N02AA56;N02AJ17;N02AJ18;N02AJ19,Urinary Retention,0,1
PA450741,oxycodone,N02AA05;N02AA55;N02AA56;N02AJ17;N02AJ18;N02AJ19,Delirium,0,1
PA450741,oxycodone,N02AA05;N02AA55;N02AA56;N02AJ17;N02AJ18;N02AJ19,Nausea,0,1
PA450741,oxycodone,N02AA05;N02AA55;N02AA56;N02AJ17;N02AJ18;N02AJ19,somnolence,0,1
PA450741,oxycodone,N02AA05;N02AA55;N02AA56;N02AJ17;N02AJ18;N02AJ19,Pruritus,0,1
PA166182885,oxymetazoline and tetracaine,,,0,1
PA450748,oxymorphone,N02AA11,,0,1
PA450761,paclitaxel,L01CD01;L01CD51,"Carcinoma, Non-Small-Cell Lung",0,1
PA450761,paclitaxel,L01CD01;L01CD51,Ovarian Neoplasms,0,1
PA450761,paclitaxel,L01CD01;L01CD51,Breast Neoplasms,0,1
PA450761,paclitaxel,L01CD01;L01CD51,Neoplasms,0,1
PA450761,paclitaxel,L01CD01;L01CD51,Leukopenia,0,1
PA450761,paclitaxel,L01CD01;L01CD51,Neurotoxicity Syndromes,0,1
PA450761,paclitaxel,L01CD01;L01CD51,,0,1
PA450761,paclitaxel,L01CD01;L01CD51,Pancreatic Neoplasms,0,1
PA450761,paclitaxel,L01CD01;L01CD51,Peripheral Nervous System Diseases,0,1
PA450761,paclitaxel,L01CD01;L01CD51,Lung Neoplasms,0,1
PA450761,paclitaxel,L01CD01;L01CD51,Toxic liver disease,0,1
PA450761,paclitaxel,L01CD01;L01CD51,Neutropenia,0,1
PA450761,paclitaxel,L01CD01;L01CD51,Drug Toxicity,0,1
PA450761,paclitaxel,L01CD01;L01CD51,Nausea,0,1
PA166153469,palbociclib,L01EF01,,0,1
PA163518919,paliperidone,N05AX13,Bipolar Disorder,0,1
PA163518919,paliperidone,N05AX13,,0,1
PA163518919,paliperidone,N05AX13,Psychotic Disorders,0,1
PA163518919,paliperidone,N05AX13,Weight gain,0,1
PA163518919,paliperidone,N05AX13,schizoaffective disorder,0,1
PA163518919,paliperidone,N05AX13,Depressive Disorder,0,1
PA10352,palonosetron,A04AA05;A04AA55,Nausea,0,1
PA10352,palonosetron,A04AA05;A04AA55,Neoplasms,0,1
PA10352,palonosetron,A04AA05;A04AA55,,0,1
PA10352,palonosetron,A04AA05;A04AA55,Vomiting,0,1
PA166115579,pamaquine,,,1,0
PA450767,pamidronate,M05BA03,Multiple Myeloma,0,1
PA450767,pamidronate,M05BA03,Osteonecrosis,0,1
PA162373091,panitumumab,L01FE02,Colorectal Neoplasms,0,1
PA162373091,panitumumab,L01FE02,,0,1
PA162373091,panitumumab,L01FE02,Neoplasms,0,1
PA166161307,panobinostat,L01XH03,,0,1
PA450774,pantoprazole,A02BC02;A02BD04;A02BD11,Ulcer,0,1
PA450774,pantoprazole,A02BC02;A02BD04;A02BD11,,0,1
PA450774,pantoprazole,A02BC02;A02BD04;A02BD11,Helicobacter Infections,0,1
PA166184497,"Paracetamol, combinations excl. Psycholeptics (Vicks MediNait Sirup)",,,0,1
PA166162420,paramethoxymethamphetamine,,,0,1
PA164713150,Parathyroid Hormones And Analogues,,,0,1
PA450801,paroxetine,N06AB05,Bipolar Disorder,0,1
PA450801,paroxetine,N06AB05,,0,1
PA450801,paroxetine,N06AB05,Mood Disorders,0,1
PA450801,paroxetine,N06AB05,Depression,0,1
PA450801,paroxetine,N06AB05,Panic Disorder,0,1
PA450801,paroxetine,N06AB05,"Depressive Disorder, Major",0,1
PA450801,paroxetine,N06AB05,Depressive Disorder,0,1
PA450801,paroxetine,N06AB05,Mental Disorders,0,1
PA165291492,pazopanib,,,0,1
PA165291492,pazopanib,,"Carcinoma, Renal Cell",0,1
PA165291492,pazopanib,,Kidney Neoplasms,0,1
PA164771236,pegaptanib,S01LA03,Choroidal Neovascularization,0,1
PA164771236,pegaptanib,S01LA03,,0,1
PA164760860,pegaspargase,L01XX24,,0,1
PA164760860,pegaspargase,L01XX24,Osteonecrosis,0,1
PA164760860,pegaspargase,L01XX24,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0,1
PA164749390,peginterferon alfa-2a,L03AB11;L03AB61,,0,1
PA164749390,peginterferon alfa-2a,L03AB11;L03AB61,"Hepatitis B, Chronic",0,1
PA164749390,peginterferon alfa-2a,L03AB11;L03AB61,HIV Infections,0,1
PA164749390,peginterferon alfa-2a,L03AB11;L03AB61,Hepatitis C,0,1
PA164749390,peginterferon alfa-2a,L03AB11;L03AB61,"Hepatitis C, Chronic",0,1
PA164749390,peginterferon alfa-2a,L03AB11;L03AB61,Myeloproliferative Disorders,0,1
PA164784024,peginterferon alfa-2b,L03AB10;L03AB60,HIV Infections,0,1
PA164784024,peginterferon alfa-2b,L03AB10;L03AB60,Myeloproliferative Disorders,0,1
PA164784024,peginterferon alfa-2b,L03AB10;L03AB60,"Hepatitis C, Chronic",0,1
PA164784024,peginterferon alfa-2b,L03AB10;L03AB60,,0,1
PA164784024,peginterferon alfa-2b,L03AB10;L03AB60,Hepatitis C,0,1
PA164784024,peginterferon alfa-2b,L03AB10;L03AB60,"Hepatitis B, Chronic",0,1
PA164784024,peginterferon alfa-2b,L03AB10;L03AB60,Anemia,0,1
PA165963961,pegloticase,,Hemolysis,0,1
PA165963961,pegloticase,,,0,1
PA165963961,pegloticase,,Methemoglobinemia,0,1
PA164749630,pegvisomant,H01AX01,,0,1
PA166124615,pembrolizumab,,,0,1
PA10810,pemetrexed,L01BA04,Mesothelioma,0,1
PA10810,pemetrexed,L01BA04,"Carcinoma, Non-Small-Cell Lung",0,1
PA10810,pemetrexed,L01BA04,,0,1
PA10810,pemetrexed,L01BA04,Neoplasms,0,1
PA450840,penicillamine,M01CC01,,0,1
PA450842,penicillin g,J01CE01;J01CE08;J01CR50;S01AA14,,1,0
PA450842,penicillin g,J01CE01;J01CE08;J01CR50;S01AA14,Drug Hypersensitivity,1,0
PA164745442,penicillin v,J01CE02;J01CE10;J01CR50,Drug Hypersensitivity,1,0
PA164745442,penicillin v,J01CE02;J01CE10;J01CR50,,1,0
C551441,Perampanel,,,0,1
PA450877,perindopril,C09AA04;C09BA04;C09BB04;C09BX01;C09BX02;C09BX04;C10BX11;C10BX12;C10BX13;C10BX14;C10BX15,Coronary Artery Disease,0,1
PA450877,perindopril,C09AA04;C09BA04;C09BB04;C09BX01;C09BX02;C09BX04;C10BX11;C10BX12;C10BX13;C10BX14;C10BX15,,0,1
PA450877,perindopril,C09AA04;C09BA04;C09BB04;C09BX01;C09BX02;C09BX04;C10BX11;C10BX12;C10BX13;C10BX14;C10BX15,Diabetes Mellitus,0,1
PA450877,perindopril,C09AA04;C09BA04;C09BB04;C09BX01;C09BX02;C09BX04;C10BX11;C10BX12;C10BX13;C10BX14;C10BX15,Hypertension,0,1
PA450882,perphenazine,N05AB03,,0,1
PA450882,perphenazine,N05AB03,Schizophrenia,0,1
PA164713160,Pertussis vaccines,,,1,0
PA165290933,pertuzumab,,,0,1
PA166180939,phenazepam,,,0,1
PA166180939,phenazepam,,Alcoholism,0,1
PA164746899,phenazopyridine,G04BX06,"Anemia, Hemolytic",0,1
PA164746899,phenazopyridine,G04BX06,Hemolysis,0,1
PA450911,phenobarbital,N03AA02;N05CB01,Epilepsy,0,1
PA450911,phenobarbital,N03AA02;N05CB01,,0,1
PA450911,phenobarbital,N03AA02;N05CB01,Stevens-Johnson Syndrome,0,1
PA450911,phenobarbital,N03AA02;N05CB01,Psychotic Disorders,0,1
PA450921,phenprocoumon,B01AA04,,0,1
PA450921,phenprocoumon,B01AA04,Hemorrhage,0,1
PA450921,phenprocoumon,B01AA04,time above therapeutic range,0,1
PA450921,phenprocoumon,B01AA04,over-anticoagulation,0,1
PA450935,phenylephrine,C01CA06;R01AA04;R01AB01;R01BA03;R01BA53;S01FB01;S01FB51;S01GA05;S01GA55,,0,1
PA450947,phenytoin,N03AB02;N03AB52,severe cutaneous adverse reactions,0,1
PA450947,phenytoin,N03AB02;N03AB52,Maculopapular Exanthema,0,1
PA450947,phenytoin,N03AB02;N03AB52,"Epidermal Necrolysis, Toxic",0,1
PA450947,phenytoin,N03AB02;N03AB52,Stevens-Johnson Syndrome,0,1
PA450947,phenytoin,N03AB02;N03AB52,,0,1
PA450947,phenytoin,N03AB02;N03AB52,Craniofacial Abnormalities,0,1
PA450947,phenytoin,N03AB02;N03AB52,Psychotic Disorders,0,1
PA450947,phenytoin,N03AB02;N03AB52,Epilepsy,0,1
PA450947,phenytoin,N03AB02;N03AB52,Congenital Abnormalities,0,1
PA450947,phenytoin,N03AB02;N03AB52,drug reaction with eosinophilia and systemic symptoms,0,1
PA450947,phenytoin,N03AB02;N03AB52,Drug interaction with drug,0,1
PA450947,phenytoin,N03AB02;N03AB52,Drug Toxicity,0,1
PA165984462,photodynamic therapy,,Choroidal Neovascularization,0,1
PA165984462,photodynamic therapy,,,0,1
PA165984462,photodynamic therapy,,Macular Degeneration,0,1
PA450962,pilocarpine,N07AX01;S01EB01;S01EB51,,0,1
PA450965,pimozide,N05AG02,,0,1
PA450970,pioglitazone,A10BD05;A10BD06;A10BD09;A10BD12;A10BG03,,0,1
PA450970,pioglitazone,A10BD05;A10BD06;A10BD09;A10BD12;A10BG03,Diabetes Mellitus,0,1
PA450970,pioglitazone,A10BD05;A10BD06;A10BD09;A10BD12;A10BG03,"Diabetes Mellitus, Type 2",0,1
PA166212681,piritramide,,,0,1
PA450985,piroxicam,M01AC01;M02AA07;S01BC06,,0,1
PA142650384,pitavastatin,C10AA08,,0,1
PA166185163,pitolisant,,,0,1
PA165983754,pitrakinra,,Asthma,0,1
PA165983754,pitrakinra,,,0,1
PA164713175,Platelet aggregation inhibitors excl. heparin,,,0,1
PA150595617,platinum,,Neoplasms,0,1
PA150595617,platinum,,Pancreatic Neoplasms,0,1
PA150595617,platinum,,,0,1
PA150595617,platinum,,Ovarian Neoplasms,0,1
PA150595617,platinum,,Colorectal Neoplasms,0,1
PA150595617,platinum,,Esophageal Neoplasms,0,1
PA150595617,platinum,,Osteosarcoma,0,1
PA164713176,Platinum compounds,,Gastrointestinal Neoplasms,0,1
PA164713176,Platinum compounds,,,0,1
PA164713176,Platinum compounds,,Neoplasms,0,1
PA164713176,Platinum compounds,,Dermatitis,0,1
PA164713176,Platinum compounds,,Nasopharyngeal Neoplasms,0,1
PA164713176,Platinum compounds,,Anemia,0,1
PA164713176,Platinum compounds,,Myelosuppression,0,1
PA164713176,Platinum compounds,,Colorectal Neoplasms,0,1
PA164713176,Platinum compounds,,overall survival,0,1
PA164713176,Platinum compounds,,Mesothelioma,0,1
PA164713176,Platinum compounds,,mucositis,0,1
PA164713176,Platinum compounds,,Lung Neoplasms,0,1
PA164713176,Platinum compounds,,Esophageal Neoplasms,0,1
PA164713176,Platinum compounds,,Osteosarcoma,0,1
PA164713176,Platinum compounds,,Ovarian Neoplasms,0,1
PA164713176,Platinum compounds,,Pancreatic Neoplasms,0,1
PA164713176,Platinum compounds,,Drug Toxicity,0,1
PA164713176,Platinum compounds,,Leukopenia,0,1
PA164713176,Platinum compounds,,Nausea,0,1
PA164713176,Platinum compounds,,Hematologic Diseases,0,1
PA164713176,Platinum compounds,,gastrointestinal toxicity,0,1
PA164713176,Platinum compounds,,Neutropenia,0,1
PA164713176,Platinum compounds,,Vomiting,0,1
PA164713176,Platinum compounds,,pneumonitis,0,1
PA164713176,Platinum compounds,,Thrombocytopenia,0,1
PA164713176,Platinum compounds,,adverse events,0,1
PA164713176,Platinum compounds,,"Carcinoma, Non-Small-Cell Lung",0,1
PA164713176,Platinum compounds,,Stomach Neoplasms,0,1
PA165980594,ponatinib,L01EA05,,0,1
PA151958574,posaconazole,J02AC04,,1,0
PA166235321,pralsetinib,,,0,1
PA164742949,pramipexole,N04BC05,,0,1
PA164742949,pramipexole,N04BC05,Parkinson Disease,0,1
PA154410481,prasugrel,B01AC22,,0,1
PA154410481,prasugrel,B01AC22,Acute coronary syndrome,0,1
PA451089,pravastatin,C10AA03;C10BA03;C10BA11;C10BA12;C10BX02,Vascular Diseases,0,1
PA451089,pravastatin,C10AA03;C10BA03;C10BA11;C10BA12;C10BX02,,0,1
PA451089,pravastatin,C10AA03;C10BA03;C10BA11;C10BA12;C10BX02,Hypertension,0,1
PA451089,pravastatin,C10AA03;C10BA03;C10BA11;C10BA12;C10BX02,Myalgia unspecified,0,1
PA451089,pravastatin,C10AA03;C10BA03;C10BA11;C10BA12;C10BX02,Coronary Artery Disease,0,1
PA451089,pravastatin,C10AA03;C10BA03;C10BA11;C10BA12;C10BX02,statin-related myopathy,0,1
PA451089,pravastatin,C10AA03;C10BA03;C10BA11;C10BA12;C10BX02,Myocardial Infarction,0,1
PA451089,pravastatin,C10AA03;C10BA03;C10BA11;C10BA12;C10BX02,Coronary Disease,0,1
PA451089,pravastatin,C10AA03;C10BA03;C10BA11;C10BA12;C10BX02,Hypercholesterolemia,0,1
PA451089,pravastatin,C10AA03;C10BA03;C10BA11;C10BA12;C10BX02,Hyperlipoproteinemia Type II,0,1
PA451089,pravastatin,C10AA03;C10BA03;C10BA11;C10BA12;C10BX02,Acute coronary syndrome,0,1
PA451089,pravastatin,C10AA03;C10BA03;C10BA11;C10BA12;C10BX02,Hyperlipidemias,0,1
PA451089,pravastatin,C10AA03;C10BA03;C10BA11;C10BA12;C10BX02,Diabetes Mellitus,0,1
PA164764583,praziquantel,P02BA01,,1,0
PA451096,prednisolone,A01AC04;A01AC54;A07EA01;C05AA04;D07AA03;D07BA01;D07CA03;D07XA02;H02AB06;R01AD02;R01AD52;S01BA04;S01BB02;S01CA02;S01CB02;S02BA03;S02CA01;S03BA02;S03CA02;V03AB05,Kidney Transplantation,0,1
PA451096,prednisolone,A01AC04;A01AC54;A07EA01;C05AA04;D07AA03;D07BA01;D07CA03;D07XA02;H02AB06;R01AD02;R01AD52;S01BA04;S01BB02;S01CA02;S01CB02;S02BA03;S02CA01;S03BA02;S03CA02;V03AB05,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0,1
PA451096,prednisolone,A01AC04;A01AC54;A07EA01;C05AA04;D07AA03;D07BA01;D07CA03;D07XA02;H02AB06;R01AD02;R01AD52;S01BA04;S01BB02;S01CA02;S01CB02;S02BA03;S02CA01;S03BA02;S03CA02;V03AB05,Prostatic Neoplasms,0,1
PA451096,prednisolone,A01AC04;A01AC54;A07EA01;C05AA04;D07AA03;D07BA01;D07CA03;D07XA02;H02AB06;R01AD02;R01AD52;S01BA04;S01BB02;S01CA02;S01CB02;S02BA03;S02CA01;S03BA02;S03CA02;V03AB05,,0,1
PA451100,prednisone,A07EA03;H02AB07,Organ Transplantation,0,1
PA451100,prednisone,A07EA03;H02AB07,Osteonecrosis,0,1
PA451100,prednisone,A07EA03;H02AB07,"Leukemia, Lymphocytic, Chronic, B-Cell",0,1
PA451100,prednisone,A07EA03;H02AB07,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0,1
PA451100,prednisone,A07EA03;H02AB07,,0,1
PA451100,prednisone,A07EA03;H02AB07,Transplantation,0,1
PA451100,prednisone,A07EA03;H02AB07,"Lymphoma, Large B-Cell, Diffuse",0,1
PA451100,prednisone,A07EA03;H02AB07,"Lymphoma, Non-Hodgkin",0,1
PA164754814,pregabalin,N02BF02,adverse events,0,1
PA164754814,pregabalin,N02BF02,neuropathic pain,0,1
PA164754814,pregabalin,N02BF02,,0,1
PA166115441,pridopidine,,,0,1
PA451101,prilocaine,N01BB04;N01BB54,,0,1
PA451103,primaquine,P01BA03,,1,0
PA451105,primidone,N03AA03;N05CB01,,0,1
PA451106,probenecid,G01AE10;M04AB01,,0,1
PA451108,procainamide,C01BA02,,0,1
PA451112,procarbazine,L01XB01,,0,1
PA451114,prochlorperazine,N05AB04,Nausea,0,1
PA451114,prochlorperazine,N05AB04,,0,1
PA451123,progesterone,G03DA04;G03FA04,,0,1
PA451124,proguanil,P01BB01;P01BB51;P01BB52,,1,0
PA451131,propafenone,C01BC03,"Arrhythmias, Cardiac",0,1
PA451131,propafenone,C01BC03,,0,1
PA451131,propafenone,C01BC03,Tachycardia,0,1
PA451140,propionic acid derivatives,,,0,1
PA451141,propofol,N01AX10,Hypotension,0,1
PA451141,propofol,N01AX10,,0,1
PA451145,propranolol,C07AA05;C07BA05;C07FX01,Temporomandibular joint-pain-dysfunction syndrome,0,1
PA451145,propranolol,C07AA05;C07BA05;C07FX01,,0,1
PA451145,propranolol,C07AA05;C07BA05;C07FX01,Liver Cirrhosis,0,1
PA451156,propylthiouracil,H03BA02,Agranulocytosis,0,1
PA451156,propylthiouracil,H03BA02,,0,1
PA451156,propylthiouracil,H03BA02,Graves Disease,0,1
PA449479,prostaglandin I2,B01AC09,,0,1
PA451159,protease inhibitors,,Hepatitis C,1,0
PA451159,protease inhibitors,,,1,0
PA164713207,Proton pump inhibitors,,,0,1
PA451168,protriptyline,N06AA11,,0,1
PA452634,purine analogues,,,0,1
PA452634,purine analogues,,"Lupus Erythematosus, Systemic",0,1
PA451182,pyrazinamide,J04AK01;J04AM05;J04AM06,,1,0
PA451182,pyrazinamide,J04AK01;J04AM05;J04AM06,Toxic liver disease,1,0
PA451182,pyrazinamide,J04AK01;J04AM05;J04AM06,Maculopapular Exanthema,1,0
PA451182,pyrazinamide,J04AK01;J04AM05;J04AM06,Tuberculosis,1,0
PA164713217,Pyrazolones,,,0,1
PA164749650,pyridoxal phosphate,A11HA06,,0,1
PA451193,pyrimethamine,P01BD01;P01BD51;P01BF04;P01BF09,,1,0
PA451193,pyrimethamine,P01BD01;P01BD51;P01BF04;P01BF09,Malaria,1,0
PA451193,pyrimethamine,P01BD01;P01BD51;P01BF04;P01BF09,"Malaria, Falciparum",1,0
PA164713220,Pyrimidine analogues,,,0,1
PA451201,quetiapine,N05AH04,Schizophrenia,0,1
PA451201,quetiapine,N05AH04,schizoaffective disorder,0,1
PA451201,quetiapine,N05AH04,Drug Toxicity,0,1
PA451201,quetiapine,N05AH04,,0,1
PA451201,quetiapine,N05AH04,Hypertriglyceridemia,0,1
PA451201,quetiapine,N05AH04,Bipolar Disorder,0,1
PA451201,quetiapine,N05AH04,Depressive Disorder,0,1
PA451201,quetiapine,N05AH04,Weight gain,0,1
PA451201,quetiapine,N05AH04,Autism Spectrum Disorder,0,1
PA451201,quetiapine,N05AH04,Psychotic Disorders,0,1
PA451205,quinapril,C09AA06;C09BA06,,0,1
PA451205,quinapril,C09AA06;C09BA06,Coronary Artery Disease,0,1
PA451209,quinidine,C01BA01;C01BA51;C01BA71,short qt syndrome 1,0,1
PA451209,quinidine,C01BA01;C01BA51;C01BA71,,0,1
PA451213,quinine,M09AA72;P01BC01,,1,0
PA451216,rabeprazole,A02BC04;A02BC54;A02BD12;A02BD13;M01AA05;M02AA03,Peptic Ulcer,0,1
PA451216,rabeprazole,A02BC04;A02BC54;A02BD12;A02BD13;M01AA05;M02AA03,Helicobacter Infections,0,1
PA451216,rabeprazole,A02BC04;A02BC54;A02BD12;A02BD13;M01AA05;M02AA03,,0,1
PA451216,rabeprazole,A02BC04;A02BC54;A02BD12;A02BD13;M01AA05;M02AA03,Gastroesophageal Reflux,0,1
PA166122986,radiotherapy,,Stomach Neoplasms,0,1
PA166122986,radiotherapy,,Rectal Neoplasms,0,1
PA166122986,radiotherapy,,Prostatic Neoplasms,0,1
PA166122986,radiotherapy,,,0,1
PA166122986,radiotherapy,,progression-free survival,0,1
PA166122986,radiotherapy,,mucositis,0,1
PA166122986,radiotherapy,,overall survival,0,1
PA166122986,radiotherapy,,Myelosuppression,0,1
PA166122986,radiotherapy,,Nasopharyngeal Neoplasms,0,1
PA166122986,radiotherapy,,Dermatitis,0,1
PA166122986,radiotherapy,,"Carcinoma, Squamous Cell",0,1
PA166122986,radiotherapy,,Thrombocytopenia,0,1
PA166122986,radiotherapy,,Anemia,0,1
PA166122986,radiotherapy,,Neutropenia,0,1
PA166122986,radiotherapy,,pneumonitis,0,1
PA166122986,radiotherapy,,Leukopenia,0,1
PA451221,raloxifene,G03XC01,bone density,0,1
PA451221,raloxifene,G03XC01,Menopause,0,1
PA451221,raloxifene,G03XC01,Schizophrenia,0,1
PA451221,raloxifene,G03XC01,,0,1
PA451221,raloxifene,G03XC01,Breast Neoplasms,0,1
PA451221,raloxifene,G03XC01,Osteoporosis,0,1
PA166213482,raloxifene 6-glucuronide,,,0,1
PA166213481,raloxifene-4-glucuronide,,,0,1
PA164888966,raltegravir,,,1,0
PA131625240,raltitrexed,L01BA03,,0,1
PA131625240,raltitrexed,L01BA03,Colorectal Neoplasms,0,1
PA451223,ramipril,C09AA05;C09BA05;C09BB05;C09BB07;C09BX03;C09BX05;C10BX04;C10BX06;C10BX17;C10BX18,,0,1
PA451223,ramipril,C09AA05;C09BA05;C09BB05;C09BB07;C09BX03;C09BX05;C10BX04;C10BX06;C10BX17;C10BX18,Hypertension,0,1
PA166184558,ramucirumab,,,0,1
PA164746012,ranibizumab,S01LA04,Choroidal Neovascularization,0,1
PA164746012,ranibizumab,S01LA04,,0,1
PA164746012,ranibizumab,S01LA04,Macular Degeneration,0,1
PA164746007,ranolazine,C01EB18,,0,1
PA164764584,rasagiline,N04BD02,Parkinson Disease,0,1
PA164764584,rasagiline,N04BD02,,0,1
PA10176,rasburicase,M04AX01;V03AF07,,0,1
PA10176,rasburicase,M04AX01;V03AF07,Methemoglobinemia,0,1
PA10176,rasburicase,M04AX01;V03AF07,Hemolysis,0,1
PA166277861,ravulizumab,,,0,1
PA166129536,regadenoson,C01EB21,,0,1
PA166114943,regorafenib,,,0,1
PA166114943,regorafenib,,Drug Toxicity,0,1
PA451232,remifentanil,N01AH06,tonsillectomy,0,1
PA451232,remifentanil,N01AH06,Pain,0,1
PA451232,remifentanil,N01AH06,,0,1
PA451232,remifentanil,N01AH06,Hypotension,0,1
PA451234,repaglinide,A10BD14;A10BX02,,0,1
PA451234,repaglinide,A10BD14;A10BX02,Diabetes Mellitus,0,1
PA451234,repaglinide,A10BD14;A10BX02,"Diabetes Mellitus, Type 2",0,1
PA165110729,rhodamine 123,,,0,1
PA451241,ribavirin,J05AP01,Anemia,1,0
PA451241,ribavirin,J05AP01,,1,0
PA451241,ribavirin,J05AP01,HIV Infections,1,0
PA451241,ribavirin,J05AP01,Hepatitis C,1,0
PA451241,ribavirin,J05AP01,"Hepatitis C, Chronic",1,0
PA166153470,ribociclib,L01EF02,,0,1
PA451249,rifabutin,A02BD16;J04AB04,,1,0
PA451250,rifampin,J04AB02;J04AM02;J04AM05;J04AM06;J04AM07;J04BA50;J04BA51,drug-induced liver injury,1,0
PA451250,rifampin,J04AB02;J04AM02;J04AM05;J04AM06;J04AM07;J04BA50;J04BA51,Tuberculosis,1,0
PA451250,rifampin,J04AB02;J04AM02;J04AM05;J04AM06;J04AM07;J04BA50;J04BA51,Toxic liver disease,1,0
PA451250,rifampin,J04AB02;J04AM02;J04AM05;J04AM06;J04AM07;J04BA50;J04BA51,Maculopapular Exanthema,1,0
PA451250,rifampin,J04AB02;J04AM02;J04AM05;J04AM06;J04AM07;J04BA50;J04BA51,,1,0
PA166256441,rilonacept,,,0,1
PA166161159,rilpivirine,,,1,0
PA451251,riluzole,N07XX02,,0,1
PA166225041,rimegepant,,,0,1
PA166235322,risdiplam,,,0,1
PA451255,risedronate,M05BA07;M05BB02;M05BB04;M05BB07,Osteitis Deformans,0,1
PA451257,risperidone,N05AX08,Psychotic Disorders,0,1
PA451257,risperidone,N05AX08,Mental Disorders,0,1
PA451257,risperidone,N05AX08,Hyperprolactinemia,0,1
PA451257,risperidone,N05AX08,Metabolic Syndrome,0,1
PA451257,risperidone,N05AX08,Weight gain,0,1
PA451257,risperidone,N05AX08,Depression,0,1
PA451257,risperidone,N05AX08,schizoaffective disorder,0,1
PA451257,risperidone,N05AX08,Substance-Related Disorders,0,1
PA451257,risperidone,N05AX08,Alzheimer Disease,0,1
PA451257,risperidone,N05AX08,Schizophrenia,0,1
PA451257,risperidone,N05AX08,Depressive Disorder,0,1
PA451257,risperidone,N05AX08,Autism Spectrum Disorder,0,1
PA451257,risperidone,N05AX08,Bipolar Disorder,0,1
PA451257,risperidone,N05AX08,Autistic Disorder,0,1
PA451257,risperidone,N05AX08,Mood Disorders,0,1
PA451257,risperidone,N05AX08,,0,1
PA451257,risperidone,N05AX08,Drug Toxicity,0,1
PA451258,ritodrine,G02CA01,,0,1
PA451258,ritodrine,G02CA01,adverse events,0,1
PA451258,ritodrine,G02CA01,Premature Birth,0,1
PA451260,ritonavir,J05AE03;J05AE30;J05AP52;J05AP53;J05AR10;J05AR23;J05AR26,Hypertriglyceridemia,1,0
PA451260,ritonavir,J05AE03;J05AE30;J05AP52;J05AP53;J05AR10;J05AR23;J05AR26,,1,0
PA451260,ritonavir,J05AE03;J05AE30;J05AP52;J05AP53;J05AR10;J05AR23;J05AR26,Hyperbilirubinemia,1,0
PA451260,ritonavir,J05AE03;J05AE30;J05AP52;J05AP53;J05AR10;J05AR23;J05AR26,nephrolithiasis,1,0
PA451260,ritonavir,J05AE03;J05AE30;J05AP52;J05AP53;J05AR10;J05AR23;J05AR26,HIV Infections,1,0
PA451260,ritonavir,J05AE03;J05AE30;J05AP52;J05AP53;J05AR10;J05AR23;J05AR26,Hyperlipidemias,1,0
PA451261,rituximab,L01FA01,"Arthritis, Rheumatoid",0,1
PA451261,rituximab,L01FA01,"Lymphoma, Non-Hodgkin",0,1
PA451261,rituximab,L01FA01,Neuromyelitis Optica,0,1
PA451261,rituximab,L01FA01,"Lupus Erythematosus, Systemic",0,1
PA451261,rituximab,L01FA01,"Lymphoma, Large B-Cell, Diffuse",0,1
PA451261,rituximab,L01FA01,Vasculitis,0,1
PA451261,rituximab,L01FA01,,0,1
PA451261,rituximab,L01FA01,"Leukemia, Lymphocytic, Chronic, B-Cell",0,1
PA165958360,rivaroxaban,,,0,1
PA451262,rivastigmine,N06DA03,,0,1
PA451262,rivastigmine,N06DA03,Lewy Body Disease,0,1
PA451262,rivastigmine,N06DA03,Alzheimer Disease,0,1
PA164754992,rocuronium,M03AC09,,0,1
PA451268,rofecoxib,M01AH02,,0,1
PA166268921,ropeginterferon alfa-2b,,,0,1
PA451271,ropivacaine,N01BB09,,0,1
PA451283,rosiglitazone,A10BD03;A10BD04;A10BG02,Weight gain,0,1
PA451283,rosiglitazone,A10BD03;A10BD04;A10BG02,,0,1
PA451283,rosiglitazone,A10BD03;A10BD04;A10BG02,"Diabetes Mellitus, Type 2",0,1
PA134308647,rosuvastatin,A10BH52;C10AA07;C10BA06;C10BA09;C10BX05;C10BX07;C10BX09;C10BX10;C10BX13;C10BX14;C10BX16;C10BX17;G01AE10,,0,1
PA134308647,rosuvastatin,A10BH52;C10AA07;C10BA06;C10BA09;C10BX05;C10BX07;C10BX09;C10BX10;C10BX13;C10BX14;C10BX16;C10BX17;G01AE10,statin-related myopathy,0,1
PA134308647,rosuvastatin,A10BH52;C10AA07;C10BA06;C10BA09;C10BX05;C10BX07;C10BX09;C10BX10;C10BX13;C10BX14;C10BX16;C10BX17;G01AE10,Coronary Disease,0,1
PA134308647,rosuvastatin,A10BH52;C10AA07;C10BA06;C10BA09;C10BX05;C10BX07;C10BX09;C10BX10;C10BX13;C10BX14;C10BX16;C10BX17;G01AE10,Muscular Diseases,0,1
PA134308647,rosuvastatin,A10BH52;C10AA07;C10BA06;C10BA09;C10BX05;C10BX07;C10BX09;C10BX10;C10BX13;C10BX14;C10BX16;C10BX17;G01AE10,Hypercholesterolemia,0,1
PA134308647,rosuvastatin,A10BH52;C10AA07;C10BA06;C10BA09;C10BX05;C10BX07;C10BX09;C10BX10;C10BX13;C10BX14;C10BX16;C10BX17;G01AE10,Myocardial Infarction,0,1
PA164713242,Rubella vaccines,,,1,0
PA166163418,rucaparib,L01XK03,,0,1
PA165107052,Rupatadine,R06AX28,,0,1
PA166123386,ruxolitinib,D11AH09;L01EJ01,,0,1
PA166177606,S-EDDP,,Opioid-Related Disorders,0,1
PA166177606,S-EDDP,,,0,1
PA166225061,sacituzumab govitecan-hziy,,,0,1
PA166131580,sacubitril,C09DX04,,0,1
PA448068,salbutamol,R03AC02;R03AK04;R03AK13;R03AL02;R03CC02,Asthma,0,1
PA448068,salbutamol,R03AC02;R03AK04;R03AK13;R03AL02;R03CC02,,0,1
PA165958416,salicylamide,,,0,1
PA451300,salmeterol,R03AC12;R03AK06;R03AK12,Asthma,0,1
PA451300,salmeterol,R03AC12;R03AK06;R03AK12,,0,1
PA166128370,salvianolic acid b,,,0,1
PA166128370,salvianolic acid b,,Coronary Disease,0,1
PA451305,saquinavir,J05AE01,,1,0
PA166235323,satralizumab,,,0,1
PA134687887,selective beta-2-adrenoreceptor agonists,,Asthma,0,1
PA134687887,selective beta-2-adrenoreceptor agonists,,,0,1
PA164713257,Selective serotonin reuptake inhibitors,,Mood Disorders,0,1
PA164713257,Selective serotonin reuptake inhibitors,,Depression,0,1
PA164713257,Selective serotonin reuptake inhibitors,,,0,1
PA164713257,Selective serotonin reuptake inhibitors,,Depressive Disorder,0,1
PA164713257,Selective serotonin reuptake inhibitors,,Obsessive-Compulsive Disorder,0,1
PA164713257,Selective serotonin reuptake inhibitors,,ability to concentrate,0,1
PA164713257,Selective serotonin reuptake inhibitors,,Diarrhea,0,1
PA164713257,Selective serotonin reuptake inhibitors,,"Depressive Disorder, Major",0,1
PA164713257,Selective serotonin reuptake inhibitors,,Dizziness,0,1
PA164713257,Selective serotonin reuptake inhibitors,,Tremor,0,1
PA451316,selegiline,N04BD01,,0,1
PA451316,selegiline,N04BD01,Parkinson Disease,0,1
PA166225084,selpercatinib,,,0,1
PA166152901,serotonin,,,0,1
PA164784002,sertindole,N05AE03,,0,1
PA451333,sertraline,N06AB06,"Sexual Dysfunctions, Psychological",0,1
PA451333,sertraline,N06AB06,"Depressive Disorder, Major",0,1
PA451333,sertraline,N06AB06,Depressive Disorder,0,1
PA451333,sertraline,N06AB06,Depression,0,1
PA451333,sertraline,N06AB06,Mental Disorders,0,1
PA451333,sertraline,N06AB06,,0,1
PA166235341,setmelanotide,,,0,1
PA451341,sevoflurane,N01AB08,Malignant Hyperthermia,0,1
PA451341,sevoflurane,N01AB08,Hypotension,0,1
PA451341,sevoflurane,N01AB08,tonsillectomy,0,1
PA451341,sevoflurane,N01AB08,,0,1
PA451344,sibutramine,A08AA10,Obesity,0,1
PA451344,sibutramine,A08AA10,,0,1
PA451346,sildenafil,G01AE10;G04BE03,Erectile Dysfunction,0,1
PA451346,sildenafil,G01AE10;G04BE03,,0,1
PA451346,sildenafil,G01AE10;G04BE03,Heart Failure,0,1
PA166129539,silibinin,A05BA03,,0,1
PA166122590,simeprevir,,,1,0
PA166122590,simeprevir,,Hepatitis C,1,0
PA166122590,simeprevir,,"Hepatitis C, Chronic",1,0
PA451363,simvastatin,A10BH51;C10AA01;C10BA02;C10BA04;C10BX01;C10BX04,statin-related myopathy,0,1
PA451363,simvastatin,A10BH51;C10AA01;C10BA02;C10BA04;C10BX01;C10BX04,Hypercholesterolemia,0,1
PA451363,simvastatin,A10BH51;C10AA01;C10BA02;C10BA04;C10BX01;C10BX04,Chronic Disease,0,1
PA451363,simvastatin,A10BH51;C10AA01;C10BA02;C10BA04;C10BX01;C10BX04,Coronary Disease,0,1
PA451363,simvastatin,A10BH51;C10AA01;C10BA02;C10BA04;C10BX01;C10BX04,Myocardial Ischemia,0,1
PA451363,simvastatin,A10BH51;C10AA01;C10BA02;C10BA04;C10BX01;C10BX04,Cardiovascular Diseases,0,1
PA451363,simvastatin,A10BH51;C10AA01;C10BA02;C10BA04;C10BX01;C10BX04,Hyperlipidemias,0,1
PA451363,simvastatin,A10BH51;C10AA01;C10BA02;C10BA04;C10BX01;C10BX04,Hyperlipoproteinemia Type II,0,1
PA451363,simvastatin,A10BH51;C10AA01;C10BA02;C10BA04;C10BX01;C10BX04,Myalgia unspecified,0,1
PA451363,simvastatin,A10BH51;C10AA01;C10BA02;C10BA04;C10BX01;C10BX04,Muscular Diseases,0,1
PA451363,simvastatin,A10BH51;C10AA01;C10BA02;C10BA04;C10BX01;C10BX04,Myocardial Infarction,0,1
PA451363,simvastatin,A10BH51;C10AA01;C10BA02;C10BA04;C10BX01;C10BX04,adverse events,0,1
PA451363,simvastatin,A10BH51;C10AA01;C10BA02;C10BA04;C10BX01;C10BX04,,0,1
PA166129446,simvastatin acid,,,0,1
PA166114434,sipoglitazar,,,0,1
PA166182736,siponimod,,,0,1
PA451365,sirolimus,L01EG04;L04AA10;S01XA23,adverse events,0,1
PA451365,sirolimus,L01EG04;L04AA10;S01XA23,gastrointestinal toxicity,0,1
PA451365,sirolimus,L01EG04;L04AA10;S01XA23,Myelosuppression,0,1
PA451365,sirolimus,L01EG04;L04AA10;S01XA23,Urinary Bladder Neoplasms,0,1
PA451365,sirolimus,L01EG04;L04AA10;S01XA23,Kidney Transplantation,0,1
PA451365,sirolimus,L01EG04;L04AA10;S01XA23,hematopoietic stem cell transplantation,0,1
PA451365,sirolimus,L01EG04;L04AA10;S01XA23,,0,1
PA451365,sirolimus,L01EG04;L04AA10;S01XA23,liver transplantation,0,1
PA451365,sirolimus,L01EG04;L04AA10;S01XA23,Transplantation,0,1
PA164748978,sitagliptin,A10BD07;A10BD12;A10BD24;A10BH01;A10BH51,,0,1
PA164748978,sitagliptin,A10BD07;A10BD12;A10BD24;A10BH01;A10BH51,"Diabetes Mellitus, Type 2",0,1
PA165110775,SN-38,,,0,1
PA165110775,SN-38,,"Carcinoma, Non-Small-Cell Lung",0,1
PA165110775,SN-38,,Colorectal Neoplasms,0,1
PA166176020,sodium benzoate / sodium phenylacetate,,,0,1
PA166115361,sodium nitrite,V03AB08,,0,1
PA166236501,sodium oxybate,,,0,1
PA166114316,sodium phenylbutyrate,,,0,1
PA166122593,sofosbuvir,J05AP08;J05AP51;J05AP55;J05AP56,"Hepatitis C, Chronic",1,0
PA166122593,sofosbuvir,J05AP08;J05AP51;J05AP55;J05AP56,Recurrence,1,0
PA166122593,sofosbuvir,J05AP08;J05AP51;J05AP55;J05AP56,,1,0
PA166163416,sofosbuvir / velpatasvir,,,1,0
PA166177517,sofosbuvir / velpatasvir / voxilaprevir,,,1,0
PA451446,somatropin recombinant,H01AC01,,0,1
PA451446,somatropin recombinant,H01AC01,Turner Syndrome,0,1
PA7000,sorafenib,L01EX02,Drug Toxicity,0,1
PA7000,sorafenib,L01EX02,Hyperbilirubinemia,0,1
PA7000,sorafenib,L01EX02,"Carcinoma, Renal Cell",0,1
PA7000,sorafenib,L01EX02,Diarrhea,0,1
PA7000,sorafenib,L01EX02,Neoplasms,0,1
PA7000,sorafenib,L01EX02,Exanthema,0,1
PA7000,sorafenib,L01EX02,Hepatitis C,0,1
PA7000,sorafenib,L01EX02,Liver Neoplasms,0,1
PA7000,sorafenib,L01EX02,,0,1
PA7000,sorafenib,L01EX02,hand-foot syndrome,0,1
PA7000,sorafenib,L01EX02,Thrombocytopenia,0,1
PA7000,sorafenib,L01EX02,Hypertension,0,1
PA7000,sorafenib,L01EX02,"Carcinoma, Hepatocellular",0,1
PA451457,sotalol,C07AA07;C07BA07;C07FX02,,0,1
PA166246441,sotorasib,,,0,1
PA452610,sparteine,C01BA04,,0,1
PA451483,spironolactone,C03DA01,Heart Failure,0,1
PA451483,spironolactone,C03DA01,Hypertension,0,1
PA451483,spironolactone,C03DA01,,0,1
PA451483,spironolactone,C03DA01,Liver Cirrhosis,0,1
PA451494,stavudine,J05AF04;J05AR07,Peripheral Nervous System Diseases,1,0
PA451494,stavudine,J05AF04;J05AR07,,1,0
PA451494,stavudine,J05AF04;J05AR07,HIV Infections,1,0
PA451512,streptomycin,A07AA04;A07AA54;J01GA01;J04AM01,Tuberculosis,1,0
PA451512,streptomycin,A07AA04;A07AA54;J01GA01;J04AM01,,1,0
PA451512,streptomycin,A07AA04;A07AA54;J01GA01;J04AM01,Ototoxicity,1,0
C081587,Strontium ranelate,,,0,1
PA451521,succimer,,,0,1
PA451522,succinylcholine,M03AB01,Apnea,0,1
PA451522,succinylcholine,M03AB01,,0,1
PA451522,succinylcholine,M03AB01,Malignant Hyperthermia,0,1
PA451522,succinylcholine,M03AB01,postanesthesia apnea,0,1
PA451527,sufentanil,N01AH03,,0,1
PA451527,sufentanil,N01AH03,Respiratory Insufficiency,0,1
PA451527,sufentanil,N01AH03,adverse events,0,1
PA451527,sufentanil,N01AH03,"Pain, Postoperative",0,1
PA451527,sufentanil,N01AH03,Pain,0,1
PA451539,sulfadiazine,G01AE10;J01EC02;J01EE02;J01EE06,,1,0
PA451540,sulfadoxine,G01AE10;P01BF09,Hemolysis,1,0
PA451540,sulfadoxine,G01AE10;P01BF09,"Malaria, Falciparum",1,0
PA451540,sulfadoxine,G01AE10;P01BF09,,1,0
PA451540,sulfadoxine,G01AE10;P01BF09,Malaria,1,0
PA451544,sulfamethoxazole,G01AE10;J01EC01;J01EE01;J04AM08,Hemolysis,1,0
PA451544,sulfamethoxazole,G01AE10;J01EC01;J01EE01;J04AM08,,1,0
PA451544,sulfamethoxazole,G01AE10;J01EC01;J01EE01;J04AM08,HIV Infections,1,0
PA10715,sulfamethoxazole / trimethoprim,,,0,1
PA10715,sulfamethoxazole / trimethoprim,,Hypersensitivity,0,1
PA10715,sulfamethoxazole / trimethoprim,,adverse events,0,1
PA10715,sulfamethoxazole / trimethoprim,,severe cutaneous adverse reactions,0,1
PA10715,sulfamethoxazole / trimethoprim,,"Anemia, Hemolytic",0,1
PA10715,sulfamethoxazole / trimethoprim,,Stevens-Johnson Syndrome,0,1
PA10715,sulfamethoxazole / trimethoprim,,"Epidermal Necrolysis, Toxic",0,1
PA10715,sulfamethoxazole / trimethoprim,,Hemolysis,0,1
PA10715,sulfamethoxazole / trimethoprim,,Acquired Immunodeficiency Syndrome,0,1
PA10715,sulfamethoxazole / trimethoprim,,Respiratory Insufficiency,0,1
PA164747038,sulfametopyrazine,G01AE10;J01ED02;P01BF04,Hemolysis,1,0
PA451545,sulfanilamide,D06BA05;G01AE10;J01EB06,,1,0
PA164779050,sulfapyridine,G01AE10;J01EB04,,1,0
PA451547,sulfasalazine,A07EC01;G01AE10,Hemolysis,0,1
PA451547,sulfasalazine,A07EC01;G01AE10,,0,1
PA451547,sulfasalazine,A07EC01;G01AE10,drug reaction with eosinophilia and systemic symptoms,0,1
PA451547,sulfasalazine,A07EC01;G01AE10,"Arthritis, Rheumatoid",0,1
PA451550,sulfinpyrazone,M04AB02,,0,1
PA10390,"sulfonamides, urea derivatives",,,0,1
PA10390,"sulfonamides, urea derivatives",,"Diabetes Mellitus, Type 2",0,1
PA10390,"sulfonamides, urea derivatives",,Diabetes Mellitus,0,1
PA451565,sulindac,M01AB02,,0,1
PA451566,sumatriptan,G01AE10;N02CC01,Cluster Headache,0,1
PA451566,sumatriptan,G01AE10;N02CC01,,0,1
PA451566,sumatriptan,G01AE10;N02CC01,Substance Withdrawal Syndrome,0,1
PA162372840,sunitinib,L01EX01,Neoplasms,0,1
PA162372840,sunitinib,L01EX01,Thrombocytopenia,0,1
PA162372840,sunitinib,L01EX01,,0,1
PA162372840,sunitinib,L01EX01,Myelosuppression,0,1
PA162372840,sunitinib,L01EX01,"Carcinoma, Renal Cell",0,1
PA162372840,sunitinib,L01EX01,Neutropenia,0,1
PA162372840,sunitinib,L01EX01,Gastrointestinal Stromal Tumors,0,1
PA162372840,sunitinib,L01EX01,Leukopenia,0,1
PA164713301,Sympathomimetics,,,0,1
PA164713301,Sympathomimetics,,Overdose,0,1
PA164713301,Sympathomimetics,,Respiratory Insufficiency,0,1
PA164713301,Sympathomimetics,,Heart Arrest,0,1
PA166238763,"synthetic conjugated estrogens, A",,,0,1
PA451578,tacrolimus,D11AH01;L04AD02,transplant rejection,0,1
PA451578,tacrolimus,D11AH01;L04AD02,"Diabetes Mellitus, Type 2",0,1
PA451578,tacrolimus,D11AH01;L04AD02,Gastroesophageal Reflux,0,1
PA451578,tacrolimus,D11AH01;L04AD02,,0,1
PA451578,tacrolimus,D11AH01;L04AD02,hematopoietic stem cell transplantation,0,1
PA451578,tacrolimus,D11AH01;L04AD02,hemopoietic stem cell transplant,0,1
PA451578,tacrolimus,D11AH01;L04AD02,Kidney Failure,0,1
PA451578,tacrolimus,D11AH01;L04AD02,heart transplantation,0,1
PA451578,tacrolimus,D11AH01;L04AD02,Organ Transplantation,0,1
PA451578,tacrolimus,D11AH01;L04AD02,"Colitis, Ulcerative",0,1
PA451578,tacrolimus,D11AH01;L04AD02,Proteinuria,0,1
PA451578,tacrolimus,D11AH01;L04AD02,liver transplantation,0,1
PA451578,tacrolimus,D11AH01;L04AD02,nephrotoxicity,0,1
PA451578,tacrolimus,D11AH01;L04AD02,Neurotoxicity Syndromes,0,1
PA451578,tacrolimus,D11AH01;L04AD02,Hyperlipidemias,0,1
PA451578,tacrolimus,D11AH01;L04AD02,Kidney Transplantation,0,1
PA451578,tacrolimus,D11AH01;L04AD02,Toxic liver disease,0,1
PA451578,tacrolimus,D11AH01;L04AD02,Transplantation,0,1
PA451578,tacrolimus,D11AH01;L04AD02,laparoscopic sleeve gastrectomy,0,1
PA451578,tacrolimus,D11AH01;L04AD02,Nephrotic Syndrome,0,1
PA451578,tacrolimus,D11AH01;L04AD02,Hypertension,0,1
PA451578,tacrolimus,D11AH01;L04AD02,lung transplantation,0,1
PA451578,tacrolimus,D11AH01;L04AD02,Infection,0,1
PA166184562,tafamidis,,,0,1
PA166115580,tafenoquine,P01BA07,,1,0
PA166115580,tafenoquine,P01BA07,Malaria,1,0
PA166182740,talazoparib,,,0,1
PA146123005,talinolol,,,0,1
PA451581,tamoxifen,L02BA01,Breast Neoplasms,0,1
PA451581,tamoxifen,L02BA01,Menopause,0,1
PA451581,tamoxifen,L02BA01,,0,1
PA166131338,tamoxifen-n-glucuronide,,,0,1
PA451583,tamsulosin,G01AE10;G04CA02;G04CA52;G04CA53;G04CA54,,0,1
PA166179720,tapentadol,N02AX06,,0,1
PA150481189,taxanes,,Breast Neoplasms,0,1
PA150481189,taxanes,,Peripheral Nervous System Diseases,0,1
PA150481189,taxanes,,,0,1
PA150481189,taxanes,,Ovarian Neoplasms,0,1
PA166277741,tebentafusp,,,0,1
PA452620,tegafur,,Neoplasms,0,1
PA452620,tegafur,,,0,1
PA452620,tegafur,,Drug Toxicity,0,1
PA452620,tegafur,,Colorectal Neoplasms,0,1
PA166115442,tegafur / gimeracil / oteracil,,,0,1
PA166115442,tegafur / gimeracil / oteracil,,Colorectal Neoplasms,0,1
PA165958354,telaprevir,J05AP02,,1,0
PA165958354,telaprevir,J05AP02,"Hepatitis C, Chronic",1,0
PA165958354,telaprevir,J05AP02,Hepatitis C,1,0
PA10202,telithromycin,J01FA15,,1,0
PA451605,telmisartan,C09CA07;C09DA07;C09DB04;C09DX08,,0,1
PA451605,telmisartan,C09CA07;C09DA07;C09DB04;C09DX08,Essential hypertension,0,1
PA451609,temozolomide,L01AX03,Glioma,0,1
PA451609,temozolomide,L01AX03,,0,1
PA164746890,temsirolimus,L01EG01,Kidney Transplantation,0,1
PA164746890,temsirolimus,L01EG01,hematopoietic stem cell transplantation,0,1
PA164746890,temsirolimus,L01EG01,,0,1
PA164746890,temsirolimus,L01EG01,Myelosuppression,0,1
PA164746890,temsirolimus,L01EG01,adverse events,0,1
PA164746890,temsirolimus,L01EG01,Urinary Bladder Neoplasms,0,1
PA164746890,temsirolimus,L01EG01,gastrointestinal toxicity,0,1
PA166249401,teneligliptin,,,0,1
PA10204,tenofovir,J05AF07;J05AR03;J05AR06;J05AR08;J05AR09;J05AR11;J05AR12;J05AR24;J05AR27,Kidney Diseases,1,0
PA10204,tenofovir,J05AF07;J05AR03;J05AR06;J05AR08;J05AR09;J05AR11;J05AR12;J05AR24;J05AR27,HIV Infections,1,0
PA10204,tenofovir,J05AF07;J05AR03;J05AR06;J05AR08;J05AR09;J05AR11;J05AR12;J05AR24;J05AR27,Fanconi Syndrome,1,0
PA10204,tenofovir,J05AF07;J05AR03;J05AR06;J05AR08;J05AR09;J05AR11;J05AR12;J05AR24;J05AR27,,1,0
C442442,Tenofovir alafenamide,,,1,0
PA166258723,tenofovir alafenamide,,,1,0
PA166201941,tenofovir disoproxil fumarate,,,1,0
PA166201941,tenofovir disoproxil fumarate,,nephrotoxicity,1,0
PA166201941,tenofovir disoproxil fumarate,,HIV Infections,1,0
PA131890625,tenoxicam,M01AC02,,0,1
PA166211181,tepotinib,,,0,1
PA451614,terbinafine,D01AE15;D01BA02,,0,1
PA451616,terbutaline,R03AC03;R03CC03;R03CC53,,0,1
C527525,Teriflunomide,,,0,1
PA451627,testosterone,G03BA03;G03EA02,,0,1
C010792,Testosterone undecanoate,,,0,1
PA451632,tetanus antitoxin,,,1,0
PA140222719,tetrabenazine,N07XX06,,0,1
PA166175754,tezacaftor,,Cystic Fibrosis,0,1
PA166175754,tezacaftor,,,0,1
PA451644,thalidomide,L04AX02,Prostatic Neoplasms,0,1
PA451644,thalidomide,L04AX02,Multiple Myeloma,0,1
PA451644,thalidomide,L04AX02,,0,1
PA451647,theophylline,R03DA04;R03DA20;R03DA54;R03DA74;R03DB04,,0,1
PA164713347,"Thiazides, plain",,Hypertension,0,1
PA164713347,"Thiazides, plain",,Essential hypertension,0,1
PA164713347,"Thiazides, plain",,,0,1
PA164713347,"Thiazides, plain",,Hypernatremia,0,1
PA164713347,"Thiazides, plain",,Diabetes Mellitus,0,1
PA452631,thiazolidinediones,,,0,1
PA452631,thiazolidinediones,,"Diabetes Mellitus, Type 2",0,1
PA451663,thioguanine,L01BB03,Crohn Disease,0,1
PA451663,thioguanine,L01BB03,Thrombocytopenia,0,1
PA451663,thioguanine,L01BB03,Neutropenia,0,1
PA451663,thioguanine,L01BB03,Inflammatory Bowel Diseases,0,1
PA451663,thioguanine,L01BB03,Osteonecrosis,0,1
PA451663,thioguanine,L01BB03,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0,1
PA451663,thioguanine,L01BB03,,0,1
PA451663,thioguanine,L01BB03,Myelosuppression,0,1
PA166160632,thioguanosine diphosphate,,,0,1
PA166160623,thioguanosine monophosphate,,,0,1
PA166160633,thioguanosine triphosphate,,,0,1
PA451666,thioridazine,N05AC02,Schizophrenia,0,1
PA451666,thioridazine,N05AC02,,0,1
PA451668,thiotepa,L01AC01,Neoplasms,0,1
PA451668,thiotepa,L01AC01,,0,1
PA164746560,thyrotropin alfa,H01AB01,Ovarian hyperstimulation syndrome,0,1
PA164746560,thyrotropin alfa,H01AB01,,0,1
PA164746560,thyrotropin alfa,H01AB01,"Infertility, Female",0,1
PA166186040,tianeptine,,"Depressive Disorder, Major",0,1
PA166186040,tianeptine,,suicidal ideation,0,1
PA166186040,tianeptine,,,0,1
PA165374673,ticagrelor,B01AC24,,0,1
PA165374673,ticagrelor,B01AC24,Acute coronary syndrome,0,1
PA451686,ticlopidine,B01AC05,,0,1
PA451686,ticlopidine,B01AC05,Toxic liver disease,0,1
PA164746412,tigecycline,J01AA12;J01AA20,,1,0
PA166212682,tilidine,,,0,1
PA451688,tiludronate,M05BA05,Osteitis Deformans,0,1
PA451690,timolol,C07AA06;C07BA06;C07DA06;S01ED01;S01ED51,,0,1
PA451690,timolol,C07AA06;C07BA06;C07DA06;S01ED01;S01ED51,Bradycardia,0,1
PA164769056,tiotropium,R03AL06;R03AL10;R03BB04;R03BB54,,0,1
PA164769056,tiotropium,R03AL06;R03AL10;R03BB04;R03BB54,Asthma,0,1
PA165110778,tipifarnib,,,0,1
PA165110778,tipifarnib,,Neoplasms,0,1
PA166184566,tipiracil / trifluridine,,,0,1
PA166171170,tipiracil hydrochloride,,Colorectal Neoplasms,0,1
PA166171170,tipiracil hydrochloride,,,0,1
PA163522473,tipranavir,J05AE09,,1,0
PA451704,tobramycin,J01GB01;S01AA12,Ototoxicity,1,0
PA165292659,tocilizumab,L04AC07,,0,1
PA165292659,tocilizumab,L04AC07,"Arthritis, Rheumatoid",0,1
PA164774902,tolazamide,A10BB05;G01AE10,,0,1
PA451718,tolbutamide,A10BB03;G01AE10;V04CA01,,0,1
PA451720,tolcapone,N04BX01,,0,1
PA166152940,tolperisone,,,0,1
PA164746757,tolterodine,G04BD07,,0,1
D000077602,Tolvaptan,,,0,1
PA451728,topiramate,A08AA51;N03AX11,,0,1
PA451728,topiramate,A08AA51;N03AX11,Alcohol-Related Disorders,0,1
PA451728,topiramate,A08AA51;N03AX11,Epilepsy,0,1
PA150481186,topoisomerase I inhibitors,,Neoplasms,0,1
PA451729,topotecan,L01CE01,,0,1
PA451729,topotecan,L01CE01,Brain Neoplasms,0,1
PA451733,torasemide,C03CA04;G01AE10,,0,1
PA451731,toremifene,L02BA02,,0,1
PA451735,tramadol,N02AJ13;N02AJ14;N02AJ16;N02AX02,,0,1
PA451735,tramadol,N02AJ13;N02AJ14;N02AJ16;N02AX02,Opioid-Related Disorders,0,1
PA451735,tramadol,N02AJ13;N02AJ14;N02AJ16;N02AX02,Respiratory Insufficiency,0,1
PA451735,tramadol,N02AJ13;N02AJ14;N02AJ16;N02AX02,neuropathic pain,0,1
PA451735,tramadol,N02AJ13;N02AJ14;N02AJ16;N02AX02,cardiotoxicity,0,1
PA451735,tramadol,N02AJ13;N02AJ14;N02AJ16;N02AX02,"Pain, Postoperative",0,1
PA451735,tramadol,N02AJ13;N02AJ14;N02AJ16;N02AX02,adverse events,0,1
PA451735,tramadol,N02AJ13;N02AJ14;N02AJ16;N02AX02,"Fractures, Bone",0,1
PA451735,tramadol,N02AJ13;N02AJ14;N02AJ16;N02AX02,"Sexual Dysfunctions, Psychological",0,1
PA451735,tramadol,N02AJ13;N02AJ14;N02AJ16;N02AX02,Pain,0,1
PA451735,tramadol,N02AJ13;N02AJ14;N02AJ16;N02AX02,Exanthema,0,1
PA166115364,trametinib,L01EE01,,0,1
PA451737,trandolapril,C09AA10;C09BB10,,0,1
PA451737,trandolapril,C09AA10;C09BB10,Hypertension,0,1
PA131890628,tranilast,,,0,1
PA131890628,tranilast,,Hyperbilirubinemia,0,1
PA451743,trastuzumab,L01FD01;L01XY02,Drug Toxicity,0,1
PA451743,trastuzumab,L01FD01;L01XY02,,0,1
PA451743,trastuzumab,L01FD01;L01XY02,Breast Neoplasms,0,1
PA451743,trastuzumab,L01FD01;L01XY02,Amenorrhea,0,1
PA166190621,trastuzumab deruxtecan,,,0,1
PA165958441,trastuzumab emtansine,,,0,1
PA451744,trazodone,N06AX05,,0,1
PA451746,tretinoin,,,0,1
PA451749,triamcinolone,A01AC01;C05AA12;D07AB09;D07BB03;D07CB01;D07XB02;H02AB08;R01AD11;R03BA06;S01BA05;S02CA04,Asthma,0,1
PA451749,triamcinolone,A01AC01;C05AA12;D07AB09;D07BB03;D07CB01;D07XB02;H02AB08;R01AD11;R03BA06;S01BA05;S02CA04,Retinal Diseases,0,1
PA451749,triamcinolone,A01AC01;C05AA12;D07AB09;D07BB03;D07CB01;D07XB02;H02AB08;R01AD11;R03BA06;S01BA05;S02CA04,,0,1
PA166115521,trichloroethylene,N01AB05,,0,1
PA166115521,trichloroethylene,N01AB05,Drug Hypersensitivity,0,1
PA451771,trifluoperazine,N05AB06,Schizophrenia,0,1
PA451771,trifluoperazine,N05AB06,,0,1
PA451775,trifluridine,L01BC59;S01AD02,Colorectal Neoplasms,0,1
PA451775,trifluridine,L01BC59;S01AD02,,0,1
PA451776,triglycerides,,,0,1
PA451776,triglycerides,,Menopause,0,1
PA451776,triglycerides,,Breast Neoplasms,0,1
PA451791,trimipramine,N06AA06,Mental Disorders,0,1
PA451791,trimipramine,N06AA06,,0,1
PA451799,troglitazone,A10BG01,"Diabetes Mellitus, Type 2",0,1
PA451799,troglitazone,A10BG01,,0,1
PA161925594,tropisetron,,,0,1
PA161925594,tropisetron,,Vomiting,0,1
PA166225141,tucatinib,,,0,1
PA164713366,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,"Spondylitis, Ankylosing",0,1
PA164713366,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,0,1
PA164713366,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,"Arthritis, Rheumatoid",0,1
PA164713366,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,Inflammatory Bowel Diseases,0,1
PA164713366,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,"Arthritis, Psoriatic",0,1
PA164713366,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,Psoriasis,0,1
PA164713366,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,"Colitis, Ulcerative",0,1
PA164713366,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,Arthritis,0,1
PA164713366,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,Crohn Disease,0,1
PA166208561,ulinastatin,,,0,1
PA166177519,umeclidinium,,,0,1
PA166184235,umeclidinium / vilanterol,,,0,1
PA166189803,upadacitinib,,,0,1
PA166178378,uric acid,,,0,1
PA451835,urofollitropin,G03GA04,"Infertility, Female",0,1
PA451835,urofollitropin,G03GA04,Ovarian hyperstimulation syndrome,0,1
PA451835,urofollitropin,G03GA04,,0,1
PA451837,ursodeoxycholic acid,A05AA02,,0,1
PA166048654,ustekinumab,,,0,1
PA166048654,ustekinumab,,Psoriasis,0,1
PA166170051,valbenazine,,,0,1
PA10227,valganciclovir,J05AB14,Kidney Transplantation,1,0
PA10227,valganciclovir,J05AB14,,1,0
PA451846,valproic acid,N03AG01,schizoaffective disorder,0,1
PA451846,valproic acid,N03AG01,Psychotic Disorders,0,1
PA451846,valproic acid,N03AG01,,0,1
PA451846,valproic acid,N03AG01,Depressive Disorder,0,1
PA451846,valproic acid,N03AG01,Bipolar Disorder,0,1
PA451846,valproic acid,N03AG01,Toxic liver disease,0,1
PA451846,valproic acid,N03AG01,Epilepsy,0,1
PA451850,vancomycin,A07AA09;J01XA01;S01AA28,drug reaction with eosinophilia and systemic symptoms,1,0
PA451850,vancomycin,A07AA09;J01XA01;S01AA28,,1,0
PA166118341,vandetanib,L01EX04,,0,1
PA10229,vardenafil,G04BE09,,0,1
PA164781343,varenicline,N07BA03;S01XA28,,0,1
PA164781343,varenicline,N07BA03;S01XA28,Tobacco Use Disorder,0,1
PA166115366,velaglucerase alfa,,,0,1
PA166163415,velpatasvir,J05AP55;J05AP56,,1,0
PA166163415,velpatasvir,J05AP55;J05AP56,"Hepatitis C, Chronic",1,0
PA165946873,vemurafenib,G01AE10;L01EC01,,0,1
PA166153473,venetoclax,L01XX52,,0,1
PA451866,venlafaxine,N06AX16,Edema,0,1
PA451866,venlafaxine,N06AX16,Anxiety Disorders,0,1
PA451866,venlafaxine,N06AX16,Drug Toxicity,0,1
PA451866,venlafaxine,N06AX16,"Depressive Disorder, Major",0,1
PA451866,venlafaxine,N06AX16,Narcolepsy,0,1
PA451866,venlafaxine,N06AX16,,0,1
PA451866,venlafaxine,N06AX16,cardiotoxicity,0,1
PA451866,venlafaxine,N06AX16,Alcohol-Related Disorders,0,1
PA451866,venlafaxine,N06AX16,Depressive Disorder,0,1
PA451866,venlafaxine,N06AX16,agitation,0,1
PA451866,venlafaxine,N06AX16,Nausea,0,1
PA451866,venlafaxine,N06AX16,dysphoria,0,1
PA451866,venlafaxine,N06AX16,Tachycardia,0,1
PA451866,venlafaxine,N06AX16,Obsessive-Compulsive Disorder,0,1
PA451866,venlafaxine,N06AX16,Vomiting,0,1
PA451866,venlafaxine,N06AX16,Depression,0,1
PA451868,verapamil,C08DA01;C08DA51;C09BB10,Coronary Artery Disease,0,1
PA451868,verapamil,C08DA01;C08DA51;C09BB10,Hypertension,0,1
PA451868,verapamil,C08DA01;C08DA51;C09BB10,Acquired Long QT Syndrome (aLQTS),0,1
PA451868,verapamil,C08DA01;C08DA51;C09BB10,,0,1
PA451868,verapamil,C08DA01;C08DA51;C09BB10,Diabetes Mellitus,0,1
PA166184233,vernakalant,,,0,1
PA451871,verteporfin,S01LA01,,0,1
PA165958346,vildagliptin,A10BD08;A10BH02,,0,1
PA165958346,vildagliptin,A10BD08;A10BH02,"Diabetes Mellitus, Type 2",0,1
PA166251581,viloxazine,,,0,1
PA166236421,viltolarsen,,,0,1
PA451877,vinblastine,L01CA01,,0,1
PA451879,vincristine,L01CA02,Osteosarcoma,0,1
PA451879,vincristine,L01CA02,"Lymphoma, Non-Hodgkin",0,1
PA451879,vincristine,L01CA02,"Leukemia, Lymphocytic, Chronic, B-Cell",0,1
PA451879,vincristine,L01CA02,Osteonecrosis,0,1
PA451879,vincristine,L01CA02,"Lymphoma, Large B-Cell, Diffuse",0,1
PA451879,vincristine,L01CA02,,0,1
PA451879,vincristine,L01CA02,Neurotoxicity Syndromes,0,1
PA451879,vincristine,L01CA02,Drug Toxicity,0,1
PA451879,vincristine,L01CA02,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0,1
PA451879,vincristine,L01CA02,Multiple Myeloma,0,1
PA10232,vindesine,L01CA03,,0,1
PA10232,vindesine,L01CA03,"Lymphoma, Non-Hodgkin",0,1
PA451881,vinorelbine,L01CA04,"Carcinoma, Non-Small-Cell Lung",0,1
PA451881,vinorelbine,L01CA04,,0,1
PA164713397,Vitamin B-complex with vitamin C,,,0,1
PA164713398,"Vitamin B-complex, Incl. Combinations",,"Depressive Disorder, Major",0,1
PA164713398,"Vitamin B-complex, Incl. Combinations",,,0,1
PA10505,"vitamin b-complex, plain",,Migraine with Aura,0,1
PA10505,"vitamin b-complex, plain",,,0,1
PA451898,vitamin c,A11GA01;A11GB01;G01AD03;S01XA15,,0,1
PA451900,vitamin e,,,0,1
PA164713404,Vitamin K,,,0,1
PA164713406,Vitamin K antagonists,,,0,1
PA166197681,Vitamin K1,,,0,1
PA166131630,volatile anesthetics,,,0,1
PA166131630,volatile anesthetics,,Malignant Hyperthermia,0,1
PA10233,voriconazole,J02AC03,Mycoses,1,0
PA10233,voriconazole,J02AC03,,1,0
PA166122595,vortioxetine,N06AX26,,0,1
PA166189802,voxelotor,,,0,1
PA166171182,voxilaprevir,,,1,0
PA166171182,voxilaprevir,,"Hepatitis C, Chronic",1,0
PA166277621,vutrisiran,,,0,1
PA451906,warfarin,B01AA03,over-anticoagulation,0,1
PA451906,warfarin,B01AA03,Cardiovascular Diseases,0,1
PA451906,warfarin,B01AA03,time in therapeutic range,0,1
PA451906,warfarin,B01AA03,,0,1
PA451906,warfarin,B01AA03,time to therapeutic inr,0,1
PA451906,warfarin,B01AA03,Thrombosis,0,1
PA451906,warfarin,B01AA03,Hemorrhage,0,1
PA451906,warfarin,B01AA03,Atrial Fibrillation,0,1
PA451906,warfarin,B01AA03,heart valve replacement,0,1
PA451906,warfarin,B01AA03,venous thromboembolism,0,1
PA166182864,XELOX,,,0,1
PA166114484,XK469,,,0,1
PA451949,zafirlukast,R03DC01,,0,1
PA166204001,zanubrutinib,,,0,1
PA451954,zidovudine,J05AF01;J05AR01;J05AR04;J05AR05,HIV Infections,1,0
PA451954,zidovudine,J05AF01;J05AR01;J05AR04;J05AR05,,1,0
PA166184503,zidovudine / lamivudine / abacavir,,,1,0
PA451955,zileuton,,Asthma,0,1
PA451955,zileuton,,,0,1
PA451961,zinc acetate,,,0,1
PA451974,ziprasidone,N05AE04,,0,1
PA451974,ziprasidone,N05AE04,Schizophrenia,0,1
PA10235,zoledronate,M05BA08;M05BB08,,0,1
PA10235,zoledronate,M05BA08;M05BB08,Multiple Myeloma,0,1
PA10235,zoledronate,M05BA08;M05BB08,Amenorrhea,0,1
PA10235,zoledronate,M05BA08;M05BB08,Osteonecrosis,0,1
PA10235,zoledronate,M05BA08;M05BB08,Neoplasms,0,1
PA451976,zolpidem,N05CF02,,0,1
PA451978,zonisamide,G01AE10;N03AX15,Stevens-Johnson Syndrome,0,1
PA451978,zonisamide,G01AE10;N03AX15,,0,1
PA451978,zonisamide,G01AE10;N03AX15,"Epidermal Necrolysis, Toxic",0,1
PA452629,zuclopenthixol,N05AF05,,0,1
PA452629,zuclopenthixol,N05AF05,Schizophrenia,0,1